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ABSTRACT
EVALUATING THE ROLE OF THE STRINGENT RESPONSE IN CLOSTRIDIOIDES
DIFFICILE SURVIVAL AND PATHOGENESIS
Astha Pokhrel
Old Dominion University, 2021
Director: Dr. Erin B. Purcell

The human pathogen Clostridioides difficile is increasingly tolerant of multiple antibiotics
and causes infections with a high rate of recurrence, creating an urgent need for new
preventive and therapeutic strategies. The stringent response, a universal bacterial
response to extracellular stresses, governs antibiotic survival and pathogenesis in diverse
organisms but has not previously been characterized in C. difficile. This dissertation
explores the ability of C. difficile to mount the stringent response. The bacteria encode a
full-length, canonical bifunctional Rel/Spo Homolog or RSH enzyme. C. difficile RSH is
incapable of utilizing GTP as a substrate but readily synthesizes putative 5’-pGpp-3’
alarmones. Transcription of rsh is stimulated by bacterial stationary phase onset, nutrient
limitation, and exposure to the antibiotics clindamycin and metronidazole. Transcriptional
suppression of rsh increases bacterial antibiotic susceptibility, suggesting that RSH
contributes to bacterial antibiotic tolerance and survival. Chemical inhibition of RSH by the
5’-ppGpp-3’ analog Relacin similarly increases antibiotic susceptibility in epidemic C.
difficile, indicating that RSH inhibitors are a viable strategy for drug development against
Clostridioides difficile infection. Finally, mechanisms contributing to C. difficile host
colonization and aspects of bacterial behavior during infection remain unclear. Therefore,
this dissertation also explores nutrient-derived motility regulation of the pathogen during
host intestinal mucus colonization. An epidemic C. difficile strain suppresses motility in the
presence of high unchained N-acetylneuraminic acid, an intestinal mucus component. The
observed motility suppression is independent of bacterial tumbling but robust singlespecies biofilm formation by R20291 and motility suppression in response to high NEU5A
concentration may be regulated by the same signaling network(s).
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NOMENCLATURE

Abbreviations

Full forms/ definitions

CDI

Clostridioides difficile infection

CDC

Centers for Disease Control and Prevention

CA-CDI

Community acquired Clostridioides difficile infection

PaLoc

Pathogenicity locus

TcdA

Toxin A

TcdB

Toxin B

RT027

Ribotype 027

CdtLoc

Clostridioides difficile transferase locus

CDT

Clostridioides difficile transferase

IDSA

Infectious Diseases Society of America

SHEA

Society for Healthcare Epidemiology of America

rCDI

Recurrent Clostridioides difficile infection

FMT

Fecal microbiota transplantation

FDA

Food and Drug Administration

T3SS

Type III Secretion System

GlcNAc

N-acetylglucosamine

PTM

Post-translational modification

TFP

Type IV Pili

c-di-GMP

Cyclic diguanylate

ECM

Extracellular matrix

SLPs

S-layer proteins

FESEM

Field scanning electron microscopy

CLSM

Confocal laser scanning microscopy

SR

Stringent response

GMP

Guanosine-5’-monophosphate

GDP

Guanosine-5’-diphosphate

GTP

Guanosine-5’-triphosphate
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ADP

Adenosine-5’-diphosphate

ppGpp

GDP-3’-diphosphate / gaunoisne tetraphosphate

pppGpp

GTP-3’-diphosphate / guanosine pentaphosphate

pGpp

GMP-3’-diphosphate

RSH

RelA/SpoT homolog

SAS

Small alarmone synthetase

SAH

Small alarmone hydrolase

HD

Hydrolase domain

SD

Synthetase domain

NTD

N-terminal domain

CTD

C-terminal domain

TGS

ThrRS, GTPase, and SpoT

ACT

Aspartate kinase, chorismate, and TyrA

GXP

GMP, GDP or GTP substrate

GppA

Guanosine pentaphosphate phosphohydrolase

NuDiX

Nucleoside diphosphate linked moiety X

RNAP

RNA polymerase

rRNA

Ribosomal RNA

30SIC

30S initiation complex

70SIC

70S initiation complex

IF2

Initiation factor 2

RF

Release factor

SETI

Structured enhancer of translational initiation

SPI-1

Salmonella pathogenicity island 1

TCP

Toxin-regulated pilus

SHX

Serine hydroxamate

NMR

Nuclear magnetic resonance spectroscopy

PPi

Inorganic pyrophosphate

Pi

Inorganic phosphate

(pp)pGpp

ppGpp, pppGpp, and pGpp

TLC

Thin layer chromatography

ix

PEI-cellulose

Polyethyleneimine-cellulose

HPLC

High-performance liquid chromatography

Std

Standard

ITC

Isothermal titration calorimetry

Magic spot

Product catalyzed by RSH enzymes

Kbp

Kilo base pair

hrs / hr

Hours

KDa

Kilo dalton

MWCO

Molecular weight cut off

mAU

Milli absorbance unit

AU

Absorbance unit

~

Approximately/around

°C

Degree Celsius

OD

Optical density

PCR

Polymerase chain reaction

qRT-PCR

Quantitative reverse transcriptase- PCR

BHIS

Brain heart fusion supplemented with yeast extract

Xg

Times gravity

ANOVA

Analysis of variance

DNA

Deoxyribonucleotide

cDNA

Complementary-DNA

RNA

Ribonucleotide

mRNA

Messenger RNA

RNAi

Ribonucleotide interference

asRNA

Antisense RNA

EDTA

Ethylenediaminetetraacetic acid

SDS

Sodium dodecyl sulfate

DTT

Dithiothreitol

PMSF

Phenylmethylsulphonyl fluoride

IPTG

Isopropyl b-D-thiogalactoside

SDS-PAG

SDS-polyacrylamide gel

x

ARA

Arabinose

GLU

Glucose

NEU5A

N-acetylneuraminic acid

sec

Second(s)

RSHCd

C. difficile RSH

RelQBs

B. subtilis RelQ

ON

Overnight

CL

Clarified lysate

L

Lysate

PCL

Prepped clarified lysate

FT

Flow through

5’UTR

5’ untranslated region

Prsh

Promoter region upstream of C. difficile rsh

PrelQ

Promoter region upstream of C. difficile relQ

Ptet

Promoter region of an empty tetracycline-inducible vector

ATc

Anhydrotetracycline

PBS

Phosphate buffered saline

w/v

Weight by volume

CV

Crystal violet

Ni-NTA

Nickel-nitrilotriacetic acid

LB

Luria Bertani

TY

Tryptone yeast

TEM

Transmission electron microscopy

DIC

Differential interface microscopy

Km

Kinetic constant

Kcat

Constant for the turnover of substrate into product

[GDP]

Concentration of GDP

MIC

Minimum inhibitory concentration

MDCK

Madin-Darby canine kidney

DMEM

Dulbecco’s modified eagle medium

xi

TABLE OF CONTENTS
Page
LIST OF TABLES ........................................................................................................ xiii
LIST OF FIGURES ...................................................................................................... xiv
Chapter
I.

INTRODUCTION ................................................................................................... 1
CLOSTRIDIOIDES DIFFICILE INFECTION ..................................................... 1
FACTORS PROMOTING CLOSTRIDIOIDES DIFFICILE VIRULENCE........... 8
THE BACTERIAL STRINGENT RESPONSE ................................................. 18
THE SCOPE OF THIS DISSERTATION ........................................................ 33

II.

BIOCHEMICAL CHARACTERIZATION OF FULL-LENGTH CLOSTRIDIOIDES
DIFFICILE RSH ................................................................................................... 35
OVERVIEW .................................................................................................... 35
METHODS AND MATERIALS ....................................................................... 39
RESULTS ....................................................................................................... 47
SUMMARY ..................................................................................................... 83

III.

CHARACTERIZATION OF RSH-MEDIATED MAGIC SPOT SIGNALING IN
CLOSTRIDIOIDES DIFFICILE ............................................................................ 85
OVERVIEW .................................................................................................... 85
METHODS AND MATERIALS ....................................................................... 87
RESULTS ....................................................................................................... 90
SUMMARY ..................................................................................................... 96

IV.

EFFECTS OF DISRUPTING THE STRINGENT RESPONSE IN
CLOSTRIDIOIDES DIFFICILE STRESS SURVIVAL .......................................... 97
OVERVIEW .................................................................................................... 97
METHODS AND MATERIALS ....................................................................... 99
RESULTS ..................................................................................................... 102
SUMMARY ................................................................................................... 106

xii

Page
V.

NUTRIENT-SPECIFIC MOTILITY AND BIOFILM REGULATION OF
CLOSTRIDIOIDES DIFFICILE .......................................................................... 108
OVERVIEW .................................................................................................. 108
METHODS AND MATERIALS ..................................................................... 113
RESULTS ..................................................................................................... 117
SUMMARY ................................................................................................... 132

VI.

CONCLUSIONS ................................................................................................ 134

REFERENCES .......................................................................................................... 140
APPENDICES
A. SUMMARY OF STRAINS AND PLASMIDS USED ...................................... 174
B. SEQUENCES OF PRIMERS USED............................................................. 176
C. SIGNAL QUANTIFICATION USING A TLC AUTORADIOGRAM ................ 178
D. RSHCd PRODUCES PUTATIVE TRIPHOSPHATE ALARMONES ............. 179
E. SUBLETHAL CONCENTRATIONS OF ANTIBIOTICS USED ..................... 180
F. SUBLETHAL CONCENTRATIONS OF ANHYDROTETRACYCLINE .......... 181
G. MOTILITY VIDEOS OF R20291 IN THE PRESENCE OF NEU5A .............. 182
H. TIME-COURSE ANALYSIS OF RSHCd ACTIVITY IN VITRO ..................... 183
I. C. DIFFICILE GENOME ENCODES FOR PUTATIVE NUDIX ENZYMES ... 184
J. SIGNIFICANCE OF RSH GENE TO C. DIFFICILE TOXICITY ..................... 185
K. MICROSCOPIC ANALYSIS OF R20291 AGGREGATION ......................... 186
L. PROPOSAL AND APPROVAL TO USE 32P ............................................... 188
M. RIGHTS AND PERMISSIONS ...................................................................... 199
VITA .......................................................................................................................... 204

xiii

LIST OF TABLES

Table

Page

1.

Stringent response is widely conserved in bacterial groups. Summary of
components of the stringent response that contribute to virulence traits and
phenotypes in diverse bacterial species. Adapted from Dalebroux et al. 2010 ...... 27

2.

Sequence alignment summary between RSHCd synthetase domain with its
relatives. RSHCd synthetase domain sequence shares high % identity and
similarity with those of RelA and RSH/Rel encoded by S. equisimilis and B.
subtilis, respectively. Table adapted from Pokhrel et al. 2020. .............................. 50

3.

C. difficile replicates normally in the presence and/or lack of different
metabolites. Doubling times of C. difficile R20291 in BHIS with 32 mM
supplementation of either ARA, GLU or NEU5A. Doubling times were
calculated between 0 and 5 hrs of growth in plain BHIS or BHIS supplemented
with the respective metabolite. Adapted from Courson et al. 2019. ..................... 122

xiv

LIST OF FIGURES

Figure

Page

1.

Diagram of a Gram-positive flagellum. Gram-positive flagellum showing the
basal body, the hook, and the filament. Adapted from Purcell et al. 2016. ................ 9

2.

Diagram of Gram-positive Type IV Pili. PilB ATPase assembles PilA pilin
subunits from the base to allow pilus extension. PilM, PilN and PilO form a
membrane complex for pilus extension. Adapted from Purcell et al. 2016............... 14

3.

Comparison of C. difficile flagella and Type IV Pili using transmission electron
microscope (TEM). Shown are the C. difficile flagella (black arrowheads) and
TFP (white arrowheads). Image scale from left to right is 5 µm, 5 µm, and 100
nm. Adapted from Purcell et al. 2016. ...................................................................... 14

4.

Chemical structure of Relacin. Relacin contains an isobutyryl group (dashed
circle). Adapted from Wexselblatt et al. 2012 and 2013........................................... 28

5.

Schematic representation of the synthetic route employed for symmetric
compounds analogous to Relacin. Reaction conditions as mentioned in the
reference Wexselblatt et al. 2013 from which the figure has been adapted. ............ 30

6.

Summary of symmetric substituents on the 3’ and 5’ positions of Relacin
deoxyguanosine ring to synthesize Relacin analogs. Adapted from Wexselblatt
et al. 2013. ............................................................................................................... 30

7.

Modification of Relacin isobutyryl group. Analogs of Relacin where the
isobutyryl group have been substituted with (A) acetylated compound and (B)
acetylated benzoylated compound. Adapted from Sayal et al. 2017. ...................... 31

8.

(pp)pGpp metabolism in C. difficile. (A) Operons of predicted (pp)pGpp
metabolism genes (blue) and beta-lactamase like proteins encoding gene
(pink). (B) Domain organization of predicted (pp)pGpp metabolism. Figure
adapted from Pokhrel et al. 2020. ............................................................................ 48

9.

Alignment of amino acid sequences of the catalytic synthetase domain RSHCd
with the primary sequence of other RSH family enzymes. Alignment of RSHCd
and RelQCd with RelP/RelQ/SAS enzymes from B. subtilis, E. faecalis, S.
aureus, and S. equisimilis. Adapted from Pokhrel et al. 2020. ................................. 49

10. Overexpression of RSHCd partially arrests bacterial growth. Growth curves of
E. coli strain carrying either empty pMMBneo vector (A) or IPTG-inducible rsh-

xv

ligated pMMBneo expression vector (B) in plain LB medium or LB
supplemented with CAA in the presence or absence of 0.5 mM IPTG. Adapted
from Pokhrel et al. 2020. .......................................................................................... 52
11. Purification of full-length RSHCd. Coomassie-stained SDS-PAG showing
lysate (L) and clarified lysate (CL) of induced BL21 strain carrying the
expression vector as well as flow-through (FT), wash 1 (W1), wash 2 (W2), and
elution fractions 1 (E1) and 2 (E2) after nickel affinity purification. RSHCd is
~85 KDa in molecular weight (dashed black circle). Adapted from Pokhrel et
al. 2018. ................................................................................................................... 54
12. Effect of increasing concentrations of Mg2+ on RSHCd-mediated magic spot
synthesis. Reaction was incubated at 37°C for 60 mins with 0.6 mM GDP, 3.0
µM RSHCd, 0.12 mM ATP, and indicated concentrations of MgCl2. TLC assay
was performed to quantitate magic spot synthesis. One-Way ordinary ANOVA
analysis with Turkey’s multiple comparisons test. Adjusted * P 0.0253. Error
bars indicate standard deviations from three independent reactions. ...................... 55
13. A typical autoradiogram of TLC assay. PEI-cellulose plate depicting the 32PATP spots, magic spots, and spot origin or location of a reaction carried out
using purified RSHCd in the presence of GDP substrate. NP denotes no
protein. Adapted from Pokhrel et al. 2018................................................................ 56
14. Functional characterization of RSHCd. (A) Absolute signal intensities of 32PATP and the magic spot as a function of time. (B) Magic spot synthesis is
represented as percentages of the total radioactive signal. Adapted from
Pokhrel et al. 2018. .................................................................................................. 57
15. Analysis of substrate preference and utilization of RSHCd. TLC autoradiogram
of in vitro RSHCd transferase activity using different substrates. RSHCd readily
transfers radioactive pyrophosphate from 32P-ATP to GDP but cannot utilize
GMP or GTP as a substrate. ATP hydrolysis appears to increase Pi levels in
the presence of GTP. Adapted from Pokhrel et al. 2020.......................................... 59
16. TLC autoradiogram of in vitro RSHCd transferase activity at different GDP:GTP
ratio. In vitro transferase reaction using equimolar concentration of GDP and
GTP (0.15 mM each) and 2X more GTP (0.2 mM) than GDP (0.1mM) keeping
the total substrate concentration equivalent to 0.3 mM. NP denotes no protein.
Adapted from Pokhrel et al. 2020. ........................................................................... 60
17. HPLC chromatogram of GTP, GDP, and GMP standards. Standards were run
separately at the concentration of 20 µM as 252 nm readout. Adapted from
Pokhrel et al. 2020. .................................................................................................. 61
18. Biochemical characterization of RSHCd. (A) Conversion of radiolabeled ATP
to magic spot increases with a corresponding increase in GDP concentrations.

xvi

(B) Nonlinear fit of velocity vs [GDP]. (C) Lineweaver-Burk plot of RSHCd
activity. Km of RSHCd for GDP is 95 µM. Figures A and C adapted from Pokhrel
et al. 2020. ............................................................................................................... 63
19. Evaluating allosteric regulation of RSHCd. RSHCd activity in the presence of
increasing concentrations of exogenous 5’-ppGpp-3’. Enzyme activity at
different 5’-ppGpp-3’ concentrations were compared by One-Way ANOVA
analysis of variance. n.s., not significant. Adapted from Pokhrel et al. 2020............ 64
20. Effect of pH on RSHCd synthetase activity. TLC autoradiograms (A) showing
the accumulation of magic spot in the presence of GDP or GTP at any given
pH value. Graphical representation of the GDP autoradiogram (B)
demonstrating that RSHCd utilizes GDP without exhibiting any pH specificity.
Magic spot synthesis at various pH values was compared to that at pH 7.5 by
One-Way ANOVA. n.s., not significant. Adapted from Pokhrel et al. 2020. ............ 66
21. Effect of divalent metal cations on RSHCd synthetase activity. TLC
autoradiogram (A) showing the accumulation of magic spot in the presence of
GDP or GTP in the presence of different metal ion cofactors at a buffer pH of
7.5. Graphical representation of the GDP autoradiogram (B) demonstrating
that RSHCd utilizes GDP without exhibiting any metal ion specificity. Levels of
magic spot synthesis were compared by One-way ANOVA. * P < 0.01. Adapted
from Pokhrel et al. 2020. .......................................................................................... 68
22. Interaction analysis of RSHCd with GDP. Isothermal titration calorimetry
thermogram (top) and Wiseman plot (bottom) of RSHCd interaction with GDP
at 37°C. The upper panel shows the raw data for titration of GDP with RSHCd,
and the lower panel shows the integrated heats of binding obtained from the
raw data. The data were fitted to a single-binding model. Each value is the
average of three repeat experiments and the standard deviation ± are shown.
RSHCd binds to GDP at a K value of 31.9 M-1. Adapted from Pokhrel et al.
2020. ........................................................................................................................ 70
23. Interaction analysis of RSHCd with GTP. Isothermal titration calorimetry
thermogram (top) and Wiseman plot (bottom) of RSHCd interaction with GTP
at 37°C. The upper panel shows the raw data for titration of GTP with RSHCd,
and the lower panel shows the integrated heats of binding obtained from the
raw data. The data were fitted to a single-binding model. Each value is the
average of three repeat experiments and the standard deviation ± are shown.
RSHCd binds to GTP at a K value of 25.1 M-1. Adapted from Pokhrel et al.
2020. ........................................................................................................................ 71
24. Cloning and overexpression of RSH-REL. (A) Schematic representation of fulllength RSHCd (1-735 amino acid residues) alongside the truncation construct;
RSH-REL (amino acid residues 113–388). The theoretical molecular weight of
the construct is provided (~33 KDa). Growth of E. coli cells carrying

xvii

pMMBneo::rsh-rel vector in LB medium supplemented with Casamino acids
(LB-CAA), glucose (LB-GLU) or both (LB-GLU-CAA). Bottom figure adapted
from Pokhrel et al. 2020. .......................................................................................... 73
25. Overexpression, purification, and functional characterization of RSH-REL. (A)
4%, 12% SDS-PAGE gel image of purified RSH-REL protein. Lanes 1 through
10 were loaded with marker (L), clarified lysate (CL), prepped CL, flow-through
(FT), CL FT2, wash 1 FT, wash 2 FT, wash 3 FT, elute 1 (E1), and elute 2 (E2).
(B) TLC autoradiogram of RSH-REL protein utilizing GDP for reaction catalysis.
(C) HPLC chromatogram of 5’-ppGpp-3’ detected in exponentially growing E.
coli cells expressing RSH-REL in the presence of the IPTG inducer. Filtered
cell extracts post-induction were run through a strong anion exchange column
at the flow rate of 1.5 mL/min. Sample readouts were obtained at 260 nm. ............ 75
26. Characterization of in vitro RSHCd hydrolase activity using TLC.
Autoradiogram of RSHCd hydrolase activity with Mn2+, full-length RSHCd, and
radiolabeled magic spot. Radiolabeled magic spots were extracted using Li2+
from a separate synthetase reaction. Failure to detect the hydrolysis product in
the autoradiogram suggests that the reaction requires effectors of the CTD
domain to produce detectable levels of PPi. ............................................................ 77
27. Analysis of in vitro RSHCd hydrolase activity via HPLC. HPLC chromatogram
comparing 5’-ppGpp-3’ signal between 0 and 4 hrs of RSHCd-mediated
hydrolysis reaction in vitro. Reaction mixture after 0 and 4 hrs of incubation
were run separately through a strong anion exchange column at the flow rate
of 1.0 mL/min. Sample readout was obtained at 260 nm. ........................................ 78
28. Analysis of RelQBs and RSHCd-catalyzed pyrophosphoryltransferase
reactions in vitro using HPLC. Reactions were conducted separately in the
presence of the indicated substrate with either 3.0 µM RSHCd or RelQBs. The
sample filtrates alongside the standards were run through a strong anion
exchange column using a gradient elution at the flow rate of 1.0 mL/min.
Absorbance at 252 nm as a readout is presented showing that RelQBs
produces ppGpp and pppGpp from GDP and GTP, respectively. Whereas
RSHCd produces triphosphate alarmones in the presence of GDP that co-elute
with the GTP standard. This experiment was conducted by and chromatogram
produced by Astha Pokhrel (Poudel et al. manuscript in preparation). .................... 81
29. Stationary phase onset stimulates C. difficile rsh transcription. (A) qRT-PCR
analysis shows that rsh mRNA levels increase by ~3-fold upon stationary
phase onset, representative of bacterial OD600 of 1.2. (B) The fluorescent
phiLOV transcriptional reporter also shows a 3-fold increase in the promoter
activity of rsh between exponentially growing cells and cells entering stationary
phase at an OD600 of 1.2. Adapted from Pokhrel et al. 2020.................................. 91

xviii

30. Nutrient limitation induces C. difficile rsh transcription. qRT-PCR analysis
shows that transcription levels of rsh increases by ~10-fold when C. difficile
cells are cultured in spent medium, representative of nutrient limitation or
starvation condition. relQ transcription in unaffected by nutrient limitation.
Multiple t test comparison between BHIS and spent BHIS. ** P 0.001220. This
experiment and figure are the courtesy of Dr. Erin B. Purcell. ................................. 92
31. Sequence alignment of the upstream promoter regions. The sequence of
promoters used in the (A) Prsh and (B) PrelQ translational reporters are
provided. A purine base substitution in the promoter sequences of rsh between
R20291 and 630Derm is depicted in a red box. Adapted from Pokhrel et al.
2020. ........................................................................................................................ 94
32. C. difficile rsh and relQ transcription is induced by antibiotic stress. PhiLOV2.1
transcriptional reporter activity after two hours of exposure to 16 μg/mL
clindamycin (A) and 0.3 μg/mL metronidazole (B) in the C. difficile 630Δerm
and R20291 genetic backgrounds. Fluorescence activity normalized by cell
density in the presence and absence of antibiotics was compared by Two-Way
ANOVA. n.s., not significant, * P < 0.05, ** P < 0.01, **** P < 0.0001. Adapted
from Pokhrel et al. 2020. .......................................................................................... 95
33. Relacin affects RSHCd synthetase activity in vitro. Relacin inhibits the activity
of RSHCd in a dose-dependent manner. Activity at each Relacin concentration
was compared to that in the 0 mM Relacin condition by ordinary One-Way
ANOVA. * P 0.0173, * P 0.0279, *** P 0.0009, **** P 0.0004. Adapted from
Pokhrel et al. 2020. ................................................................................................ 103
34. Effect of disrupting RSH-regulated stringent response mechanism in C. difficile
antibiotic survival. (A) Relacin alone has no impact on the ON accumulation of
C. difficile R20291. Cell density after overnight growth was compared with and
without Relacin by ordinary One-Way ANOVA. (B-C) 18 hrs cell density in the
presence of sublethal clindamycin (B) and metronidazole (C) with and without
Relacin. The cell density of antibiotic treated samples with and without Relacin
were compared by Unpaired t test. n.s., not significant, * P < 0.05, ** P < 0.01,
*** P < 0.001. Adapted from Pokhrel et al. 2020. ................................................... 104
35. Significance of rsh in antibiotic stress survival. Knock down of C. difficile rsh
gene with ATc inducer (0.5 µg/mL) negatively impacts the accumulation of
R20291 strain in the presence of metronidazole (0.075 µg/mL). The cell
densities of antibiotic treated samples with and without ATc were compared by
ordinary One-Way ANOVA. n.s., not significant, ** P 0.0042. Adapted from
Pokhrel et al. 2020. ................................................................................................ 106
36. C. difficile motility through soft agar is regulated by nutrients. (A, B) Migration
of C. difficile R20291 through BHIS, 0.3% agar supplemented with 1% ARA,
GLU or NEU5A. (C, D) Migration of R20291 through BHIS, 0.3% agar

xix

supplemented with 32 mM of ARA or GLU. Swarm diameters were measured
post-12 (A, C) and 24 (B, D) hrs of inoculation. Measurement of four biologically
independent swarms per condition (X2). Motility in each medium was
compared to migration in BHIS-agar by Unpaired t-test; n.s., not significant, *
P < 0.05, ** P < 0.01, **** P < 0.0001. (E) Representative images of C. difficile
R20291 24 hrs after inoculation. Adapted from Courson et al. 2019. .................... 119
37. C. difficile growth in the presence of different sugars at 32 mM concentration.
(A) Growth curves in medium supplemented with either 32 mM ARA, GLU or
NEU5A are comparable to the growth of the bacteria in plain BHIS medium.
(B) Growth curve as in (A) showing how the doubling times were calculated
between 0 and 5 hrs of growth in the respective media. Adapted from Courson
et al. 2019. ............................................................................................................. 121
38. Extended live-cell microscopy of C. difficile R20291 using a rose cell chamber.
(A) Side view of rose cell chamber assembly. (B) Cell division and growth of
R20291 within the imaging chamber in BHIS medium. Panels show the time
course in which the cells were incubated at 37°C within the chamber. Scale bar
indicated at 10 µm. Adapted from Courson et al. 2019. ......................................... 124
39. NEU5A reduces net displacement and velocity. (A) Net displacement (B) linear
swimming velocity of R20291 during unidirectional runs within 10 sec in BHIS
with indicated concentrations of NEU5A. Means and standard deviations of 49146 cells are shown per condition. One-Way ANOVA analysis of variance
comparing displacement and velocity of cells in supplemented media to those
in plain BHIS. Turkey’s multiple comparison test., n.s., not significant; **** P <
0.0001. Adapted from Courson et al. 2019. ........................................................... 126
40. NEU5A has no effect on C. difficile R20291 tumbling. (A) Tumble frequency of
C. difficile R20291 in BHIS supplemented with indicated concentrations of
NEU5A. Tumble counts were normalized by the duration of each cell’s motility
to control for cells that left the field of view during 10 secs exposure. (B)
Percentage of the total cells exhibiting the indicated number of tumbles/secs in
each condition is given. (C) Normalized frequency of cells that show a nonzero rate of tumbling. Turkey’s multiple comparison test., n.s., not significant.
Adapted from Courson et al. 2019. ........................................................................ 128
41. 32 mM NEU5A induces robust single-species biofilm formation by C. difficile
R20291. Cultures of R20291 were incubated for 48 hrs at the indicated
concentrations of NEU5A, GlcNAc, and GLU. Measurement of bacterial
biomass using 0.1% crystal violet staining and 570 nm absorbance readings
demonstrated that R20291 forms significantly more biofilm at 32 mM NEU5A.
Production of biofilm in BHIS is independent of a GlcNAc and GLU gradient.
Two-way ANOVA multiple comparison (cell means regardless of rows and
columns) analysis of biomass produced at different concentrations of the
unchained mucin monosaccharides., n.s., not significant, *** P 0.0003. Means

xx

and standard deviation of 6 biologicals are shown of two assays performed on
different days. ........................................................................................................ 130
42. Effect of NaCl on biofilm production by C. difficile R20291. (A) Biofilm formation
kinetics by R20291 in the presence of NaCl at the indicated concentrations
using 0.1% CV staining procedure and measurement of biomass at 570 nm.
Biofilm formation is comparable between 0 to 0.15 M non-sugar osmolyte but
robust at 0.3 M NaCl. (B) R20291 produce biofilm in 32 mM NEU5A as well as
in 0.3 M NaCl although at the population level, more independent biologicals
produce more biomass in 32 mM NEU5A. Statistical significance determined
by Unpaired t test., n.s., not significant, * P 0.0355. Means and standard
deviation of 6 total biologicals are shown for two separate assays performed
on different days. ................................................................................................... 131

1

CHAPTER I
INTRODUCTION

CLOSTRIDIOIDES DIFFICILE INFECTION
Clostridioides difficile (C. difficile), previously known as Clostridium difficile is a
Gram-positive, obligate anaerobic bacillus that was discovered in 1935 and identified as
a severe pathogen only in the late 1970s (1). Today, C. difficile is the most common cause
of hospital-acquired infection and C. difficile infection (CDI) in several developed countries
(2). The pathogen contributes to approximately 500,000 cases and 29,000 deaths
annually in the United States alone and in 172,000 cases annually in Europe (3-6).
According to the Antibiotic Resistance Threats in the United States 2019 report issued by
the US Center for Disease Control and Prevention (CDC), C. difficile was responsible for
~223,900 hospital admissions cases and ~12,800 deaths in 2017. The economic impact
of CDI is enormous. It has led to health care and medical expenditures of over one billion
dollars and three billion euro per annum in the US and within the European Union,
respectively (6-8). The CDC currently recognizes the pathogen as an urgent public health
threat (9).
C. difficile persist as aerotolerant spores in aerobic environments (10). The spore is
a metabolically dormant form of the bacterium that houses genetic entities preserved in
a dense hydrophobic core, externally protected by a thick proteinaceous coat (11). Due
to their dormancy and highly complex structure, C. difficile spores are intrinsically
resistant to antibiotics, and defenses from the host’s immune system (11). They are also
tolerant to bleach-free as well as alcohol-based disinfectants commonly used in
healthcare settings (11). Furthermore, C. difficile spores also survive heat assault, making
their eradication extremely challenging from contaminated surfaces (12).
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Surfaces most frequently contaminated by C. difficile spores include toilet seats,
sinks, call buttons, bed rails, and telephones, along with medical devices such as
stethoscopes, blood pressure cuffs, and pulse oximeters (9). Other reservoirs for the
bacteria include asymptomatic carriers, infected patients, and the animal intestinal tracts
(13). Around 5% of adults and 15 to 70% of infants are colonized by C. difficile, with
colonization prevalence being significantly higher in institutionalized patients, including
adults with underlying health conditions (6,13). Notably, the community-acquired
incidence of C. difficile infection has been increasing with an associated increase in
mortality, morbidity, and clinical and economic burden (14,15). According to a CDC-based
population surveillance from 2011 to 2017, the estimated burden of community-acquired
CDI in the US did not decrease like healthcare-associated CDI and contributed to ~50%
of CDI’s total national burden in the year of 2017 (16).
Upon ingestion by susceptible hosts, C. difficile spores germinate into actively
reproducing vegetative cells in the anaerobic mammalian gut. Spore germination is
triggered in response to host-derived bile salts, including taurocholate, glycocholate,
cholate and deoxycholate, and L-glycine, which is a more effective germinant than the
other naturally occurring amino acids (11,17,18). Germination into oxygen-intolerant
vegetative cells further leads to the secretion of exotoxins, toxin A (TcdA) and toxin B
(TcdB) that are internalized by host intestinal epithelial cells (10). TcdA (308 kilodalton)
and TcdB (270 kilodalton) are members of the large clostridial toxin family, encoded by
tcdA and tcdB genes, respectively (10,19). These genes are part of a highly conserved
19.6-Kb pathogenicity locus (PaLoc) of toxigenic strains (19,20). In addition to tcdA and
tcdB genes, three other open reading frames are associated with the PaLoc, including
tcdC, tcdD/tcdR, and tcdE (19). TcdC is suggested to function as a negative regulator of
toxin A and B production whereas TcdR acts as a DNA binding protein that positively
regulates toxin gene expression and production (19,21). Finally, the gene encoding TcdE
is homologous to holin proteins and is suggested to contribute to the release of the toxins
through permeabilization of the bacterial cell wall (19,22).
After receptor-mediated endocytosis, both toxins transfer a UDP-glucose to Ras
superfamily GTPases (Rho, Rac, and Cdc42), resulting in host cell morphological
changes, inhibition of cell division, and blocking of membrane trafficking (19). Rho
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GTPase is the primary regulator of the cellular actin cytoskeleton, which plays a critical
role in forming and localizing stress fibers at the focal adhesion sites (19). Rho also
regulates the formation of prejunctional rings at the apical side of epithelial cells such that
inactivation causes epithelial cell rounding from disaggregation of the actin cytoskeleton
as well as disruption of the epithelial tight junction (19,23). Consequently, neutrophils are
recruited to the intestines, macrophages are activated, and pro-inflammatory cytokines
are rapidly released to cause a massive host acute inflammatory response (19). In more
severe cases, microulcerations covered with pseudomembranes made of destroyed
intestinal cells, neutrophils, and fibrin begin to form on the intestinal mucosal surfaces
(13). Unlike Rho, Rac and Cdc42 are involved in lamellipodium and filipodium formation
that are structural extensions at the edge of migrating cells (19,24). Rac and Cdc42
facilitate cellular movement and sensing of environmental conditions during migration.
Interestingly, TcdA and TcdB promote cell migration despite glycosylating Rac and Cdc42
GTPases (19). In terms of potency, initial studies based on animal models suggested
Toxin A to be the dominant intoxicating glycosyltransferase encoded by C. difficile until
TcdA-, TcdB+ strains became responsible for CDI outbreaks (10,13,25). Studies involving
human colonic epithelial tissues and transplantation of human xenografts in
immunodeficient animal models have identified Toxin B to be more potent, although both
toxins can elicit CDI symptoms independently of one another (13,26,27).
The incidence of CDI has markedly increased in the last 20 years, largely due to the
emergence and dissemination of the C. difficile polymerase chain reaction ribotype 027
(RT027) or R20291 (28). RT027, which was first isolated in North America and Europe
back in the 2000s, is naturally hypervirulent (25,29). Hypervirulence of the strain is
associated with reduced susceptibility to a wide array of antibiotics including
fluoroquinolones (30). The strain also spreads more easily and rapidly within hospital
settings as it can produce higher levels of spores and toxins (30,31). Importantly, RT027
strain produces an additional toxin called C. difficile transferase (CDT) or binary toxin,
which is encoded by the C. difficile transferase (Ctd) locus (CdtLoc) (10). Unlike TcdA
and TcdB glucosyltransferases, C. difficile CDT, is an ADP-ribosylating enzyme that
disrupts the cytoskeleton of epithelial cells by inhibiting actin polymerization (10,19,30).
Inhibition of actin polymerization consequently leads to excessive fluid loss, cell rounding,

4

and apoptosis (10). CDT (~43 kilodalton) comprises two separate components: CDTa
and CDTb, where CDTb binds to gut epithelial cells resulting in the uptake of CDTa (30).
CDT also induces the formation of thin microtubules that promote Clostridia adherence
to host intestinal epithelial surfaces along with increasing TcdA and TcdB uptake (30,32).
In the last decade, the percentages of CDI caused by the RT027 strain is reported to be
51% and 84% in the US and Canada, respectively (33,34).
The clinical manifestation of CDI ranges from asymptomatic carriage, mild or
moderate diarrhea, to life-threatening fulminant colitis and toxic megacolon (13). Most
patients experience mild diarrhea and recover spontaneously after 5 to 10 days of
treatment withdrawal (13). In addition to watery stool, clinical features of CDI is
accompanied by abdominal pain, fever, weakness, nausea and vomiting, and loss of
appetite (13). Severe clinical presentations involve symptoms such as dehydration,
hypoalbuminemia, and subsequent circulatory shock (13). Additional complications
include colon perforation, intestinal paralysis, kidney failure, systemic inflammatory
response syndrome, and septicemia (13).
The primary risk factor for CDI development is antibiotic exposure. However, other
significant risk factors include advanced age, residence in long-term care facilities
(hospitals and nursing homes), and prior medical conditions such as immunosuppression,
inflammatory bowel diseases, and chronic kidney disease, and/or gastrointestinal
procedures (6,13,35,36). Antibiotics have serious and long-lasting effects on the bacterial
ecosystem of the host gut. The highly organized intestinal ecosystem comprises
numerous bacterial species, mainly those belonging to the Firmicutes and Bacteroidetes
phyla, whose concentration is heightened in the colon (6,37-39). The commensal
microbiota plays a crucial role in maturating the immune system and protecting against
enteric pathogens. Disruption of this well-balanced ecosystem via antibiotic exposure
alters microbial diversity and composition, promoting C. difficile colonization (6).
Antibiotics associated with the development and increased frequency of CDI include
metronidazole, vancomycin, broad spectrum penicillins and cephalosporins, clindamycin,
and fluoroquinolones (6,13). Cephalosporins are known to decrease members of the
healthy Clostridia, Lactobacilli, and Bifidobacteria taxa, whereas clindamycin decreases
species of the anaerobic Bifidobacterium, Clostridium, and Bacteroides genera (40,41).
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Another significant role of commensal bacteria, particularly those in the Lachnospiraceae,
Ruminococcacae, and Blautia families of Firmicutes as well as Clostridium spp., is to
metabolize primary bile acids into secondary bile acids via deconjugation and 7-αdehydroxylation mechanisms (42,43). As mentioned previously, C. difficile spores
germinate into replicating vegetative cells in the presence of primary bile acids such as
taurocholate and cholic acid to promote vegetative cell outgrowth (43). Secondary bile
acids, on the other hand, inhibit C. difficile growth (44,45). Antibiotic-induced alterations
of the intestinal microbiota cause an increase in the primary bile acids concentration and
a concurrent decrease in secondary bile acids concentration, enhancing colonization. The
commensal Bacteroidetes and Firmicutes phyla are depleted and changed, respectively,
with a concurrent increase in pathogenic Enterobacteriales and Proteobacteria diversity
in CDI patients (42,46).
C. difficile colonization is very common in the elderly population due to inadequate
innate or humoral immune responses and loss of commensal bacterial diversity in this
age group (6,47-51). Patients above 65 years of age carry an increased risk for CDI
development, ~5 to 10-fold higher relative to younger patients (13). Although a significant
portion of CDI incidence also occurs in the younger age group, the poor clinical outcome
of the disease (higher severity and mortality) is directly associated with advanced age
(13). Prolonged stay in healthcare institutions also corelates with CDI incidence. The
incidence of bacterial colonization during the first few days of hospitalization ranges from
2.1 to 20% and gradually increases with extended stay (52-56). Furthermore, nursing
home residents are also at high risk for CDI possibly due to older age, health
comorbidities, frequent hospitalizations, and antibiotics exposure compared to the noninstitutionalized population (13).
Prevention of CDI has mostly included the use of gloves and disposable gowns in
healthcare settings since C. difficile spore transmission occurs from person to person
contact and through the fecal oral route (13,35). After direct contact with CDI patients, it
is recommended to wash hands with soap and water (57). Since alcohol-based
disinfectants are ineffective at killing C. difficile spores, it is ideal to use chlorine-based
solutions such as sodium hypochlorite for environmental cleaning (58). Treatment wise,
primary therapy of moderate and severe CDI has included the use of metronidazole and
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vancomycin (59). While the Infectious Diseases Society of America (IDSA) and Society
for Healthcare Epidemiology of America (SHEA) guidelines issued in 2018 no longer
recommends the use of metronidazole as a first-line treatment, multiply recurrent CDI
(rCDI) is a significant problem associated with the use of vancomycin (4,29,36,60-63).
The recurrence rate after the first bout of CDI treatment (or second episode within 8 weeks
of discontinuing antibiotic therapy for primary infection) using vancomycin is ~10 to 35%,
and that the risk for subsequent recurrences is at least 40% (36,59,64). Patients with
three or more relapses often experience consecutive relapse episodes, leading to low
quality of life with minimal therapeutic options (57,59). Unlike vancomycin, fidaxomicin is
associated with a lower recurrence rate via the inhibition of C. difficile spore formation
and toxin production (65,66). Fidaxomicin targets exosporium and spore coat proteins to
inhibit germination and internalizes vegetative C. difficile cells (67). Furthermore, the use
of fidaxomicin is also advantageous over vancomycin due to the twice-daily dosing
regimen of the former antibiotic over quadrice-daily dosing (36). However, fidaxomicin is
expensive, preventing its widespread use and resistance of the epidemic strains to the
antibiotic has been reported in clinical trials (59,65,66,68). As C. difficile demonstrates
high survival rates when treated with multiple classes of antibiotic, including beta-lactams,
cephalosporins, clindamycin, and fluoroquinolones, microbiome restoration through fecal
microbiota transplantation (FMT) continues to be the most effective therapy for rCDI
(7,36,63,69,70). The introduction of suppressive bacterial species from screened and
healthy donors to C. difficile colonized gastrointestinal tracts of infected patients has
demonstrated between 80 to 90% success rate (57,71,72). Unfortunately, the technique
carries an inherent risk of transmitting undetected pathogens and chemical agents to the
recipient (73,74). Additionally, the long-term effect of the therapy remains to be
determined (74). In 2019, two immunocompromised patients were reported to develop
extended spectrum β-lactamase producing Escherichia coli infection post-FMT, which
lead to the demise of one of the patients (75).
Another significant drawback of FMT is the heterogeneity associated with the
methodological components of the procedure, including donor screening, donor and stool
sample preparation, and instillation as well as patient follow-up (36). To establish
standardization of the FMT technique for universal therapeutic usage, capsule-based
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products such as CP101 (Phase II), RBX7455 (Phase I), SER-109 (Phase III), and
enema-based RBS2660 (Phase II and III) have demonstrated appreciable efficacy in
double-blinded randomized-controlled trial (36). Nevertheless, replacement of the
conventional FMT with standardized microbiome restoration products appears to be
encouraging also because patients’ experience with and perception regarding traditional
FMT is reportedly unpleasant (36,76).
Newer approaches to managing CDI and multiply rCDI have included the
administration of monoclonal antibodies directed against C. difficile toxins in conjugation
with antibiotic therapy. Bezlotoxumab is the United States Food and Drug Administration
(FDA)-approved human monoclonal antibody that targets toxin B, and that is associated
with a substantially lower rate of rCDI (63,77). Notably, some vaccines that have entered
late-stage clinical trials include injectable anti-toxin vaccines and formalin-inactivated
toxin A and B by Sanofi Pasteur (63). Genetically and chemically inactivated toxin A and
B vaccine by Pfizer and a single recombinant fustian protein with segments of the
bacterial toxins by Valneva have also entered Phase 3 clinical trials (63). The use of
probiotics as an alternative to antibiotics and FMT is also being largely explored in the
field. Much like the native intestinal microbiota, probiotics stimulate the host immune
system, compete with enteric pathogens for nutrients, and inhibit colonization of foreign
species (78,79). Bifidobacterium as well as the combination of B. longum and B. bifidum
with prebiotics are known to be protective against C. difficile (80,81). Widely used
Lactobacilli probiotics also inhibit C. difficile growth where Lactobacillus rhamnosus GG
interfere with key metabolic pathways in the bacteria such as Stickland reactions and
butyrate metabolism, resulting in the negative regulation of toxin production (82,83).
In summary, diverse approaches are available and under development for the
management of CDI and rCDI. However, the development of more effective prevention
and therapeutic strategies continues being urgent.
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FACTORS PROMOTING CLOSTRIDIOIDES DIFFICILE VIRULENCE

Adhesion of bacteria to target cells is the first step in colonization and the
establishment of pathogenesis. Therefore, it is imperative for C. difficile to find a way to
get through the host intestinal lumen and into the mucosa to the epithelial cells for
attachment and infection. Notably, mammalian epithelial mucosal tissues are coated by
a high viscosity mucus layer composed of water and glycosylated mucin components
(84). Hence, movement or motility through the mucus barrier to the epithelial lining is
essential for successful colonization. The secretion of flagella provides many species with
ability to be motile, to colonize abiotic and/or biotic surfaces, to optimize growth, and to
survive attacks from the host (85,86). In a few gastrointestinal pathogens, including
Campylobacter jejuni and Vibrio cholerae, flagella play roles in bacterial motility,
adherence, and colonization (87-90). Therefore, flagellar mutations cause these bacteria
to become less adherent and less pathogenic in nature (91-95).
The flagellum is constituted of a basal body which contains the reversible motor that
anchors the structure to the cell membrane while powering organelle rotation, a hook that
extends out from the top of the basal body, and the filament which extends ~20 µm from
the hook to form the helical propeller when rotated (Fig. 1) (86,87,96). Self-assembly of
the flagellum is a multi-stage hierarchical process that begins with the coordinated
assembly of the flagellar type III secretion system (T3SS), the MS-ring in the cytoplasmic
membrane, and the C-ring at its cytoplasmic face (87). In Gram-negatives, the MS- and
C-rings form a scaffold for the assembly of the flagellar T3SS first followed by the
assembly of the peptidoglycan-spanning P-ring and lipopolysaccharide-spanning L-ring
(87). Notably, the L- and the P-rings are lacking in the structure of a Gram-positive
flagellum (Fig. 1). Consequently, the activated T3SS recruits, unfolds, and exports
proteins through the axial structure’s hollow core in order to assemble the periplasmspanning rod, the flagellar hook, and the filament in a highly coordinated fashion (87). As
mentioned previously, the motor of the flagellar basal body is responsible for fueling
flagellar rotation. This transmembrane protein complex transduces energy from the flow
of H+ or Na+ ions across the inner membrane, causing a conformational change in the Cring torque that is coupled to the rod, the hook, and the filament (87). The propulsive force
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generated by the flagellar rotation subsequently leads to bacterial movement at speeds
ranging from 25 to 160 µm/sec (87,97,98). Due to flagellar rotation that propels bacteria
forward in the direction of suitable niches (swimming motility) and/or for adhesion and
colonization sake, flagellated species do not rely on the Brownian motion (87).

Basal body

Figure 1. Diagram of a Gram-positive flagellum. Gram-positive flagellum showing
the basal body, the hook, and the filament. Adapted from Purcell et al. 2016.

Several genes governing the structural integrity and function of the flagellum in
relevant flagellated species have also been identified in different C. difficile strains (86).
These genes are organized into three distinct loci called F1, F2, and F3 (61,86). The
hierarchical transcription of flagellar genes is firstly initiated in the F3 regulon or ƒlgB
operon, which comprises early flagellar genes such as the ƒliA (86). This operon mainly
encodes motor and structural components of the organelle along with the alternative
sigma factor SigD necessary for flagellar assembly and bacterial movement. The SigD
alternative sigma factor regulates the transcription of flagellar genes in the late-stage F1
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and F2 operons (99,100). The F1 regulon houses three ƒliA promoter regions (86). The
same operon also encodes flagellin FliC and the protein cap FliD, both of which are
structural proteins critical for attaining complete flagellar functionality (86,101).
Interestingly, variation in the F1 regulon between C. difficile strains have been recorded,
supporting the findings that the R20291 strain is more motile with higher flagellar counts
in comparison to the non-epidemic or historical strain C. difficile 630 (61,86,102). Lastly,
genes in the F2 regulon encode proteins that play parts in filament glycosylation (86,90).
Notably, the F2 operon of C. difficile 630 strain carries four genes encoding glycosyl
transferases, whereas that of R20291 carries six (61).
Post-translational modification (PTM) of C. difficile flagella is critical for flagellar
assembly and bacterial motility. In 2009, Twine and group determined that C. difficile
flagellin undergoes modification by O-linked glycans and that this modification varies
between C. difficile strains (103). According to Twine et al., the addition of N-acetyl
hexosamine is dependent on the specific glycosyltransferase gene (CD0240) from C.
difficile 630 F1 operon such that inactivation results in the loss of surface-associated
flagellin protein and in impaired bacterial motility (103). Years later, Faulds-Pain et al.
showed that a β-O-linked N-acetylglucosamine (GlcNAc) glycan is attached to either
serine and/or methylated phosphor-threonine of the flagellin to induce PTM (104).
Nevertheless, mutations in the CD0240 gene and those downstream of CD0240 in the
F2 operon (with putative roles in flagellin modification) lead to bacterial autoagglutination,
increased cellular binding to abiotic surfaces, and reduced colonization in a relapsing
model of CDI (104). Autoagglutination is a process of bacterial cells either clumping
together or with host cells. Several surface structures in bacteria influence
autoagglutination. For instance, C. jejuni employs a flagellin-dependent autoagglutination
strategy to promote virulence (86,105). The degree of autoagglutination in C. difficile is
strain-specific and that this dependency is majorly due to differences in flagellar
glycosylation pattern (61,86). Valiente et al. studied genes in RT027 with predicted roles
in flagellar glycosylation and PTM (106). Mutation of two putative glycosyltransferase
genes, GT2 and GT3 as well as those with predicted coding sequences of the F2 operon,
immediately downstream of ƒliC gene demonstrated reduced motility but an increase in
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autoagglutination (106). This suggests that the PTM of C. difficile flagellin influences
pathogenesis.
Flagellum-mediated motility contributes to bacterial colonization and virulence in
many species. Flagellar filaments are responsible for probing the host cell surface for
contact and interaction with polymeric proteins, proteoglycans, glycolipids, and
phospholipids (84). Flagella contributes to C. difficile adherence to epithelial cells in vitro
and host colonization in a strain-specific manner. Mutation in the ƒliC gene of the RT027
strain has been shown to reduce bacterial adherence to mammalian cell lines and
colonization in mouse models (107). Surprisingly, a mutation in the same gene from C.
difficile 630Δerm (RT012) strain, an erythromycin sensitive variant of the non-epidemic
630 isolate, increased bacterial adherence to mammalian cells without affecting
colonization (107,108). This indicates that flagella-driven motility is not necessary for
colonization in all genetic variants of C. difficile, but the flagellum can function as an
adhesin is some, promoting bacterial interactions with the host (90). Aubury et al. also
used 630Δerm strain to generate early-stage flagellar gene mutants and late-stage ƒliC
and ƒliD mutants (109). They found mutations in early stage flagellar genes to attenuate
virulence in hamster models of infection, whereas ƒliC and ƒliD mutations lead to
increased virulence and quick transitioning of infection models to a moribund state (109).
The same study also recorded a decrease in toxin production due to early-stage flagellar
gene mutations (109). The association between flagellar genes and toxin production can
be explained by the role of the flagellar alternative sigma factor SigD. SigD regulates tcdA
and tcdB gene expression and toxin production in C. difficile via tcdR activation such that
sigD mutations lead to decreased toxin expression, production, and virulence during
infection (109). Nevertheless, the flagellum is an essential organelle of C. difficile
physiology with roles in bacterial motility and colonization, even motility-driven dispersal
of cells to find new surfaces to colonize (87).
Another surface-associated protein encoded by many Gram-negative and select
Gram-positive species is the Type IV pili (TFP) that regulate bacterial movement,
adherence to host cells, DNA uptake, transformation, and protein secretion (Fig. 2) (110112). TFP can also act as nanowires carrying electric current and that pilus biosynthesis
occurs through the type II protein translocation pathway (112,113). This surface-
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associated macromolecule is polymerized from an inner membrane-bound pool of pilin
monomers (PilA) via the PilB ATPase, and is held to the pilus filament via hydrophobic
interactions and assembly of the PilM, PilN, and PilO proteins required for extension (Fig.
2) (112). Retraction of the pilus, on the other hand, is controlled by the disassembly of
the PilA pilin subunits into the inner membrane, a mechanism powered by the PilT
ATPase (113).
In contrast to the flagellar filament, TFP make thinner and shorter filaments that
extend from the bacterial surface (Fig. 3) (110). Interestingly, both flagellum and TFP can
coordinate with each other to facilitate bacterial adhesion and colonization. In some
cases, for instance, TFP reinforce flagella-mediated transient and reversible interactions
of bacteria, resulting in more robust and permanent associations (110,114).
Mechanistically, TFP promotes bacterial motility through the extension, attachment, and
retraction of the pilin fiber along a solid surface (110). The TFP-based motility that aid in
bacterial propulsion to reach target sites has been described in many species including,
Neisseria, Pseudomonas, Myxococus xanthus, C. difficile, and Clostridium perfringens
(115,116). Furthermore, in C. difficile, TFP contributes to in vitro cell aggregation in a 3’5’ cyclic diguanylate (c-di-GMP)-dependent manner (117). Inactivation of pilA1 (encoding
PilA monomer) and pilB1 (encoding PilB ATPase) genes from the primary TFP loci
hinders pilus formation and reduces C. difficile autoaggregation (117). c-di-GMP is a
bacterial second messenger that regulates the switch of cells from motile, free-living, or
planktonic state to sessile while playing multifaceted roles in bacterial physiology and
virulence. The cytoplasmic levels of c-di-GMP is regulated by GGDEF-domain containing
diguanylate cyclases and EAL or HD-GYP-domain containing phosphodiesterases that
synthesize and hydrolyze the signaling molecule, respectively (110). In Gram-positives,
two protein receptors for c-di-GMP have included the PilZ-domain protein and the
transcription factor BidD. Furthermore, class I and II types of riboswitches have also been
identified in different bacterial groups that bind c-di-GMP and regulate gene transcription
(110). Importantly, the C. difficile 630 genome encodes 37 predicted c-di-GMP cyclases
and phosphodiesterases (31 of which are conserved in R20291), one PilZ domain, 12
predicated class I, and four class II riboswitches (110). An increase in the intracellular cdi-GMP concentration via the overexpression of DccA synthetase (GGDEF-domain
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carrying diguanylate cyclase) inhibits flagellar-driven motility and induces C. difficile cell
clumping (117-119). According to Purcell and colleagues, repression of flagella-mediated
motility at elevated c-di-GMP levels is due to the binding of c-di-GMP to the type I
riboswitch located upstream of the ƒlgB flagellar biosynthesis operon (119). As mentioned
previously, the ƒlgB or F3 operon includes sigD, which regulates tcdA and tcdB gene
expression and toxin production via the tcdR of the PaLoc. Therefore, increased
concentration of cytoplasmic c-di-GMP also inhibits C. difficile toxin production via
premature transcription termination of the sigD (99). c-di-GMP-dependent motility
suppression and induction of cell aggregation via the TFP has been reported to involve a
c-di-GMP riboswitch that transcriptionally regulates TFP biosynthesis genes (117).
Binding of c-di-GMP to the class II_4 riboswitch located upstream of the TFP primary
locus facilitates C. difficile autoaggregation, which contributes to biofilm formation (117).
In 2018, McKee et al. evaluated the role of TFP in the ability of C. difficile to adhere to
and colonize the intestinal epithelial cells (120). Based on their observations, c-di-GMP
promotes TFP-mediated attachment of C. difficile to colonic epithelial cells such that
mutations in TFP genes (pilA1 and pilB1) result in reduced bacterial adherence (120).
Overall, these findings suggest that c-di-GMP signaling regulates virulence in C. difficile
by inhibiting flagella-dependent swimming and enhancing TFP-dependent aggregation
and biofilm formation in the colonic epithelial surface.
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Figure 2. Diagram of Gram-positive Type IV Pili. PilB ATPase assembles PilA pilin
subunits from the base to allow pilus extension. PilM, PilN and PilO form a membrane
complex for pilus extension. Adapted from Purcell et al. 2016.

Figure 3. Comparison of C. difficile flagella and Type IV Pili using transmission
electron microscope (TEM). Shown are the C. difficile flagella (black arrowheads)
and TFP (white arrowheads). Image scale from left to right is 5 µm, 5 µm, and 100
nm. Adapted from Purcell et al. 2016.
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Biofilms are the predominant state of most bacteria in natural environments (110).
Biofilm formation is initiated by bacterial interaction with a surface where surfaceadhesion is facilitated by flagella and TFP (121). Post-surface attachment, adherent cells
secrete a dense and very protective extracellular polymeric substance or matrix (ECM)
(121,122). The ECM comprises polysaccharides, proteins, lipids, complex sugars,
extracellular DNA, and ions such as Ca2+ (121,123). The surface-attached cell mass also
harbors many pathogenic species that are inherently more drug-tolerant than planktonic
species, suggesting that biofilm plays a crucial role during host infection (122,124).
Irreversible attachment and maturation of the biofilm through development of
microcolonies ultimately results

in a

robust

three-dimensional community

of

microorganisms (122). The major roles of the ECM include securing the biofilm
community to the surface, trapping nutrients within, providing structural support, and
protecting the community from host immune defenses as well as antimicrobial agents
(122). Furthermore, the ECM is responsible for enabling cell-to-cell communication via
autoinducer molecules and the exchange of genetic materials via horizontal gene transfer
mechanism within the community (122). Upon maturation, to disperse bacterial infection,
mature biofilms release cells from the main community so that free cells can swim to new
locations for surface attachment (122).
Mechanisms contributing to bacterial drug tolerance and survival within a biofilm
community include occlusion of the penetration of chemical agents by the thick ECM,
sequestering of antimicrobial agents within the matrix, and the inner hostile environment
of biofilms that reduce growth rate and render bacteria metabolically inactive (122,124).
In humans, 80% of bacterial infections are due to biofilm-producing pathogens such as
those belonging to the Staphylococcus, Pseudomonas, Enterococcus, and Streptococcus
genera (124). Furthermore, biofilms also contribute to bacterial persistence and infection
recurrence (90). Bacterial persistence is an antibiotic stress-response phenomenon in
which a subpopulation of cells survives antibiotic exposure without acquiring genetic
alteration(s) in their genome that can otherwise confer antibiotic resistance (125,126).
Over the years, biofilm formation has been characterized in a handful of anaerobic
species that colonize the gut. Both C. difficile 630 and R20291 strains can form wellstructured and thick biofilms in vitro, with the latter strain forming substantially more
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biofilm (127). The biofilm matrix of C. difficile is mainly composed of glycoproteins,
lipoproteins, phosphoproteins, and extracellular DNA in addition to fiber-like structures
(127). The surface-structures flagella and TFP, and members of the S-layer regulate
biofilm formation in C. difficile. The C. difficile S-layer is composed of S-layer proteins
(SLPs) that present as heterodimeric complex with putative functions in bacterial
adherence and evasion of the immune system (128). The maturation of the S-layer
proteins is dependent on proteolytic cleavage by Cwp84. Therefore, isogenic mutants of
cwp84 and ƒliC dramatically suppress biofilm formation during the early and late stages
of biofilm maturation, respectively (127). Quorum sensing, which is a process that permits
bacteria to coordinate group behaviors for sharing information about cell density and gene
expression, also influences biofilm formation (129). The role of quorum sensing regulators
in biofilm production, such as luxS has been documented in B. subtilis and C. perfringens
(130,131). Notably, luxS mutants in C. difficile also cause dramatic defects in biofilm
formation, suggesting that the luxS-mediated quorum sensing system contributes to
mature biofilm formation in this organism (127). Furthermore, the master regulator of the
sporulation pathway called Spo0A is also involved in C. difficile biofilm formation in vitro
(127). The biofilm environment is known to support sporulation processes making spores
one of the members of the biofilm ecosystem, particularly under nutrient-limiting
conditions (127,132). While Dapa et al. found C. difficile biofilms to contain significantly
lower numbers of spores in vitro, other studies have found C. difficile biofilms to be
densely populated with spores harnessing reduced germination efficiency (127,133). In
agreement with precedent findings, Dawson and group recently demonstrated that both
R20291 and 630 strains have significantly increased spore titers within the biofilm matrix
compared to the planktonic phase (134). The discrepancy between these findings can be
attributed to differences in strain types and growth conditions used in the studies (90).
Nevertheless, field emission scanning electron microscopy (FESEM) and confocal
laser scanning microscopy (CLSM) based studies have revealed biofilms produced by C.
difficile to contain mats of rod-shaped vegetative cells, spores, and sporulating cells
interconnected through a network of ECM, and string-like materials connecting the cells
(135). Arguably, it is reasonable for C. difficile biofilms to constitute a higher proportion of
non-germinating

spores

since

germination

suppression

enables

more

spore
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dissemination and transmission. Spores are highly resilient to a vast range of
environmental insults and it can persist in the gut to cause recurrent infection (136,137).
Garth et al. have found fidaxomicin, an inhibitor of the sporulation process, to be more
potent than metronidazole and vancomycin at penetrating and disrupting C. difficile
biofilms in vitro, indirectly supporting precedent findings that C. difficile biofilms constitute
a significant number of spores (137). Additionally, their study revealed surotomycin to be
effective at disrupting C. difficile biofilms by killing vegetative cells within this community
(137). Unfortunately, the development of surotomycin remains incomplete due to poor
outcomes in a reported Phase 3 clinical trial (137,138). Nonetheless, the establishment
of persistent cells and spores within the biofilms potentially cause rCDI. In vivo, C. difficile
associates with commensal microbes within the mucus during CDI (139-141). Clumps or
aggregates (containing polysaccharides and extracellular DNA consistent with a typical
biofilm matrix) of C. difficile cells have also been observed in mouse models with
damaged intestinal tissues (86,90,139,141,142). In support of these findings, Normington
and group, using a model reflective of human colon, recently showed that C. difficile cells
and spores associate with polymicrobial biofilm communities, which leave vancomycin
and FMT treatments ineffective at depleting bacterial load (143). Composed of synergistic
species, including Candida parapsilosis, Staphylococcus warneri, and Bacteroides
thetaiotaomicron, the polymicrobial biofilms encase C. difficile via species-specific ECM
and facilitate bacterial growth (143). Since 8 to 18% of FMT patients are reported to
experience relapsing episode of CDI, it can be suggested that C. difficile within multispecies biofilm are responsible for causing rCDI (143).
In summary, C. difficile encodes flagella and TFP that aid in bacterial motility and
attachment to surfaces of the intestinal epithelial cells. Various motility modes such as
swimming, swarming, twitching, and gliding are coupled to signaling mechanisms and
nutritional sources that promote bacterial colonization in the host (144). Bacterial flagella
and TFP directly influence biofilm formation as deletion of either or both surface
appendages cause serious impairments in cell attachment, growth, and virulence
(135,144). Biofilm formation by C. difficile is further regulated by SLPs, Spo0A and the
luxS-mediated quorum sensing system (135).
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THE BACTERIAL STRINGENT RESPONSE
Bacteria are exposed to several adverse environmental conditions when colonizing a
potential host, including nutrient limitation, heat, and pH changes, high osmolarity,
reactive oxygen species, and antimicrobial peptides of the host innate immune system
(145-147). Bacteria must respond and adapt to these conditions efficiently to maintain
growth and survival (147). Therefore, bacteria have evolved several stress response
pathways that enable adaptation and survival, including the ubiquitous stringent response
(SR) mechanism (147). The SR is mediated by the nucleotide alarmones GDP-3’diphosphate (5’-ppGpp-3’) and GTP-3’-diphosphate (5’-pppGpp-3’) produced from GDP
and GTP, respectively (147-149). These nucleotides are produced by the members of the
RelA/SpoT homolog (RSH) protein superfamily (149). Synthesis involves transferring a
pyrophosphate group of ATP to the 3’OH group of the ribose moiety of GDP or GTP via
a nucleophilic attack of the β-phosphate of ATP by the 3’OH group of the substrate
(149,150). Furthermore, the presence of guanosine GMP-3’-diphosphate (5’-pGpp-3’)
has also been confirmed in numerous species, including Mycobacterium tuberculosis,
Enterococcus

faecalis,

Staphylococcus

aureus,

Mycobacterium

smegmatis,

Corynebacterium glutamicum, and Bacillus subtilis (151-157). To produce pGpp, bacteria
can directly utilize primary GMP and/or GMP that result from phosphatases-induced ester
hydrolysis of GTP (151). All three nucleotides or small nucleotide messengers are
collectively known as (pp)pGpp (149).
Three main groups of enzymes in the RSH superfamily regulate the intracellular levels
of (pp)pGpp, including long RSH or full-length RSH enzymes, small alarmone
synthetases (SAS), and small alarmone hydrolases (SAH) (148,149,158). Long RSH
enzymes have a hydrolase domain (HD) and a synthetase domain (SD) in their N-terminal
domain (NTD), and a regulatory C-terminal domain (CTD) (158). The CTD is comprised
of ThrRS, GTPase, and SpoT (TGS), helical, conserved cysteine (CC), and aspartate
kinase, chorismate, and TyrA (ACT) domains (158). The NTD contains RSHs’ catalytic
region where the hydrolase and synthetase domains act coherently to maintain an
optimum level of cytoplasmic (pp)pGpp based on immediate environmental conditions
(149,159-161). Binding of the substrate (GXP) and the ATP precursor to the synthetase
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domain of long RSH enzymes alters protein conformation, resulting in the activation of
the SD (149,162). Binding of ppGpp to the HD domain, on the other hand, induces
conformational changes that inactivates the SD while activating the HD to facilitate
nucleotide hydrolysis (149,162). Notably, the switch between domain activities is
presumed to occur via protein-protein interactions or small-molecule binding by the
enzymes’ non-catalytical CTD (147,159,160,163-166). The model Gram-negative
organism, E. coli, contains two long RSH enzymes. The monofunctional RelA has a
catalytically inactive pseudo-HD domain, while the bifunctional enzyme SpoT exhibits
weak synthetase activity and strong hydrolase activity (148,149). Gram-positive species
such as B. subtilis, Streptococcus equisimilis, S. mutans, and bacteria outside the βproteobacteria and γ-proteobacteria group also encode a single long RSH enzyme
bearing great sequence homology to E. coli RelA and SpoT (149). Gram-positive bacteria
also oftenly possess one or two monofunctional synthetases (167,168). The SASs lack a
hydrolase domain and are divided into several subfamilies that are spread across species
(169). RelQ and RelP from Firmicutes such as B. subtilis and S. aureus are the most
extensively characterized SASs. Other SASs that have been studied include RelV from
the Proteobacterium V. cholerae, and RelS as well as RelZ from the Actinobacterium
group (155,170). RelZ encoded by M. smegmatis is the only SAS enzyme whose
synthetase domain is fused to an RNase HII domain that separates RNA-DNA hybrid
structures during DNA replication, repair, and transcription (171). The last group of RSH
superfamily proteins is the SAH recently identified in C. glutamicum (172). C. glutamicum
RelH is a member of the metazoan SpoT homolog 1 L (Mesh1-L) subgroup that lacks a
SD and can hydrolyze (pp)pGpp in vitro (172). Interestingly, genes encoding for (pp)pGpp
synthetases and hydrolases are conserved in a few plants, including green algae,
Physcomitrella patens moss, Oryza sativa, and dicotyledon Arabidopsis thaliana,
Nicotiana tabacum, and Capsicum annnum (173). According to Ito et al., RSH encoding
genes were first introduced in proto-plant cells via the lateral gene transfer mechanism
from different bacteria (173,174). Very recently, Ito and colleagues demonstrated that
ppGpp accumulates in Mesh1 encoding Drosophila at all stages of metazoan
development (175). As in bacteria, overaccumulation of ppGpp in Drosophila causes
changes in cellular metabolome and cell death (175).
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Proteins that are not members of the RSH superfamily can also metabolize (pp)pGpp
in bacteria. For instance, E. coli encodes guanosine pentaphosphate phosphohydrolase
(GppA) that lacks the enzymatic domains of the long RSH NTD (176). GppA converts
pppGpp to ppGpp through its guanosine pentaphosphate phosphohydrolase activity,
presumably to refine ppGpp potency (176-178). In B. subtilis and Bacillus anthracis, a
nucleoside diphosphate linked moiety X (NuDiX) hydrolase called NahA degrades
pppGpp and ppGpp to pGpp in vitro and in vivo (156,157). Hydrolysis of pppGpp and
ppGpp between the 5’-α and 5’-β phosphate groups is postulated to fine-tune alarmone
regulation in the bacterial cells (157). Interestingly, Gram-negative E. coli also encodes
for NuDiX hydrolases such as MutT, NudG, and RppH to cleave pppGpp and ppGpp to
5’-pGp-3’ in vivo (179,180). However, Gram-positive species are not yet reported to
encode for GppA homolog(s) or enzyme(s) with identical GppA functionality (181).
Long RSH enzymes are regulated at the transcriptional level, with transcription
increasing during the late exponential or stationary phase of bacterial growth or upon
induced nutrient depletion by inhibitors of biosynthetic pathways (147,158,182-184). The
specific nutrients that trigger (pp)pGpp synthesis also vary between bacteria (182,185187). In E. coli, the relA gene is under the control of four promoters, two σ70-dependent
promoters, relAP1 and relAP2, and σ54-dependent P3 and P4 promoters (158,188).
Transcription from relAP1 is constitutive throughout growth, and activity is dependent on
a UP element (158,188). Transcription from relAP2 is induced when bacteria transition
from exponential growth to stationary phase (158,188). Conversely, transcription from
relAP3 and relAP4 is activated from nitrogen starvation in an NtrC-dependent manner
where NtrC is a master regulator of nitrogen limitation in the niche (158,188). E. coli relA
is further transcriptionally regulated by HipB, and 6S RNA. HipB is an anti-toxin
component of the type II toxin-antitoxin module HipAB involved in E. coli persister cells
formation (189,190). HipB negatively regulates relA transcription in E. coli by binding to a
sequence upstream of the P3 promoter (189,190). 6S RNA is a small non-coding RNA
that binds σ70-RNA polymerase (RNAP) to suppress E. coli relA transcription (190). Amy
et al. demonstrated that E. coli cells lacking 6S RNA present with increased transcription
of E. coli relA and subsequent accumulation of cytoplasmic ppGpp (191).
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Transcriptional regulation of Gram-positive long RSHs have not been characterized
as extensively as that of E. coli RelA. Swantjie et al. evaluated the response of S. aureus
to mupirocin or pseudomonic acid, which is a structural analog of isoleucyl-adenylate that
binds eubacterial and archaeal isoleucyl-tRNA synthetases (192). Binding of mupirocin
to isoleucyl-tRNA synthetases (which otherwise bind isoleucyl-tRNA-isoleucyl adenylate)
restricts the charging of isoleucyl-tRNA with isoleucine, resulting in the accumulation of
uncharged isoleucyl-tRNA (193,194). The increased concentration of uncharged tRNAs
represents amino acid starvation in cells that triggers the stringent response. Therefore,
the treatment of cells with mupirocin mimics amino acid limitation stress. According to
Swantjie et al., mupirocin induces S. aureus rel transcription in the S. aureus background
(192). In M. tuberculosis, rel gene encoding the long RSH enzyme is a part of the σE
regulon, which is positively regulated by polyphosphate chains that serve as a phosphate
donor to histidine Kinase MprB (158). MprB senses polyphosphate chains to
phosphorylate MprA, resulting in the upregulation of SigE transcription (158). SigE is an
alternative sigma factor, one of the master regulators of bacterial gene expression
involved in bacterial survival during stressful conditions. In M. tuberculosis, SigE
contributes to increased bacterial tolerance and persistence to antitubercular drugs (195).
Based on a study conducted by Kamakshi and colleagues, MrpA-P-driven activation of
SigE positively regulates M. tuberculosis rel transcription (196).
Transcriptional control of SASs has been elucidated for some Gram-positive bacteria.
Under stresses, SAS genes from B. subtilis are differentially regulated during growth
phases (158). The gene encoding B. subtilis RelQ (relQ) is transcriptionally regulated
during exponential growth, with mRNA transcript levels decreasing as cells transition into
the stationary growth phase (168). Conversely, the RelP encoding gene (relP) is induced
in the late exponential phase when there is a concurrent decrease in relQ transcription
(168). Of the seven identified sigma factors in the genome of B. subtilis, relP is part of the
σM and σW-induced regulons (158,197,198). Both sigma factors respond to cell wall
stresses, including vancomycin and alkaline shock, suggesting that SAS enzymes in this
organism are activated from extracytoplasmic stresses (158,168). Transcription of S.
aureus relP and relQ is also induced by vancomycin and exposure to ethanol, increasing
relP transcription by more than 20-fold (199,200).
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The intracellular accumulation of (pp)pGpp has a diverse range of biological
consequences in bacteria. (pp)pGpp can control critical metabolic pathways and
processes in a cell such as DNA replication, transcription, nucleotide synthesis, and
translation or protein synthesis. In E. coli, ppGpp directly binds to and inhibits the priming
activity of DnaG, a DNA primase that synthesizes RNA primers needed for DNA
replication (201,202). In B. subtilis, pppGpp not ppGpp binds DnaG primase to inhibit
replication elongation (203). Another consequence of (pp)pGpp accumulation during the
SR is a rapid change in gene transcriptional profiles. Ribosomal RNA (rRNA) synthesis,
tRNA synthesis, and transcription of genes involved in the metabolism of DNA and
phospholipids are dramatically suppressed with a coincident increase in the transcription
of amino acid biosynthesis genes and nutrient transporters (149,204). In all studied
Proteobacteria, ppGpp directly interacts with RNAP to influence gene transcription (178).
In E. coli, binding of ppGpp to RNAP σ70 holoenzyme in the presence of DksA
transcription factor allosterically potentiates alarmone-mediated inhibition of gene
transcription (204).
In contrast to Proteobacteria, (pp)pGpp in Firmicutes, Actinobacteria, and
Deinococcus Thermus do not bind RNAP but indirectly contribute to transcriptional
regulation (205). During the SR, the GTP nucleotide pool decreases due to the production
of (pp)pGpp via RSH enzyme-catalyzed pyrophosphoryltransferase reaction. A decrease
in the GTP pool is also attributable to the inhibition of GTP biosynthesis enzymes,
including inosine monophosphate dehydrogenase (GuaB) and guanylate kinase by
(pp)pGpp (157,206,207). In B. subtilis, a decrease in GTP levels reduces the transcription
frequency of σA -dependent promoters at the +1 position during amino acid starvation that
otherwise use GTP as a transcription initiating nucleotide (205,208). Similarly, GTP at +1
to +4 positions also have a role in S. aureus gene transcription during SR activation,
suggesting that initial mRNA elongation step is also sensitive to the intracellular GTP pool
(209). A global transcriptional repressor called CodY is also able to utilize GTP along with
branched-chain amino acids as cofactors to regulate gene expression (210). Present only
in Gram-positive species with low G + C content in their genomes, this nutritional regulator
senses changes in nutrient availability such that when the GTP concentration is high,
CodY binds the promoter regions of target genes to block the transcription of genes
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involved in carbon and nitrogen metabolism as well as in amino acid biosynthesis and
transport (210-212). When GTP levels are low, CodY-mediated repression of genes are
de-repressed enabling the transcription and adaptation of bacteria to the immediate
environment. In 2012, Geiger et al. demonstrated a direct association between the
stringent response and the CodY regulon (213). They found that out of 150 genes in S.
aureus that are upregulated during leucine and valine starvation, 143 are positively
regulated from CodY de-repression (213).
(pp)pGpp alarmones also inhibit protein synthesis. During the SR, (pp)pGpp targets
the guanine binding domain of translational GTPases initiation factor 2 (IF2) to prevent
30S initiation complex (30SIC) formation and translation (149,214,215). IF2 is the only
initiation factor that binds ribosome to facilitate 30SIC formation and subsequent
assembly of the 70S initiation complex (70SIC), which results in the formation of the
initiation dipeptide and the ribosomal pretranslocation complex (215). (pp)pGpp also
suppresses translation by targeting elongation factors EF-TU and EF-G. These
elongation factors are essential for charged tRNA delivery and translocation of the peptide
chain during protein synthesis (149). Additionally, (pp)pGpp inhibits the termination factor
F3, which during termination plays a critical role in the removal of release factors (RF) 1
and 2 (that hydrolyze and release the completed nascent chain from the P-site tRNA)
from the ribosome (149,216). Binding of ppGpp to RF3 reportedly slows down translation
(216). Finally, (pp)pGpp halts protein synthesis via inhibition of ribosomal maturation.
(pp)pGpp targets GTPases such as RsgA, RbgA, Era, HfIX, and Obg that function in the
maturation of individual 50S and 30S ribosomal subunits prior to the formation of mature
70S ribosomes (149,217).
Despite interfering with protein synthesis at different stages, (pp)pGpp can still
activate the transcription and translation of several genes required for the SR cascade.
Recently, Vinogradova and group showed that 30S-bound IF2 exhibits different tolerance
to 5’-ppGpp-3’ based on the mRNA present in the 30S pre-IC state (218). In E. coli,
structured enhancer of translational initiation (SETI) confers ppGpp tolerance for tuƒA
(encoding elongation factor EF-TU) and rnr (encoding RNase R) mRNA under
physiological concentrations of GTP (218). According to Vinogradova and group, SETImRNA binds to 30S pre-IC complexed with ppGpp and enables the substitution of ppGpp
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for GTP to allow translation (149,218). Furthermore, pppGpp bound to IF2 also enables
the permissive synthesis of proteins, albeit at higher IF2 concentrations (149,218).
One of the most intriguing aspects of the stringent response is its association with
virulence phenotypes (motility, adhesion, and invasion) and traits such as biofilm
formation, sporulation, toxin production, and antibiotic survival (Table 1) (147,149,219).
For instance, ppGpp is required for host cell invasion and regulation of virulence gene
expression in Salmonella typhimurium. Using a (pp)pGpp-null mutant of Salmonella
enterica subsp. enterica serovar Typhimurium, Pizarro et al. demonstrated that bacterial
invasion of intestinal epithelial cells is attenuated in the animal infection model (220).
Based on their study, a (pp)pGpp-null mutant exhibited reduced expression of hilA and
invF that encode two essential transcriptional activators of the Salmonella pathogenicity
island 1 (SPI-1) operon (220). SPI-1 encodes a type III secretion system responsible for
secreting factors that support bacterial uptake and invasion (220). (pp)pGpp also binds
to S. typhimurium SlyA transcriptional activator leading to SlyA dimerization in vivo (221).
The SlyA dimers subsequently bind to the target promoter DNA and influence the
transcription of the pagC virulence gene (221). PagC is an outer-membrane protein that
confers an appreciable degree of serum resistance to S. enterica serovar Choleraesuis
enabling infection establishment (222). The importance of (pp)pGpp to Salmonella
invasion was further explored by Dasgupta and colleagues who discovered that a
(pp)pGpp-null mutant strain displays decreased flagellar-motility and phagocytic uptake
by macrophages owing to diminished bacterial adhesion (223). Additionally, the role of
(pp)pGpp in bacterial invasion and intra-epithelial survival has been evaluated in C. jejuni.
In C. jejuni, the stringent response is specifically regulated by SpoT, and according to
Gaynor et al., a SpoT mutant strain exhibits poor invasion of human epithelial cell lines,
along with defects in host cell survival (224). Interestingly, the ΔSpoT strain also exhibits
higher susceptibility to rifampicin in comparison to the WT strain, suggesting that the SR
contributes to antibiotic resistance in C. jejuni (224).
The stringent response is critical for pathogenesis in P. aeruginosa as well. A relA
spoT double mutant strain of P. aeruginosa is severely attenuated in virulence in animal
models (225,226). According to Vogt et al., the double mutant strain secretes a reduced
amount of virulence factors, including pyocyanin, elastase, and the siderophore
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pyoverdine (225). Reduced production of these virulence factors is presumably due to
altered expression of the Las and/or RhI quorum sensing systems, suggesting that
quorum sensing signaling also contributes to the ability of P. aeruginosa to cause chronic
infection (225). The contribution of ppGpp in antibiotic tolerance to quinolone in P.
aeruginosa has also been evaluated. Knockout mutants of P. aeruginosa SpoT and dksA
appear to show higher survival rate in the presence of ofloxacin and ciprofloxacin
compared to relA knockout strain, suggesting that lower levels of ppGpp in the later strain
renders the mutant less tolerant to quinolones (227). Furthermore, the relA spoT double
mutant displays impaired flagellum-mediated swarming and TFP-mediated motility
compared to the WT strain, suggesting that (pp)pGpp is required for P. aeruginosa
adhesion (225). Since biofilm formation is dependent on bacterial motility, adhesion, and
translocation, the relA spoT double mutant strain of P. aeruginosa also exhibits reduced
biofilm formation and cell viability (226).
The contribution of (pp)pGpp in biofilm formation has also been implicated in other
species, including E. coli, V. cholerae, and S. mutans (228-230). In E. coli, fimbriae are
important factors for bacterial attachment to host cells (149). The expression of type 1
fibrial genes in uropathogenic E. coli is upregulated by (pp)pGpp via transcriptional
activation of the ƒimB gene whose protein product acts as a recombinase switch to turn
on the ƒimAICDFGH operon (149,228). Activation of the ƒimAICDFGH operon promotes
transcription of many fimbria-encoding genes with roles in bacterial adhesion and initial
steps of biofilm formation (228). (pp)pGpp-null uropathogenic E. coli mutants fail to
display fimbriae on their surface, resulting in impaired biofilm formation (228). In V.
cholerae, genes involved in biofilm formation are regulated by the transcriptional
activators vpsR and vpsT of the Vibrio exopolysaccharide operon, which in turn are
regulated by the stationary phase sigma-factor σS (rpoS) (229). According to He et al., all
three SR-mediating synthetases play a distinct role in the positive transcriptional
regulation of vpsR and vpsT, suggesting that biofilm formation is controlled by (pp)pGpp
(229). S. mutans form biofilms to tolerate pH changes and nutrient limitation in the human
oral cavity (230). S. mutans relA insertional mutants also show a significant reduction in
biofilm formation (230). Interestingly, Lemos and group found the biofilms of the relA
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mutants to be more resistant to acid killing, suggesting that the physical barrier of biofilms
contributes minimally to acid diffusion in this organism (230).
Apart from adhesion, antibiotic tolerance, and biofilm formation, (pp)pGpp also
regulates sporulation and toxin production in bacteria. During amino acid starvation, a
relA deletion mutant of B. anthracis demonstrates significantly reduced sporulation,
notably, without affecting bacterial virulence in animal models of infection (231). Upon
germination, B. anthracis produce toxins and a capsule where the toxin-form constitutes
of a protective antigen (encoded by pagA) with either the lethal factor (encoded by lef) or
oedema factor (encoded by cya) (231). The capsule, which is composed of poly-γ-Dglutamate aids in inhibiting bacterial phagocytosis during infection (231). Both toxins and
capsule formation in the organism are regulated by AtxA (231). However, relA deletion
does not impact pagA and atxA transcription, suggesting that the SR in B. anthracis is
more critical in priming cells to sporulate than in virulence factors production during
nutrient limitation (231). In V. cholerae, the toxin-coregulated pilus (TCP) and cholera
toxin are major virulence factors responsible for host colonization and symptomatic
infection (232). Expression of genes encoding these virulence factors is controlled by the
ToxR regulon, which includes ToxR (encoded by toxRS), TcpP (encoded by tcpPH), and
ToxT (encoded by toxT) transcriptional activators (232). Where ToxT directly initiates
cholera toxin and TCP genes transcription, TcpP and ToxR control the expression of ToxT
(232). TcpP is needed for bacterial colonization of the small intestine during early stages
of infection so that toxin production can be enabled (232). Recently, Raskin and group,
using ΔrelAΔspoTΔrelV strains demonstrated that tcpPH and toxT expression are
decreased in cells devoid of (pp)pGpp with a corresponding defect in bacterial
colonization and toxin production, suggesting that the SR regulates cholera toxin and TCP
induction in V. cholerae (232).
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Table 1.
Stringent response is widely conserved in bacterial groups. Summary of components
of the stringent response that contribute to virulence traits and phenotypes in diverse
bacterial species. Adapted from Dalebroux et al. 2010.
Pathogen

RSH enzyme(s)

Phenotypes/traits

Yersinia pestis

RelA, SpoT, DksA

Infection, dissemination

Legionella pneumophila

RelA, SpoT, DksA

Macrophage transmission

Shigella flexneri

RelA, SpoT, DksA

Intracellular spread

Mycobacterium tuberculosis

RelA

Persistence

Listeria monocytogenes

RelA, RelQ, RelP

Adherence, survival

Staphylococcus aureus

RelA, RelQ, RelP

Viability

Helicobacter pylori

SpoT

Macrophage survival

Due to the role of (pp)pGpp in bacterial virulence factor production, antibiotic
tolerance, infection, and persistence, there has already been some interest in inhibiting
the SR cascade. One of the first molecules to be synthesized for the targeted inhibition
of the SR-regulating RSH enzymes is Relacin (233). Relacin is a ppGpp analog in which
the molecule’s pyrophosphate moieties at positions 5’ and 3’ are substituted with a glycylglycine dipeptide linked to the sugar ring by a carbamate bridge (Fig. 4) (233,234).
Functionally, Relacin perturbs stationary phase onset and viability of Gram-positive B.
subtilis, Deinococcus radiodurans, and Streptococcus pyogenes (233). In vitro analyses
by Wexselblatt et al. also demonstrated that Relacin inhibits (pp)pGpp synthesis driven
by B. subtilis RelA and D. radiodurans RelA in a dose-dependent manner (233).
Furthermore, in B. subtilis and B. anthracis, Relacin largely inhibits sporulation by
lowering the number of cells expressing sporulation-specific enzymes required in different
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stages of the sporulation process (233). Relacin also reduces B. subtilis biofilm formation
(233). E. coli RelA-mediated (pp)pGpp synthesis is also inhibited by Relacin in vitro,
although the compound fails to inhibit E. coli growth and survival (233). Furthermore,
Relacin has no effect on the (pp)pGpp synthetase activity of SAS family synthetases,
indicating that the compound’s activity is specific for long RSH enzymes (152).
Employing the crystal structure of the N-terminal catalytic fragment of the long RSH
enzyme encoded by S. equisimilis, Wexselblatt and group also modeled the interaction
of Relacin with the enzyme’s SD to determine the molecule’s mechanism(s) of inhibition
(233). Based on their putative model, Relacin adopts an optimal conformation upon
binding to the extremely polar Rel/Spo synthetase domain active site (233). In this
conformation, Relacin forms a net of hydrogen bonds and strong hydrophobic interactions
with relevant amino acid residues within the domain’s GDP-binding pocket (233).
Additionally, the hydrophobic isobutyryl group of the compound at position N2 of the
guanosine base (Fig. 4, black dashed circle) makes contact with a defined hydrophobic
patch within the SD active site, ensuring high-affinity interaction and effective occlusion
of substrate binding (233).

Figure 4. Chemical structure of Relacin. Relacin contains an isobutyryl group
(dashed circle). Adapted from Wexselblatt et al. 2012 and 2013.
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Despite its efficacy at inhibiting RSH/Rel-mediated (pp)pGpp synthesis in vitro and
in vivo, and the long-term survival strategies employed by some deadly pathogens,
Relacin is only effective at millimolar concentrations. Therefore, efforts have been made
to increase the potency of Relacin by synthesizing analogs of the molecule (235,236).
Wexselblatt et al. synthesized a series of analogs that were symmetrically substituted
with several amino substituents (Fig. 6) in place of the moieties at positions 5’ and 3’
deoxyribose ring of Relacin (Fig. 5) (235). The activity of the inhibitors was also tested in
vitro using Rel enzymes encoded by B. subtilis, D. radiodurans, and E. coli. According to
Wexselblatt et. al., of all the symmetrically substituted analogs, compounds 2a and 2d
demonstrated highest inhibitory activity, potentially due to the replacement of basic
dimethylamino groups with carboxylic acid(s) (Fig. 6) (235). Between compounds 2a and
2d that only differ in the number of negatively charged species and in bulkiness,
compound 2a reduced intracellular levels of serine hydroxamate (SHX)-induced
(pp)pGpp levels in B. subtilis (235). SHX is a derivative of L-serine that serves as a
completive inhibitor of seryl-tRNA synthetases, mimicking amino acid starvation in
bacterial cells and evoking the SR (237). Compound 2d deemed significantly more
effective at reducing B. subtilis (pp)pGpp levels in vivo (235). Furthermore, compound 2d
was more effective at inhibiting (pp)pGpp synthesis via E. coli RelA and D. radiodurans
Rel/Spo in vitro (235). The efficacy and potency of compound 2d are directly attributable
to the two glutamyl-glutamic acid moieties of the analog (235). The six-total number of
carboxylic acids in this analog makes it more acidic and voluminous than the parent
Relacin molecule, enabling more hydrogen bonding and electrostatic salt bridges
formation during interaction with bacterial RSH synthetase domain (235).
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Relacin

Figure 5. Schematic representation of the synthetic route employed for
symmetric compounds analogous to Relacin. Reaction conditions as mentioned in
the reference Wexselblatt et al. 2013 from which the figure has been adapted.

Figure 6. Summary of symmetric substituents on the 3’ and 5’ positions of Relacin
deoxyguanosine ring to synthesize Relacin analogs. Adapted from Wexselblatt et
al. 2013.
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A

B

Figure 7. Modification of Relacin isobutyryl group. Analogs of Relacin where the
isobutyryl group have been substituted with (A) acetylated compound and (B)
acetylated benzoylated compound. Adapted from Sayal et al. 2017.

Syal et al. substituted the isobutyryl group at the second position of Relacin
guanosine base with either a bulkier benzoyl group or a less bulkier acetyl group called
acetylated benzoylated compound (AB) and acetylated compound (AC), respectively
(Fig. 7) (236). They found both compounds to inhibit M. smegmatis Rel-driven pppGpp
synthesis in vitro and in vivo, with compound AB being a more potent inhibitor of the
bacterial Rel protein (236). The group further demonstrated that both synthetic
compounds affect long-term M. smegmatis survival and biofilm formation (236). These
nontoxic and cell permeable agents also disrupt preformed biofilms produced by M.
smegmatis and arrest biofilm formation in M. tuberculosis (236). Overall, the chemical
modifications of Relacin render the molecule more potent, providing further modification
opportunities so that inhibitor activity in the nanomolar range can be attained for use in
the clinical settings.
Apart from Relacin and its structural analogs, molecules that interfere with the
bacterial SR have included vitamin C and an inhibitor peptide called peptide 1018 (234).
Vitamin C is an antioxidant agent that has roles in strengthening host immune system,
speeding recovery from a tuberculosis infection, and impeding pathogen progression,
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even killing M. tuberculosis (238). Vitamin C also alters regulatory pathways linked to
bacterial stress response and dormancy (238). Structurally, vitamin C has a furan ring
with 1,2 dihydroxy ethyl moiety that bears remarkable similarity to the chemical structure
of GDP. Sayl et al. showed that vitamin C inhibits (pp)pGpp synthesis in vitro in a dosedependent manner and in vivo via direct interaction with M. smegmatis Rel enzyme (238).
Furthermore, vitamin C lowers bacterial viability and the ability of M. smegmatis to form
biofilms, suggesting that vitamin C affects the SR in this organism by altering the levels
of (pp)pGpp (238). Unlike Relacin, Relacin derivatives, and vitamin C, synthetic peptide
1018 directly targets (pp)pGpp nucleotides (239,240). Peptide 1018 is a board-spectrum
anti-biofilm agent that prevents biofilm formation by diverse species, including P.
aeruginosa, S. enterica, E. coli, S. aureus, Klebsiella pneumoniae, Burkholderia
cenocepacia, and Acinetobacter baumannii at concentrations as low as 10 µg/mL (240).
During the stringent response, peptide 1018 specifically binds ppGpp as per coprecipitation and nuclear magnetic resonance spectroscopy (NMR)-based analyses
(240). Peptide-bound ppGpp nucleotides in P. aeruginosa undergo rapid molecular
degradation, leading to the inhibition of biofilm formation, cell death within biofilm
communities, and dispersal in matured biofilms (240). This suggests that peptide 1018
prevents (pp)pGpp signaling and the consequences of the signaling cascade, such as
virulence factors production in pathogenic strains. The synergistic effects of peptide 1018
against biofilms in conjugation with conventional antibiotics have also been investigated
(239). Reffuveille et al. demonstrated that peptide 1018 in combination with ciprofloxacin,
ceftazidime, imipenem, or tobramycin prevents biofilm formation and disrupts preformed
biofilms in a diverse group of bacteria (239). Furthermore, interaction between the peptide
and antibiotics results in a considerable decrease in antibiotic concentrations needed to
inhibit biofilm production (239). Notably, the peptide and ciprofloxacin combination
substantially increases the susceptibility of planktonic P. aeruginosa cells during SHXinduced stringent response, suggesting that the targeted degradation of (pp)pGpp by
peptide 1018 contributes to one, increased antibiotic susceptibility and two, decreased
biofilm production (239).
Recently, a diterpene analog, 4-(4,7-Dimethly-1,2,3,4-tetrahydroNapthalene-1yl)Pentatonic acid or DMNP was shown to suppress M. smegmatis persistence and

33

biofilm formation at concentrations as low as 0.14 mM (~14 X less than the efficacious
dose of Relacin) (241). The synthetic DMNP compound targets M. smegmatis Rel and
SAS (RelZ) to inhibit (pp)pGpp synthesis while also increasing bacterial antibiotic
susceptibility to streptomycin and rifampicin (241). Taken together, the bacterial SR
mechanism is a largely conserved stress signaling with diverse triggering factors. The
hallmark of the stress response, (pp)pGpp, which is metabolized by enzymes of the RSH
superfamily and beyond, have distinct but partially overlapping functions in bacterial
physiology. Due to the contributions of the stringent response in bacterial stress
tolerance, survival, and pathogenesis, both RSH enzymes and small alarmone
nucleotides catalyzed by RSHs are targets for pharmaceutical and pharmacological
interventions.
THE SCOPE OF THIS DISSERTATION
The main objectives of the work presented in this dissertation are to:
1. Investigate whether Clostridioides difficile can mount the stringent response using
recombinant gene expression and protein purification techniques; confirm protein
function and perform biochemical characterization of C. difficile full-length RSH
enzyme using thin layer chromatography assays and high-performance liquid
chromatography (Chapter II). This chapter is based on the publications Pokhrel et al.
2018 and Pokhrel et al. 2020.
2. Characterize full-length RSH-mediated (pp)pGpp signaling in C. difficile using
quantitative reverse transcriptase-polymerase chain reaction and an oxygenindependent fluorescent transcriptional reporter. Bacterial response to stationary
phase onset, nutrient limitation, and antibiotics exposure was examined (Chapter III).
This chapter is majorly based on the publication Pokhrel et al. 2020.
3. Evaluate the effect(s) of disrupting the stringent response in C. difficile stress
tolerance and survival using Relacin and RNA interference gene-silencing tool
(Chapter IV). This chapter is based on the publication Pokhrel et al. 2020.
4. Evaluate nutrient-derived motility regulation and single-species biofilm formation by
C. difficile using a home-built rose cell chamber for single cell motility analyses and
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plate-based biofilm production assays (Chapter V). Major aspects of this chapter are
based on the publication Courson et al. 2019.
Overall, this dissertation aims to introduce the ability of Clostridioides difficile to elicit
the stringent response pathway via the synthetase activity of its long RSH enzyme. The
research herein allows a greater understanding of a ubiquitous signaling system that is
also significant for the survival and pathogenesis of C. difficile. Additionally, this
dissertation aims at expanding the knowledge about factors contributing to C. difficile host
colonization and virulence factors production, such as motility and biofilm. These data
provide the foundation necessary for the synthesis and screening of small molecule
inhibitors of the enzyme that demonstrate high specificity. The use of C. difficile RSHspecific inhibitors in place of antibiotics or in conjugation with clinically available antibiotics
could significantly minimize antibiotics-induced risk factor development for CDI, along
with the side effect of bacterial antibiotic resistance in the host. The development of an
alternative therapy will alleviate the international health and economic burden associated
with C. difficile infection.
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CHAPTER II

BIOCHEMICAL CHARACTERIZATION OF FULL-LENGTH CLOSTRIDIOIDES
DIFFICILE RSH

OVERVIEW
The stringent response is a globally conserved stress signaling pathway, primarily
characterized by the cytoplasmic accumulation of ppGpp and pppGpp alarmones. ppGpp
and pppGpp are produced by members of the RSH superfamily from GDP and GTP,
respectively (149,158). The presence of pGpp (formed from GMP and/or degradation of
ppGpp and pppGpp has also been confirmed in several species (149). Together,
(pp)pGpp regulates key physiological processes within the cells, including the inhibition
of DNA replication, nucleotide synthesis and protein synthesis, with a concomitant
increase in the transcription of amino acid biosynthesis and transport genes (149).
Importantly, (pp)pGpp downregulates transcription of factors needed for growth and
division, while upregulating stress response and virulence genes (182). Genes encoding
proteins for (pp)pGpp metabolism are common in the genomes of Proteobacteria,
Eubacteria, and eukaryotes as well as metazoa (160,175).
Most Gram-positive RSH exhibit net (pp)pGpp hydrolysis activity under normal
growth conditions. The first crystal structure of the N-terminal catalytic fragment of fulllength S. equisimilis Rel (RelSeq) revealed two conformations of the fragment, hydrolaseOFF/synthetase-ON and hydrolase-ON/synthetase-OFF (159). Of the two conformations,
RelSeq assumes the default (pp)pGpp-hydrolase-ON/(pp)pGpp-synthetase-OFF state
until substrate binding to either catalytic site induces a mechanical switch of the
conformational state; a process controlled by the enzyme’s CTD (159,160,242). The
catalytical domain (aa residues 1- 347) and regulatory domain (aa residues 363 – 739) of
RelSeq is presumed to be linked by a solvent-exposed, flexible hinge (160,242). When
the two enzymatic domains of the NTD are aligned with one another and to the CTD, the
hydrolase domain is activated (160). However, when the contact between the NTD and
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CTD is perturbed, the NTD folds and undergoes a conformational change that leads to
the activation of the synthetase domain (160).
For instance, full-length RelSeq exhibits weak pyrophosphoryl transfer activity for
basal (pp)pGpp synthesis due to its interaction with the CTD. However, the transferase
reaction is activated ~12-fold in the absence of the C-terminal region of the enzyme in
vitro, suggesting that the CTD of RelSeq participates in the reciprocal regulation of the
two opposing catalytic activities of the NTD (160). Unlike RelSeq, M. tuberculosis Rel
(RelMtb) catalyzes both transferase and hydrolase reactions at the maximal rate in vitro
(243). But binding of full-length RelMtb to a complex containing uncharged tRNA,
ribosome, and mRNA results in a 20-fold increase in the rate constant for the catalytic
conversion of GXP to (pp)pGpp with a concurrent 2-fold decrease in the Kcat for (pp)pGpp
hydrolysis (243). The presence of uncharged tRNAs, which is caused by amino acid
limitation in bacterial cells, rapidly increases bifunctional Rel/RSH-catalyzed (pp)pGpp
synthesis while exhibiting an opposite effect when treated with charged tRNAs (243). The
regulation of the opposing catalytic activities of full-length RSH enzymes is extremely
critical since equally active, unregulated hydrolase and synthetase domains would
catalyze a futile cycle of alarmone synthesis and hydrolysis (242). Too much synthetase
activity would elevate cytoplasmic (pp)pGpp levels provoking the SR, whereas too little
(pp)pGpp from uncontrolled hydrolysis activity would restrict cells from responding
appropriately to extracellular stresses (242). Gram-positive bacteria also oftenly encode
one or two SAS enzymes that lack both N-terminal hydrolase and C-terminal regulatory
domains of the long RSHs (158). Studies have shown that deletion of RelQ, RelP or both
while leaving an intact RSH enzyme has minimal effects on the intracellular (pp)pGpp
accumulation during the stringent response (167,168). However, in the absence of an
intact long RSH enzyme, constant yet low production of alarmones by SAS results in an
increased basal (pp)pGpp levels in E. faecalis, suggesting that SASs contribute to basal
levels of (pp)pGpp under normal physiological conditions (244-246).
The synthetase reactions catalyzed by RSH and SAS enzymes are universally
dependent on Mg2+ cofactor(s) although both enzymes differ in their catalytic mechanism
of (pp)pGpp synthesis. According to Sajish et al., a charge reversal in the highly
conserved RXKD motif of the long RSH synthetase domain to EXDD in the SAS domain
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contributes to the differential effect of metal cofactor and also impacts substrate
preference (151,247). When concentrations of Mg2+ are higher than that of the total
nucleotide pool, binding of Mg2+ to the full-length RSH enzyme presumably causes a
protein conformational change that occludes substrate binding, resulting in the inhibition
of (pp)pGpp synthesis (160,243,247). Using fluorescent-based nucleotide binding assays
and circular dichroism studies, Sajish and group revealed that the RXKD motif of
bifunctional RSH enzymes contribute to poor nucleotide binding and structural
transitioning of the catalytic loop (α-13/β-4 loop of the SD as per the crystal structure of
the N-terminal catalytic domain of RelSeq) strongly in favor of an alpha-helix in the
presence of high Mg2+ (159,247).
Of note, high Mg2+ concentrations do not affect enzyme-catalyzed reactions for
proteins employing a dual-divalent cation mechanism (247). The closest structural relative
to the SD of RelSeq is the palm domain of mammalian DNA polymerase β (polβ) (159).
Of the three highly conserved aspartate amino residues that coordinate two Mg2+ ions in
polyβ, only two carboxylic acid groups (D264 and E323) are conserved in the RelSeq
synthetase domain, suggesting that the absence of a third carboxylic group potentially
enables a single-divalent cation mechanism for RSH-mediated (pp)pGpp catalysis
(159,247). In the contrary, high Mg2+ concentrations appear to have no effect on SASmediated (pp)pGpp synthesis (247). The two additional negative charges in the EXDD
motif of SAS enzymes create a second Mg2+ binding site lacking in the RXKD motif,
suggesting that SASs follow a dual-divalent cation-mediated catalysis (247).
Furthermore, the charge reversal in the RKXD motif of long RSH proteins to EXDD in
SASs also influences substrate specificities. Full-length RSH proteins with an RXKD motif
preferentially utilize GTP to produce pppGpp, whereas SASs with an EXDD motif prefer
GDP as the primary substrate to produce ppGpp (151).
During host colonization and infection, C. difficile encounters and adapts to
environmental changes using different stress response pathways. We have found that C.
difficile genome encodes a putative long RSH and a SAS, RelQ, suggesting that the
organism is capable of mounting the SR (147). The long RSH protein contains the wellconserved RXKD motif and we predict the enzyme to be bifunctional (147). To determine
the substrate preference and kinetics of RSH encoded by C. difficile (RSHCd), we
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expressed hexa-histidine tagged recombinant RSHCd in a non-native background and
purified the enzyme using metal affinity chromatography (248). We subsequently
performed in vitro (pp)pGpp synthesis reactions in the presence of guanosine phosphate
derivatives and commercially available γ-32P-ATP or 32P-ATP and monitored enzymecatalyzed pyrophosphoryl transfer activity using thin layer chromatography (TLC)
(147,248). While characterizing the contribution of RSHCd to (pp)pGpp synthesis in vitro,
we found RSHCd incapable of utilizing GTP and GMP (147). Based on the enzyme’s strict
GDP utilization unlike its Gram-positive full-length RSH homologs, we previously reported
that RSHCd produces 5’-ppGpp-3’ (147,248). We also found GDP utilization by RSHCd
to be independent of environmental pH and to lack metal cofactor specificity (147).
We initially predicted that the production of ppGpp by RSHCd is either due to the
exclusive utilization of GDP or rapid degradation of unstable pppGpp to ppGpp under the
experimental conditions used although RSHCd binds GTP with poor affinity, indicating
that the interaction likely doesn’t occur in vivo (147). In Gram-negative bacteria, pppGpp
is broken down to ppGpp via GppA, whose homologs remain to be identified in Grampositive species. Very recently, Yang et al. identified NahA, a NuDiX hydrolase encoded
by B. subtilis and B. anthrasis to be able to hydrolyze pppGpp and ppGpp to pGpp (157).
Like other SR-regulating alarmones, pGpp regulate purine nucleotide biosynthesis in
bacterial cells without interacting with GTPases (157). To confirm that the exclusive 5’ppGpp-3’ synthesis is a unique feature of RSHCd, we have used purified RelQ from B.
subtilis (RelQBs) as a positive control to detect the products catalyzed by in vitro
(pp)pGpp synthesis reactions using anion exchange chromatography. We found that
incubation of RelQBs with GTP and GDP results in the formation of pppGpp and ppGpp,
respectively (Poudel et al. in preparation). Unexpectedly, high performance liquid
chromatography showed that the consumption of ATP by RSHCd occurred concurrently
with the apparent formation of triphosphate species, leading us to hypothesize that
RSHCd produces pGpp instead of ppGpp in the presence of GDP substrate. In support
of this hypothesis, our thin layer chromatography assay demonstrated that incubation of
RelQBs with GMP and 32P-ATP results in the formation of spot (representing pGpp) that
in polyethyleneimine (PEI)-cellulose plate migrates similar distance with putative pGpp
produced by RSHCd (Poudel et al. in preparation). The principal rule governing (pp)pGpp
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synthesis requires a pyrophosphate moiety from ATP to be transferred to the 3’-OH group
of GMP, GDP or GTP substrate by members of the RSH superfamily (243). Based on this
rule, we postulate that GDP is being degraded to GMP, enabling RSHCd to catalyze an
ATP-dependent pyrophosphate transfer to synthesize pGpp (Poudel et al. manuscript in
preparation). Additionally, we postulate that RSHCd hydrolysis activity requires regulation
by the CTD via interaction with branched-chain amino acids and that the enzyme
harnesses a default synthetase activity in isolation or independent of biological effectors.
We found that the overexpression of the monofunctional RSH-REL domain is extremely
toxic to bacterial cells, suggesting that the CTD and the HD domain of full-length RSH
coordinate to prevent excessive intracellular accumulation of (pp)pGpp in C. difficile.
Overall, this chapter focuses on characterizing the synthetase activity of full-length
C. difficile RSH, which is predicted to be regulated by the enzyme’s intact hydrolase and
C-terminal regulatory domains. Segments of this chapter previously appeared as articles
in the references (248) and (147). The rights and permission to use the materials of the
publications is given in Appendix M. Published figure numbers and formats have been
modified unless stated otherwise in the legends.
METHODS AND MATERIALS
Overexpression and purification of C. difficile RSH
Restriction enzymes and DNA ligase used in this study were purchased from New
England Biolabs (NEB). Phusion DNA polymerase for polymerase chain reactions (PCR)
was purchased from Themro Fisher Scientific. rsh (CDR20291_2633) gene was amplified
from the genomic DNA of C. difficile R20291 using primers (Appendix B) that added a Cterminal hexa-histidine tag, ligated into the pMMBneo expression vector at the KpnI and
PstI restriction sites, and transformed into E. coli BL21. The plasmid was confirmed by
PCR using rsh gene-specific primers (Appendix B).
E. coli expression strain carrying pMMBneo vector ligated with hexa-histidine
tagged rsh gene was grown in Luria Bertani (LB) treated with 50 µg/mL kanamycin (Kan50)
at 37 degrees Celsius (°C) to an optical density (OD) of 0.16 to 0.25 at 600 nm (if OD600
reached above this range, cell cultures were back diluted into fresh LB-Kan50 at the
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desired OD value or range), at which point the temperature was dropped to 30°C and
expression was induced using 0.5 mM isopropyl β-d-1-thiogalactopyranoside (IPTG) for
16 hours (hrs). Cells were lysed by sonication in the lysis buffer composed of 10 mM TrisHCl pH 7.8, 300 mM NaCl, 5 mM MgCl2, 50 mM NaH2PO4, 10% glycerol, 0.5 mg/mL
lysozyme,

10

mM

imidazole,

0.25

mM

dithiothreitol

(DTT)

and

5

mM

phenylmethylsulphonyl fluoride (PMSF). After treatment with the lysis buffer, the lysates
were clarified by centrifugation and subsequently transferred to a gravity column filled
with 1 mL of HisPure Ni-nitrilotriacetic acid (Ni-NTA) resin (G-Biosciences). Protein
purification was conducted according to the manufacturer’s protocol. Notably, all
purification buffers included 5 mM MgCl2 which was found to be critical for protein
stabilization and purification. Purification fractions were run on a Sodium dodecyl sulfate
polyacrylamide gel (SDS-PAG) (4% stacking and 10% separating) via electrophoresis to
resolve the elutant fractions. Purified RSHCd (elutant fraction 2) was dialyzed overnight
(ON) at 4°C against dialysis buffer composed of 15.7 mM Tris-HCl pH 7.6, 471.9 mM
NaCl, 15.69 mM MgCl2, 1.57 mM DTT, 1.5 mM PMSF, and 15.7% glycerol. A 30 kilodalton
(KDa) molecular weight cutoff (MWCO) dialysis membrane (Spectra/Por Spectrum®
Laboratories Inc.) was used for protein dialysis. Concentration of C. difficile RSH was
determined from Beer’s law by measuring the absorbance at 280 nm and using the
calculated molar extinction coefficient 82085 M-1cm-1. Aliquots of the protein were stored
at -80°C for subsequent use.
Purification of B. subtilis RelQ
Plasmid bearing E. coli BL21 strain (received from the Bauer laboratory, Indiana
University, USA) were grown to OD600 of 0.4 in LB-Kan50 before ON induction for protein
expression at 16°C with the addition of 0.2 M IPTG. Cells were collected by centrifugation
and resuspended in StrepTactin wash buffer (IBA Lifesciences) composed of 0.1 M TrisHCl pH: 8.08, 0.15 M NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), and 20%
glycerol. Cells were lysed by sonication and the lysates were clarified by centrifugation at
12,000 revolutions per minute (RPM) (Beckman coulter JA 12.0 rotor) at 4°C prior to
loading onto a StrepTactin resin column (IBA Lifesciences). The column was washed with
the wash buffer (IBA Lifesciences) followed by protein elution with elution buffer
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composed of 0.1 M Tris-HCl pH: 7.92, 0.15 M NaCl, 1 mM EDTA, and 2.5 mM
desthiobiotion (IBA Lifesciences). The elutants were collected in three separate fractions
and stored at - 80°C in 5 to 10 µL aliquots to be used for subsequent enzymatic assays.
When necessary, fractions were combined, and spin concentrated at 4,500 RPM
(Beckman Coulter JA-12 rotor) for 15 minutes (mins) using a 10 KDa MWCO spin
concentrator

(Sartorius).

Concentration

of

B.

subtilis

RelQ

was

determined

spectrophotometrically.
Overexpression and purification of C. difficile RSH-REL
rsh-rel, a truncation construct of the full-length rsh gene, was amplified from
pMMBneo::rsh expression vector using primers (Appendix B) that also added a Cterminal hexa-histidine tag. The amplicon was subsequently digested and ligated into
pMMBneo vector at the KpnI and PstI cut sites and transformed into E. coli DH5-α
background. The plasmid was confirmed by PCR using rsh-rel-specific primers (Appendix
B). Amplified rsh-rel was also digested and ligated into pBAD33 vector at the KpnI and
PstI sites. The plasmid pBAD33::rsh-rel (Appendix A) was subsequently transformed into
DH5-α first, followed by plasmid extraction from DH5-α background and transformation
into E. coli BL21. The plasmid was confirmed by PCR using rsh-rel-specific primers
(Appendix B).
For RSH-REL purification, rsh-rel was amplified from pMMBneo::rsh expression
vector using primers (Appendix B), digested and ligated at the NdeI and XhoI cut sites
into pET24a vector fused with a hexa-histidine tag. The plasmid, pET24a::rsh-rel
(Appendix A) was transformed into E. coli BL21 expression strain. Transformation was
confirmed using gene-specific primers (Appendix B). The expression strain was
eventually grown in LB-Kan50 supplemented with 0.5% casamino acid (CAA) and 0.5%
glucose (GLU) at 37°C ON. The following day, the ON starter culture was spun at 4°C
using a JA-12 rotor (Beckman Coulter) at 500 RPM for 30 mins. The pellet was
resuspended in plain LB-Kan50 medium and allowed to grow till the cell density reached
0.5 to 0.8 at 600 nm. At this point the cells were diluted down in fresh plain LB-Kan50 to
bring the OD600 at ~0.14. When the new OD600 value was between 0.14 to 0.16, the
temperature was dropped to 30°C and expression was induced using 0.5 mM IPTG ON
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(16 to 20 hrs). After induction, cells were lysed by sonication in the lysis buffer composed
of 10 mM Tris-HCl pH 7.8, 300 mM NaCl, 5 mM MgCl2, 50 mM NaH2PO4, 10% glycerol,
0.5 mg/mL lysozyme, 10 mM imidazole, 0.25 mM DTT, and 5 mM PMSF after which the
lysates were clarified by centrifugation and subsequently purified using HisPure Ni-NT
resin (G-Biosciences) according to the manufacturer’s protocol. Like RSHCd purification,
all RHS-REL purification buffers included 5 mM MgCl2. Purification fractions were run on
a 4% stacking and 12% separating SDS-PAG via electrophoresis. Concentration of the
elutant fraction (resolving in a clean band) was determined spectrophotometrically.
Purified RSH-REL were stored at -80°C in 5 to 10 µL aliquots to be used for enzymatic
assays.
Growth curves
Growth curve was performed using a 96-welled microtiter plate (BrandTech) after
the induction of C. difficile rsh in E. coli DH5-α background. Log phase cultures of E. coli
cells were inoculated in LB-Kan50 in the presence or absence of 0.5 mM IPTG inducer.
The plate was incubated at 37⁰C shaking for a total of 12 hrs. Growth of induced vs
uninduced cells were monitored every 30 mins. Growth curve assays following the
induction of C. difficile rsh-rel in E. coli DH5-alpha background was also conducted in the
same manner. Supplementation with nutrient sources, including CAA and GLU were
initiated from time point 0 mins for both pMMBneo::rsh and pMMBneo::rsh-rel vector
carrying strains in the presence of the 0.5 mM IPTG inducer.
In

vitro

measurement

of

RSHCd

synthetase

activity

using

Thin

layer

chromatography (TLC)
RSHCd synthetase assays were conducted in buffer containing 10 mM Tris-HCl
(pH 7.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT and 0.12 mM ATP (ATP at
the working concentration of 0.6 mM can also be used). A 5X buffer stock was mixed with
the indicated concentrations of GDP/GTP/ADP (0.2 – 0.6 mM), MgCl2 always 2X more
than the concentration of GXP or AXP, and 1.0 μCi of γ-32P-ATP. The use of 32P-ATP
radioisotope was presented as a proposal to and approved by the University’s Radiation
Safety Office committee prior to experiment designing and conduction (Appendix L).

43

Pyrophosphate transfer reactions were initiated by adding RSHCd at a final concentration
of 3.0 µM and a reaction volume of 10 µL. Post-incubation at 37°C for indicated time
points, reactions were stopped by spotting 2 µL samples on PEI-cellulose plates, allowing
the spots to dry. The plates were subsequently developed in 1.5 M KH2PO4 (pH 3.64 ±
0.05) and autoradiographed using the Storm 860 Phosphorimager from GE Healthcare
Life Sciences. RSHCd-catalyzed product signal was quantitated using ImageJ software
as previously described (249). RSHCd synthetase activity was expressed as the
percentage of 32P-ATP converted into inorganic phosphate (Pi) for alarmone synthesis
(Appendix C).
Allosteric feedback regulation of RSHCd by 5’-ppGpp-3’ was evaluated in the
same manner in the presence of 0 to 10 µM of exogenous ppGpp (TriLink). Furthermore,
the effect of different divalent metal cations as well as buffer pHs on RSHCd synthetase
activity were also investigated under reaction conditions mentioned above. Metal
cofactors studied included Mg2+, Mn2+, Co2+, Cu2+, Zn2+, Ni2+, Ca2+, and Fe2+ at the
working concentration of 1.2 mM. Buffer pH studied included values of 5.0, 6.0, 7.5, 9.0,
and 10.0. The effect of both metal cations and pH values on RSHCd pyrophosphoryl
transfer activity was assayed at least three times. Post-incubation, the reaction mixtures
were spotted on PEI-cellulose plates to perform the standard one-dimensional TLC
assay.
High-performance liquid chromatography (HPLC)
Instrumentation for all HPLC analyses included the use of a dual-pump Ultra-HighPerformance Liquid Chromatograph system with ultraviolet detectors (Schimazdu). The
analytical column used for running nucleotide samples was a strong anion exchange
DNAPacTM PA100 (4 x 250 mm) column with a guard column (4 x 50 mm) from
ThermoScientific. HPLC mobile phase buffer A and B was composed of 50 mM KH2PO4
and 500 mM KH2PO4 and 500 mM Na2SO4, respectively. The buffers were adjusted to a
neutral pH (7.00 ± 0.09) using HPLC grade concentrated orthophosphoric acid and
potassium hydroxide. The following sections include a detailed procedure for the use of
the HPLC system for the analysis of various samples.
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A. Nucleotide standards run
Nucleotide standards, including GDP (Alfa Aesar), GTP (BioBasic), and GMP
(BioWorld) at the concentration of 20 µM were separated using a gradient elution at the
flow rate of 1.0 mL/min and absorbance at 252 nm. Total run duration was set at 22 mins
per sample.
B. Sample preparation for the analysis of intracellular (pp)pGpp in RSH-REL expressing
E. coli cells using HPLC
For analysis of intracellular (pp)pGpp in RSH-REL-induced E. coli cells, ON starter
cultures of E. coli strain carrying either empty vector pBAD33 or pBAD33::rsh-rel were
inoculated in LB medium treated with 10 µg/mL chloramphenicol. Cultures were allowed
to grow till OD600 reached ~0.5. At mid log phase, cells were induced with 0.5% arabinose
(ARA) for 3 hrs at 30°C. Post-induction, cell densities were remeasured (OD600 1.1 – 1.3)
followed by spinning the cells at the maximum speed using a JS 5.3 rotor (Beckman
Coulter). The supernatants were discarded appropriately, and cell pellets were stored in
-20°C ON. The following day, pellets were thawed and resuspended in extraction buffer
composed of MeOH/ acetonitrile/ Millipore water at the ratio of 40:40:20 with 0.1 N formic
acid by vigorous shaking or vortexing. The pellets were incubated in the extraction buffer
at -20°C for 30 mins by positioning the conical tubes upright. The resuspensions were
subsequently transferred into new Eppendorf tubes on ice and cell debris were pelleted
by centrifugation at 13,000 RPM for 5 mins at 4°C using a benchtop centrifuge. Postcentrifugation, ~200 µL of the extractions were recovered which underwent neutralization
with 4 µL of 15% NH4HCO3 (pH 7.0 – 7.7) per 100 µL of sample. After neutralization,
samples were filter sterilized with 0.45 µm filter units and speed vacuumed for over 30
mins. Samples were finally diluted in Millipore water and stored in -20°C ON prior to
running through an anion exchange column.
For HPLC, a gradient elution was set up where the concentrations of mobile phase
Buffers A and B were changed accordingly for a total run duration of 31 mins per sample.
Samples were separated at a flow rate of 1.5 mL/min and absorbance at 260 nm was
used to detect the eluted nucleotides.
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C. Analysis of in vitro RSHCd and RelQBs synthetase reactions using HPLC
RSHCd synthetase activity was separately conducted in a buffer composed of 10
mM Tris-HCl (pH 7.5 ± 0.02), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT, 0.12
mM ATP (ATP up to 0.6 mM can also be used), 0.2 or 0.6 mM GXP, and 1.2 mM MgCl2.
Reactions were started by adding RSHCd at a final concentration of 3.0 µm and incubated
at 37°C on a portable heat block for a total duration of 30 mins. After 30 mins, ~100 µL
samples were transferred into a VIVA SPIN 500 spin column (Corning) with a MWCO of
30 KDa and spun at 12,000 times gravity (X g) for 5 mins at 20°C. The filtrates were saved
in a new Eppendorf tube and stored in -20°C ON to run through the anion exchange
column the next day.
Likewise, RelQBs synthetase activity was separately conducted in a buffer
composed of 10 mM Tris-HCl (pH 7.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM
DTT, 0.12 mM ATP, 0.2 mM GDP or GTP, 5 mM MgCl2, and 3.0 µM RelQBs. Reactions
were incubated at 37°C on a portable heat block for 30 mins. Post-30 mins, ~45 µL
samples were transferred into a VIVA SPIN 500 spin column (Sartorius) with a MWCO of
10 KDa and spun at 12,000 X g for 5 mins. The filtrates were saved in a new Eppendorf
tube and stored in -20°C ON to run through the anion exchange column the next day.
Notably, all samples were run on the HPLC system using a gradient elution profile where
absorbance at 252 nm was used to detect enzyme-catalyzed (pp)pGpp alarmones.
C. Analysis of in vitro RSHCd hydrolase reactions using HPLC
RSHCd hydrolysis activity was conducted against a buffer containing 50 mM TrisHCl (pH 7.52), 25 mM ammonium acetate, 10 mM KCl, 1 mM DTT, 0.2 mM ATP, 0.1 mM
exogenous 5’-ppGpp-3’ (Trilink), and 0.2 mM MnCl2 in a mini plastic vial. Reactions were
initiated by adding RSHCd at a final concentration of 0.6 µM into a dialysis tubing with a
MWCO of 12 to 14 KDa (Spectra/Pro) and incubated at 37°C. The whole reaction was
conducted within an incubator (Thermofisher) set at 37°C for a total duration of 4 hrs in a
manner similar to the standard dialysis procedure. At 0 and 4 hrs time points, ~20 µL
samples were drawn from the hydrolase reaction mixture outside of the membrane tubing
and pipetted into mini HPLC-grade vials (AQ Brand) to run through the anion exchange
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column at 1.0 mL/min flow rate. Absorbance at 260 nm was used to detect the reduction
in ppGpp signal between 0 and 4 hrs of reaction incubation.
LiCl-based extraction of radiolabeled nucleotides for RSHCd hydrolysis activity
RSHCd pyrophosphate transferase reaction was conducted separately in the order
mentioned above and separated on a PEI-cellulose plate. The plate was left to dry after
which the retention factor of RSHCd-catalyzed product was manually calculated.
Radioactive strips corresponding to the radiolabeled spots was subsequently cut from the
plate using sterile scissors. The strips were then immersed in 15 mL of 4 M LiCl into a 50
mL conical tube. The strips were incubated in the LiCl solution for 15 mins at room
temperature. The solution was then filter sterilized using a 45 mm, 0.2 µm filter. The pH
of the solution was measured and adjusted to 7.24 with concentrated formic acid and
ammonium hydroxide. After acid-base neutralization, the solution was aliquoted into 1.5
mL Eppendorf tubes (9X) and spun at 4,000 X g using the benchtop centrifuge. Following
centrifugation, the precipitates were washed with 95% ethanol (5 mL total) to remove
residual LiCl. The ethanol washed-radioactive nucleotides were centrifuged for 5 mins at
4,000 X g and finally suspended in Millipore water to store in -20°C for further use.
Measurement of in vitro RSHCd hydrolysis activity using TLC
In vitro hydrolase assay was conducted in a buffer containing 10 mM Tris-HCl (pH
7.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT and 0.12 mM ATP. A 5X buffer
stock was mixed with ~0.5 µL of radiolabeled LiCl-extracted nucleotide product in the
presence of 1.2 mM MnCl2. The use of 32P-ATP for the synthetase and hydrolase
reactions was approved by the University’s Radiation Safety Office committee (Appendix
L). Reactions were initiated by adding RSHCd at a final concentration of 3.0 µM and a
total reaction volume of 10 µL. Reactions were stopped by spotting 2 µL samples on a
PEI-cellulose plate, allowing the spots to dry for at least 10 mins. The plate was
subsequently developed in 1.5 M KH2PO4 (pH 3.64). The plate was exposed to the
phosphor cassette for at least 4 hrs and autoradiographed using the Storm 860
phosphorimager from GE Healthcare Life Sciences.
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Isothermal Titration Calorimetry (ITC)
ITC analyses were conducted using an ITC200 Micro-Calorimeter from Malvern.
300 µL of purified RSHCd was added onto the cell component of the instrument and the
syringe was filled by 40 µL of GXP ligand. Protein and ligand were prepared in the same
buffer composed of 10 mM Tris-HCl (pH 7.5), 5mM ammonium acetate, 1.2 mM MgCl2,
0.2 mM DTT, 0.012 mM ATP, and 2 mM KCl. 1.2 µM protein and 12 µM ligand
concentrations were used in the interaction analysis experiments at 37⁰C. ITC
experiments were repeated at least three times where the heat of dilution obtained
through the titration of ligand into the reference solution was used as a blank and
subtracted from all binding curves attained in the presence of RSHCd and GXP. The data
obtained were fitted using a single-binding-site model by Origin Software. The same
software was also used for peak integration and thermodynamics calculation.
RESULTS
C. difficile has conserved (pp)pGpp metabolism genes
The complete genome sequence of C. difficile strain R20291 has been searched
for homologs to the conserved (pp)pGpp synthetase domain of RelA/SpoT-like proteins
in diverse bacteria. The analysis has identified two putative open reading frames, rsh
(KEGG ID, CD2633) in an operon with predicted beta-lactamase gene and a gene for
tRNA metabolism, D-aminoacyl-tRNA deacylase dtd (148). C. difficile R20291 also
encodes a conserved SAS, relQ (KEGG ID, CD1607) in a predicted operon with a putative
beta-lactamase gene (148). As both rsh and relQ share predicted operons with yet to be
characterized beta-lactamase like proteins, it can be suggested that the proteins may
confer bacterial tolerance in C. difficile to beta-lactam family of antibiotics such as
ampicillin and penicillin (Fig. 8A) (147). The product of rsh is a putative Rel/SpoT homolog
(RSHCd) with two conserved N-terminal synthetase and hydrolase domains and ACT and
TGS C-terminal regulatory domains (Fig. 8B) (147). C. difficile RelQ (RelQCd) is a
proposed single-domain small alarmone synthetase (Fig. 8B). Based on our
bioinformatics analysis, both rsh and relQ genes are completely conserved between the
non-epidemic 630, 630Derm, and the epidemic R20291 strain (147).

48

Figure 8. (pp)pGpp metabolism in C. difficile. (A) Operons of predicted (pp)pGpp
metabolism genes (blue) and beta-lactamase like proteins encoding gene (pink). (B)
Domain organization of predicted (pp)pGpp metabolism. Figure adapted from Pokhrel
et al. 2020.
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Figure 9. Alignment of amino acid sequences of the catalytic synthetase domain
RSHCd with the primary sequence of other RSH family enzymes. Alignment of
RSHCd and RelQCd with RelP/RelQ/SAS enzymes from B. subtilis, E. faecalis, S.
aureus, and S. equisimilis. Adapted from Pokhrel et al. 2020.
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Table 2.
Sequence alignment summary between RSHCd synthetase domain with its
relatives. RSHCd synthetase domain sequence shares high % identity and similarity
with those of RelA and RSH/Rel encoded by S. equisimilis and B. subtilis, respectively.
Table adapted from Pokhrel et al. 2020.

% Identity

% similarity

S. equisimilis RelA

43.6

62.9

B. subtilis Rel or RSH

50.7

69.4

Alignment of the amino acid sequence of RSHCd with those of known proteins
belonging to the RSH superfamily of enzymes revealed that the sequences exhibit high
similarities, particularly to the substrate binding and product coordination regions of the
N-terminal synthetase domain (Fig. 9) (147). Many functionally significant and charged
amino acid residues, including D264, Y308, E323, G240, H342, and A335 from S.
equisimilis RelA (RelSeq; GenBank accession no. X72832) are conserved in RSHCd,
suggesting that the enzymes share functional, and presumably structural homology (Fig.
9) (147,159,168). Several hydrophobic amino acid residues found in the synthetase
domain of B. subtilis Rel/RSH (GenBank accession no. U86377), which are predicted to
coordinate Relacin binding to the active site, are also conserved in the RSHCd synthetase
domain (Table 2) (147,168). The great percentage identity and similarity between RSHCd
and B. subtilis RSH suggests that RSHCd can potentially be inhibited by Relacin in a
manner comparable to B. subtilis RSH inhibition (Table 2) (147).
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Expression of RSHCd causes partial growth arrest in E. coli
Precedent studies have revealed that the intracellular accumulation of (pp)pGpp,
as a result of amino acid starvation, leads to a delayed bacterial growth phenotype in
exponentially growing E. coli cells (242,250). Upon the IPTG-dependent induction of fulllength C. difficile rsh, we also observed a partial growth inhibition of exponentially growing
E. coli cells (Fig. 10) (147). The observed inhibition of E. coli growth suggests that RSHCd
mediates the production and cytoplasmic accumulation of (pp)pGpp while also inducing
native E. coli stringent response. We found that the partial growth arrest of cells due to
the overaccumulation of (pp)pGpp can be rescued through supplementation with CAA
(Fig. 10B) (147). This shows that C. difficile potentially responds to amino acid starvation
via activation of the stringent response, followed by RSH-mediated (pp)pGpp synthesis,
which slows growth and rapid division, favoring survival (147).
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Figure 10. Overexpression of RSHCd partially arrests bacterial growth. Growth
curves of E. coli strain carrying either empty pMMBneo vector (A) or IPTG-inducible
rsh-ligated pMMBneo expression vector (B) in plain LB medium or LB supplemented
with CAA in the presence or absence of 0.5 mM IPTG. Adapted from Pokhrel et al.
2020.
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RSHCd exclusively utilizes GDP to produce magic spot in vitro
The enzymatic activity of full-length RSHCd has also been studied to confirm that
the enzyme is a (pp)pGpp synthetase (248). Hexa-histidine-tagged C. difficile R20291 rsh
has been expressed in E. coli and its product purified using nickel affinity chromatography
and SDS-PAG electrophoresis in the presence of 5 mM MgCl2 (Fig. 11) (248). We found
that failure to include MgCl2 results in the loss of protein activity even upon including the
metal cation in the activity buffer, indicating that the divalent cation plays a crucial role in
protein folding and stability in addition to enzyme catalysis. To confirm the synthetase
activity of RSHCd, radiolabeled y-32-PATP has been utilized to directly monitor the
transfer of a radiolabeled pyrophosphate group from ATP to the non-radiolabeled GDP
substrate (248). Thin layer chromatography has been used subsequently to separate and
quantify radiolabeled alarmones using autoradiograms (248). Nearly five decades ago,
E. coli responding to amino acid starvation lead to the production of molecules, which in
TLC autoradiograms “magically” appeared as spots that weren’t synthesized by nonstarving bacterial cells (242,251). Since the molecules hadn’t yet been characterized to
be the derivatives of GDP and GTP, researchers began denoting the spots of the
autoradiograms as “magic spot”. We also denote the RSHCd-produced alarmones
collectively as the magic spot in this dissertation. For quantification purpose, magic spot
signal was presented as a percentage of the total radioactive signal (Fig. 13 and 14B,
Appendix C) (248). By doing so, we ensured for data reproducibility and prevented the
introduction of random noises (which can be caused from pipetting errors and/or
radioactive decay) in our analyses (Appendix C) (248).
Based on the primary sequence of RSHCd N-terminal synthetase domain, the
enzyme contains the well conserved RXKD domain (Fig. 9). Consistent with precedent
observations regarding the effect of increasing metal ion concentrations on basal RelSeq
and RelMtb synthetase activity, we found that RSHCd also exhibits reduced magic spot
synthesis in the presence of higher Mg2+ concentrations (Fig. 12) (247). This finding
suggests that RSHCd depends on a single-divalent cation mechanism to synthesize the
magic spot. Furthermore, inhibition of enzyme catalysis at higher Mg2+ concentrations
also suggests that the RXKD motif of RSHCd negatively impacts GDP binding of the
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protein while potentially causing a conformational change in the predicted synthetase
domain catalytical loop as reported for RelMtb (247).

~ 85 KDa

Figure 11. Purification of full-length RSHCd. Coomassie-stained SDS-PAG showing
lysate (L) and clarified lysate (CL) of induced BL21 strain carrying the expression vector
as well as flow-through (FT), wash 1 (W1), wash 2 (W2), and elution fractions 1 (E1)
and 2 (E2) after nickel affinity purification. RSHCd is ~85 KDa in molecular weight
(dashed black circle). Adapted from Pokhrel et al. 2018.
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Figure 12. Effect of increasing concentrations of Mg2+ on RSHCd-mediated magic
spot synthesis. Reaction was incubated at 37°C for 60 mins with 0.6 mM GDP, 3.0
µM RSHCd, 0.12 mM ATP, and indicated concentrations of MgCl2. TLC assay was
performed to quantitate magic spot synthesis. One-Way ordinary ANOVA analysis with
Turkey’s multiple comparisons test. Adjusted * P 0.0253. Error bars indicate standard
deviations from three independent reactions.
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Figure 13. A typical autoradiogram of TLC assay. PEI-cellulose plate depicting the
32P-ATP spots, magic spots, and spot origin or location of a reaction carried out using
purified RSHCd in the presence of GDP substrate. NP denotes no protein. Adapted
from Pokhrel et al. 2018.
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Figure 14. Functional characterization of RSHCd. (A) Absolute signal intensities of
32P-ATP and the magic spot as a function of time. (B) Magic spot synthesis is
represented as percentages of the total radioactive signal. Adapted from Pokhrel et al.
2018.
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Interestingly, the RXKD motif of RSHCd appears to have no influence on the
enzyme’s substrate preference as is the case for RelSeq and RelMtb (151,247). Unlike
RelSeq and RelMtb, RSHCd does not utilize GTP to synthesize pppGpp (Fig. 15) (147).
Notably, GTP appears to stimulate ATP hydrolysis by RSHCd, which corresponds to the
robust inorganic phosphate (Pi) spots in the autoradiogram, suggesting that the enzyme
recognizes the substrate but cannot accommodate the triphosphate form of the nucleotide
in its active site to enable pyrophosphate transfer (147). Furthermore, SAS enzymes from
E. faecalis and B. subtilis can also utilize GMP to produce pGpp, but RSHCd does not
utilize GMP either, demonstrating high specificity for GDP (Fig. 15) (147,152,168).
The finding that RSHCd does not utilize GTP despite carrying the highly conserved
RXKD motif in its synthetase domain was further explored. RSHCd was incubated with a
mixture of GDP and GTP at the ratio of either 1:1 or 1:2 in the presence of ATP. Reaction
products were subsequently separated using TLC. Based on the TLC autoradiogram,
RSHCd failed to utilize GTP at equimolar concentration of GDP and at an excess
concentration of GTP in the same reaction mixture (Fig. 16) (147). Furthermore,
commercially available GMP, GDP, and GTP nucleotide standards were also run
separately through an anion exchange column in the HPLC system. We found that the
GTP peak resolves in the chromatogram completely devoid of contaminants and
derivative compounds (Fig. 17) (147). This suggests that the inability of RSHCd to utilize
GTP is not due to substrate impurity and/or degradation (147).
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Figure 15. Analysis of substrate preference and utilization of RSHCd. TLC
autoradiogram of in vitro RSHCd transferase activity using different substrates. RSHCd
readily transfers radioactive pyrophosphate from 32P-ATP to GDP but cannot utilize
GMP or GTP as a substrate. ATP hydrolysis appears to increase Pi levels in the
presence of GTP. Adapted from Pokhrel et al. 2020.
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Figure 16. TLC autoradiogram of in vitro RSHCd transferase activity at different
GDP:GTP ratio. In vitro transferase reaction using equimolar concentration of GDP and
GTP (0.15 mM each) and 2X more GTP (0.2 mM) than GDP (0.1mM) keeping the total
substrate concentration equivalent to 0.3 mM. NP denotes no protein. Adapted from
Pokhrel et al. 2020.
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Figure 17. HPLC chromatogram of GTP, GDP, and GMP standards. Standards were
run separately at the concentration of 20 µM as 252 nm readout. Adapted from Pokhrel
et al. 2020.

Biochemical characterization of RSHCd synthesis activity
We found RSHCd to exclusively utilize GDP, therefore, we next measured the
kinetic constant (Km) for the RSHCd-mediated (pp)pGpp synthetase reaction. The
synthesis reaction that was assayed involved the incubation of RSHCd at 3.0 µM with
0.12 M ATP and 1.0 µCi 32P-ATP in the presence of various concentrations of GDP.
Based on our reactions, the ability of RSHCd to convert GDP and excess radioactive ATP
to the magic spot increases with increasing concentrations of GDP (Fig. 18A and 18B)
(147). As a magic spot synthetase that only utilizes GDP for a substrate, we found that
RSHCd binds GDP with a Km of 95 µM (Fig. 18C), which is physiologically relevant to the
levels of GDP (< 128 µm) in the cytoplasm of exponentially growing E. coli cells (147,252).
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Furthermore, ppGpp and pppGpp is a positive allosteric regulator of magic spot
synthesis catalyzed by E. coli RelA and B. subtilis SAS, respectively (150,253). In E. coli,
rapid production of ppGpp resulting in the activation of a positive feedback response is
postulated to concurrently activate a fast-coordinated response that is mediated by the
SpoT enzyme (253). As a strong (pp)pGpp hydrolase, E. coli SpoT serves as a threshold
filter that controls cells from committing to full stringency during the SR cascade (253).
Since RSHCd is a putative bifunctional enzyme with an intact synthetase and hydrolase
domains, we investigated whether its synthetase activity (in the presence of GDP) is
allosterically regulated by the ppGpp product. Upon incubation of RSHCd with GDP, ATP,
and increasing concentrations of exogenous 5’-ppGpp-3’ (Trilink), we found that the
magic spot synthesis activity of RSHCd is not regulated by a positive feedback
mechanism (Fig. 19) (147).
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Figure 18. Biochemical characterization of RSHCd. (A) Conversion of radiolabeled
ATP to magic spot increases with a corresponding increase in GDP concentrations. (B)
Nonlinear fit of velocity vs [GDP]. (C) Lineweaver-Burk plot of RSHCd activity. Km of
RSHCd for GDP is 95 µM. Figures A and C adapted from Pokhrel et al. 2020.
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Figure 19. Evaluating allosteric regulation of RSHCd. RSHCd activity in the
presence of increasing concentrations of exogenous 5’-ppGpp-3’. Enzyme activity at
different 5’-ppGpp-3’ concentrations were compared by One-Way ANOVA analysis of
variance. n.s., not significant. Adapted from Pokhrel et al. 2020.
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RSHCd synthetase activity is unaffected by pH or the type of metal ion cofactor
Like several biochemically characterized long RSH enzymes, RSHCd is an overall
basic protein with an isoelectric point of 8.81 (147,160,254). RSHCd synthesizes magic
spot, presumably ppGpp, in the presence of GDP at a buffer pH of 7.5 (147,248). Notably,
a pH of 7.5 is a value that corresponds to the pH range (7.1 - 7.5) of the normal colonic
perimucosa (147,255). To investigate the effect of environmental pH on the substrate
utilization of RSHCd, in vitro pyrophosphate transfer reactions were carried out separately
in various buffer pH values, including 5.0, 6.0, 7.5, 9.0, and 10.0. (Fig. 20). We found that
RSHCd synthesizes magic spot at all buffer conditions studied but fails to utilize GTP at
any tested pH value (Fig. 20) (147). This finding suggests that RSHCd cannot bind to or
accommodate GTP regardless of the titration status or the ionic strength of the SD amino
acid residues (Fig. 20) (147) .
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Figure 20. Effect of pH on RSHCd synthetase activity. TLC autoradiograms (A)
showing the accumulation of magic spot in the presence of GDP or GTP at any given
pH value. Graphical representation of the GDP autoradiogram (B) demonstrating that
RSHCd utilizes GDP without exhibiting any pH specificity. Magic spot synthesis at
various pH values was compared to that at pH 7.5 by One-Way ANOVA. n.s., not
significant. Adapted from Pokhrel et al. 2020.

67

Pyrophosphokinases and nucleic acid-metabolizing enzymes need metal cofactor(s) to
coordinate negative charge(s) for enzymatic reactions (147). Magnesium is abundantly
present in the bacterial cytoplasm (~100 mM) and is the most utilized ion for nucelotidyl
transfer reactions (147,256). Previous studies have shown that Mg2+ is employed by
RelMtb and RelSeq for the optimal synthesis of (pp)pGpp in vitro (159,160,243,257).
Recently, Methylobacterium extorquens RSH was shown to synthesize pppGpp more
efficiently in the presence of Co2+ than Mg2+ (147,258). The catalytic palm domain of
human DNA polymerase b bears structural kinship with the active site of RelSeq
synthetase domain (147,159,247). According to Vashistha et al., human Polb can use
Zn2+, Mn2+, and Co2+ along with Mg2+ to catalyze primer extension (147,259,260).
Notably, Zn2+, Mn2+, and Co2 have an ionic radius similar to that of Mg2+ (147,259,260).
Ca2+ has an ionic radius that is significantly larger than that of Mg2+ and does not enable
primer extension, suggesting that the human Polb exhibits selectivity for specific metal
cofactors (260).
To investigate the metal cofactor selectivity of RSHCd, we performed in vitro
pyrophosphate transfer reactions in the presence of different divalent cations (Fig. 21)
(147). Of the eight metals tested, including Mg2+, Mn2+, Co2+, Cu2+, Fe2+, Zn2+, Ni2+, and
Ca2+, only Cu2+ significantly yet modestly reduced RSHCd-driven magic spot synthesis
(Fig. 21) (147). This suggests that the enzyme readily employs a wide array of structurally
diverse cations for a cofactor to catalyze pyrophosphate transfer (147). We postulate that
the substitution of Mg2+ with different cations becomes most relevant to C. difficile under
environmental condition(s) where specific metal ions are depleted and/or during
competition for metals with host-metal sequestering proteins (147).

68

Figure 21. Effect of divalent metal cations on RSHCd synthetase activity. TLC
autoradiogram (A) showing the accumulation of magic spot in the presence of GDP or
GTP in the presence of different metal ion cofactors at a buffer pH of 7.5. Graphical
representation of the GDP autoradiogram (B) demonstrating that RSHCd utilizes GDP
without exhibiting any metal ion specificity. Levels of magic spot synthesis were
compared by One-way ANOVA. * P < 0.01. Adapted from Pokhrel et al. 2020.
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RSHCd binds GTP with poor affinity
To further investigate the lack of GTP utilization by RSHCd, we examined the
interaction of RSHCd with GDP and GTP using isothermal titration calorimetry (147).
Based on our ITC data, we found that RSHCd binds to GDP and GTP with an association
constant of 31.9 M-1 (Fig. 22) and 25.1 M-1 (Fig. 23), respectively (147). This finding
indicates that RSHCd interacts with GTP despite failing to catalyze the synthesis of
pppGpp. During exponential growth, bacterial cells maintain GTP at concentrations
ranging from 900 to 1,100 µM, a 2 to 10-fold excess compared to the concentrations of
GDP (147,252,261,262). During stationary phase onset, both ATP and GTP are rapidly
depleted, with ATP levels recovering more faster from the conversion of guanosine
nucleotides to (pp)pGpp (252,262). Despite interaction, we found the binding affinity of
RSHCd for GTP to be lower than that for GDP (147). During stationary phase, the
physiological concentrations of GDP is relatively higher than that of GTP, indicating that
RSHCd can preferentially utilize GDP as a substrate due to its abundancy and availability
(147). Notably, we found RSHCd to bind GTP at a protein to substrate ratio of 1:10 (147).
However, failure to utilize GTP to produce pppGpp was observed at a much larger protein
to substrate ratio of 1:200 (147). Nevertheless, these results suggest that RSHCd may
transiently bind to GTP at different stages of bacterial growth, but the consistent
abundancy of GDP in the bacterial cytoplasm potentially enables the enzyme to readily
respond to the substrate for enzyme catalysis (147). Furthermore, the “K” value from our
ITC data represents the association constant computed from a single-site-binding model
(Fig. 22 and 23) (147). We observed that the K value of RSHCd for GDP is lower than the
Km value of 95 µM quantitated through TLC (147). We hypothesize that the observed
variation in K values is arising from nonspecific interaction of GDP with the C-terminal
domain of full-length RSHCd (147,163).
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Figure 22. Interaction analysis of RSHCd with GDP. Isothermal titration calorimetry
thermogram (top) and Wiseman plot (bottom) of RSHCd interaction with GDP at 37°C.
The upper panel shows the raw data for titration of GDP with RSHCd, and the lower
panel shows the integrated heats of binding obtained from the raw data. The data were
fitted to a single-binding model. Each value is the average of three repeat experiments
and the standard deviation ± are shown. RSHCd binds to GDP at a K value of 31.9 M1

. Adapted from Pokhrel et al. 2020.
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Figure 23. Interaction analysis of RSHCd with GTP. Isothermal titration calorimetry
thermogram (top) and Wiseman plot (bottom) of RSHCd interaction with GTP at 37°C.
The upper panel shows the raw data for titration of GTP with RSHCd, and the lower
panel shows the integrated heats of binding obtained from the raw data. The data were
fitted to a single-binding model. Each value is the average of three repeat experiments
and the standard deviation ± are shown. RSHCd binds to GTP at a K value of 25.1 M1

. Adapted from Pokhrel et al. 2020.
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RSH-REL lacks regulation by the HD and CTD of full-length RSHCd
As mentioned previously, the C-terminal regulatory domains of long RSH enzymes
control the opposing hydrolase and synthetase activity of the N-terminal region (159,160).
In E. coli (pp)pGpp synthesis is negatively regulated by the CTD either by mediating RelA
oligomerization or via intramolecular interaction with the enzyme’s N-terminal domain
(160,263,264). However, upon binding to uncharged (non-aminoacyl) tRNA in complex
with ribosomes, CTD positively regulates RelA-mediated (pp)pGpp synthesis (264).
RelSeq and RelMtb NTD are also positively regulated by the enzymes’ CTD in the
presence of uncharged tRNAs such that (pp)pGpp synthesis increases when uncharged
tRNAs are bound to a complex of ribosome + mRNA (160,243). Interestingly, regulation
of the Rel/RSH hydrolase domain, capable of hydrolyzing the small molecule alarmones,
also appears to involve the CTD in diverse bacterial species. Fang et al. demonstrated
that the ACT domain present in Rhodobacter capsulatus Rel, along with S. equisimilis
Rel, B. subtilis Rel and E. coli SpoT bind branched-chain amino acids to stimulate its
hydrolysis activity (166). Very recently, Shin and colleagues solved the atomic structure
of the interaction between valine and the ACT domain of RelMtb using NMR, confirming
the role of the CTD of bifunctional RelMtb in the positive allosteric regulation of (pp)pGpp
hydrolysis (265).
In order to determine whether RSHCd synthetase domain activity is regulated by
the RSHCd CTD, we designed and cloned a truncation construct of RSHCd called RSHREL, which is a monofunctional synthetase derivative of the full-length RSHCd (Fig.
24A). Overexpression of RSH-REL appeared to be extremely toxic to E. coli even in the
absence of the IPTG inducer, suggesting that the enzyme is hyperactive (Fig. 24B) (147).
It is so active that trace transcription of rsh-rel from an uninduced, leaky promoter results
in sufficient RSH-REL protein product to produce inhibitory/potent levels of magic spot
(147). RSH-REL-driven toxicity can be partially rescued by supplementation with 1% CAA
and is further enhanced by the additional supplementation with 1% GLU (Fig. 24B) (147).
The finding that full-length RSHCd slows E. coli growth while RSH-REL completely
arrests it suggests that (pp)pGpp toxicity is modulated by the presence of and the activity
of the regulatory CTD and/or activation of the hydrolase domain in RSHCd (147).
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Figure 24. Cloning and overexpression of RSH-REL. (A) Schematic representation
of full-length RSHCd (1-735 amino acid residues) alongside the truncation construct;
RSH-REL (amino acid residues 113–388). The theoretical molecular weight of the
construct is provided (~33 KDa). Growth of E. coli cells carrying pMMBneo::rsh-rel
vector in LB medium supplemented with Casamino acids (LB-CAA), glucose (LB-GLU)
or both (LB-GLU-CAA). Bottom figure adapted from Pokhrel et al. 2020.
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RSH-REL produces magic spot in vitro
To confirm the functionally of RSH-REL enzyme, recombinant RSH-REL was
purified using metal affinity chromatography. We found that the protein runs at a higher
molecular weight (MW) (between 40 and 45 KDa) on a 4% stacking, 12% separating
SDS-PAG (Fig. 25A). This finding suggests that the enzyme could be undergoing posttranslational modification such as glycosylation and phosphorylation or the protein is
interacting with potential binding partners, contributing to its increased weight. Peptide
amino acid composition has been directly linked to the difference between SDS-PAGEdisplayed MW and the theoretical MW of enzymes. Guan et al. demonstrated that the
difference in MW of several enzymes is linearly correlated with the percentage of acidic
amino acid that fits the equation y = 276.5x - 31.33 (where x represents the percentage
of D and E amino acids combined, and y represents the average ΔMW per amino acid
residue) (266). Based on the equation, y = 0 when x = 11.3% in which case the observed
MW on an SDS-PAG is identical to the enzyme’s theoretical MW (266). RSH-REL
constitutes approximately 16% acidic amino acids in its primary sequence and with the
application of the “y = 276.5x - 31.33” equation, it can be inferred that the band size
discrepancy is not due to PTM. The calculated ΔMW (~5 KDa) also corresponds to the
approximate added weight to the theoretical MW of RSH-REL enzyme (Fig. 25A). Like
full-length RSHCd, RSH-REL enzyme utilizes GDP and ATP to produce the magic spot
but appears to be incapable of utilizing GTP (Fig. 25B). Furthermore, expression of RSHREL results in the cytoplasmic accumulation of ppGpp in E. coli cells (Fig. 25C).
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Figure 25. Overexpression, purification, and functional characterization of RSHREL. (A) 4%, 12% SDS-PAGE gel image of purified RSH-REL protein. Lanes 1 through
10 were loaded with marker (L), clarified lysate (CL), prepped CL, flow-through (FT),
CL FT2, wash 1 FT, wash 2 FT, wash 3 FT, elute 1 (E1), and elute 2 (E2). (B) TLC
autoradiogram of RSH-REL protein utilizing GDP for reaction catalysis. (C) HPLC
chromatogram of 5’-ppGpp-3’ detected in exponentially growing E. coli cells expressing
RSH-REL in the presence of the IPTG inducer. Filtered cell extracts post-induction were
run through a strong anion exchange column at the flow rate of 1.5 mL/min. Sample
readouts were obtained at 260 nm.
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RSHCd HD requires activation by biological effectors of the CTD
The differential regulation of the synthetase and hydrolase domain activities in
bifunctional S. aureus Rel (RelSau), RelSeq and RelMtb has been characterized
(160,164,243). Like E. coli, the synthetase domain activity of RelMtb is activated in the
presence of uncharged tRNAs alone or from an imbalance in the ratio of uncharged
tRNAs to charged tRNAs, which is characteristic of cytoplasmic amino acid depletion
(243). But in vitro synthetase activity significantly increases in the presence of and upon
complex formation of RelMtb with ribosome, uncharged tRNA, and mRNA (243).
Similarly, the synthetase domain of RelSeq, an enzyme exhibiting a net specific activity
strongly in favor of (pp)pGpp degradation, is also activated in a stalled ribosomedependent manner (159,160). The CTD of RelSeq is directly involved in the reciprocal
regulation of the two opposing activities in the NTD of RelSeq (160). Free RSHCd
optimally utilizes GDP to produce basal levels of magic spot at Mg2+ concentrations
approximately 2-fold higher than the concentration of GDP substrate (147,248).
To investigate how the opposing synthesis and hydrolysis activities of RSHCd are
differently regulated, we evaluated the hydrolase activity of RSHCd. The hydrolase assay
involved the extraction and use of radiolabeled magic spot (product of a separate
pyrophosphate transfer reaction) as a substrate, Mn2+ metal cofactor, and full-length
RSHCd for pyrophosphohydrolase catalysis. Based on literature evidence, Mn2+ optimally
coordinates (pp)pGpp to the hydrolase domain of long RSHs (160,243). For instance,
RelSeq in the presence of Mn2+ optimally catalyzes (pp)pGpp hydrolysis at 2 to 3-fold
molar excess over the total concentration of nucleotide substrate at pH values ranging
from 7.2 to 9.5 (160). However, we found RSHCd to exhibit a net synthesis activity in
isolation (Fig. 26). The failure to hydrolyze the magic spot to yield inorganic
pyrophosphate (PPi), suggests that the hydrolase domain requires regulation by
branched-chain amino acids and/or yet to be characterized biological effector(s) of
alarmone metabolism. Analysis of in vitro RSHCd pyrophosphohydrolase activity through
HPLC also resulted in a modest reduction of the exogenous ppGpp signal after 4 hrs of
reaction incubation, further suggesting that the hydrolase domain of RSHCd requires
regulation by the CTD, presumably via interaction of the ACT domain with branched
chained amino acids, including valine, isoleucine, and leucine (Fig. 27).
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Figure 26. Characterization of in vitro RSHCd hydrolase activity using TLC.
Autoradiogram of RSHCd hydrolase activity with Mn2+, full-length RSHCd, and
radiolabeled magic spot. Radiolabeled magic spots were extracted using Li2+ from a
separate synthetase reaction. Failure to detect the hydrolysis product in the
autoradiogram suggests that the reaction requires effectors of the CTD domain to
produce detectable levels of PPi.
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Figure 27. Analysis of in vitro RSHCd hydrolase activity via HPLC. HPLC
chromatogram comparing 5’-ppGpp-3’ signal between 0 and 4 hrs of RSHCd-mediated
hydrolysis reaction in vitro. Reaction mixture after 0 and 4 hrs of incubation were run
separately through a strong anion exchange column at the flow rate of 1.0 mL/min.
Sample readout was obtained at 260 nm.
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RSHCd produces triphosphate product in the presence of GDP
The unique finding that RSHCd utilizes only GDP for a substrate was further
evaluated through the functional characterization of RelQ from B. subtilis. RelQBs is a
small alarmone synthetase that shares the conserved synthetase fold with the long RSH/
Rel enzyme. Unlike monomeric Rel/RSH proteins, RelQBs forms highly symmetric
homotetramers and binds ATP and GXP in a sequential order to catalyze pyrophosphate
transfer (150). A unique feature of the RleQBs homotetramer is the presence of a cleft in
its center that enables the binding of two allosteric pppGpp molecules (150). Cell wall
antibiotics and perturbations of cell envelope from alkaline stress induce B. subtilis relQ
expression, leading to a strong accumulation of (pp)pGpp, which can be detected via high
performance liquid chromatography-coupled mass spectrometry (168,198).
Recently, Fung et al. demonstrated that the expression of gene encoding RelQBs
also results in the accumulation of 5’-pppApp-3’ in addition to (pp)pGpp in vivo (267). The
increase in the levels of these alarmones are dramatically suppressed in a synthetase
mutant strain of RelQBs (SASD87G), suggesting that the accumulation of multiple
alarmones apart from (pp)pGpp are also dependent on the magic spot synthesis activity
of RelQBs (267). Of the multiple alarmones, pGpp is the most strongly induced small
alarmone nucleotide for several reasons (267). Firstly, ppGpp is rapidly degraded to pGpp
by the NuDiX family hydrolase, NahA (156). Secondly, RelQBs is capable of directly
producing pGpp through the utilization of GMP for a substrate as ΔnahA strains
accumulate lower but detectable levels of pGpp (156). Fung et al. also reported that the
accumulation of diverse alarmones corresponds with changes in the levels of intracellular
purine nucleotide (267). Rapid depletion of GTP is postulated to occur from the inhibition
of GMP kinase by pGpp, suggesting that (pp)pGpp target de novo purine biosynthesis
enzymes (156,267). Based partially on the purification protocol established in Fang et al.
2018 as well as direct consultations with the first author of the publication, we purified
RelQBs from an E. coli expression strain and performed in vitro pyrophosphate transfer
reactions to subsequently run reaction products through an anion exchange column in
the HPLC system (Fig. 28) (166). We also incubated RelQBs and RSHCd separately with
GMP, GDP, GTP or ADP (RSHCd only), 1.0 µCi γ-32P-ATP, and ATP at 37°C to
subsequently perform one-dimensional TLC assay (Appendix D). As expected, RelQBs
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synthetized pGpp, ppGpp, and pppGpp from GMP, GDP and GTP, respectively
(Appendix D). RSHCd specifically utilized GDP to synthesize magic spot (Appendix D).
However, RSHCd-produced magic spot ran parallelly with RelQBs-produced pGpp as
depicted in the autoradiograms, indicating that RSHCd is not producing ppGpp alarmone
(Appendix D). To confirm that RSHCd-mediated catalysis is yielding a triphosphate
product rather than a tetraphosphate product using GDP as the substrate, we tested the
ability of RSHCd to utilize ADP (Appendix D). B. subtilis RelQ can utilize ADP as a
substrate to yield 5’-diphsophate-adenosine-3’-diphosphate (5’-ppApp-3’), which migrate
similar distances to guanosine-three phosphate alarmones on a PEI-cellulose plate
(258,267). The similarity in the retention factor or migration of ppApp with guanosinethree phosphate molecules is due to the steric hindrance imposed by or the higher mass
of the guanosine base in comparison to the adenosine base. Since mobility of molecules
in TLC is dependent on its molecular weight as much as its affinity for the stationary
phase, and since RSHCd does not utilize GMP, we hypothesized that RSHCd uses ADP
to produce ppApp (248). Contrary to our hypothesis, we found that RSHCd fails to utilize
ADP, confirming that RSHCd is producing guanosine-triphosphate alarmone in the
presence of GDP under the experimental conditions used (Appendix D).
Analysis of in vitro RSHCd and RelQBs-mediated (pp)pGpp synthesis via the
highly sensitive HPLC technique also revealed that RSHCd produces a triphosphate
alarmone that co-elutes with the GTP standard (Fig. 28). We postulate that the minor
discrepancy in the retention times between RSHCd-produced alarmone and the GTP
standards is due to slight variations in the pH value of the mobile phase buffers, which
are prepared fresh and filter sterilized every time prior to sample running. The pH values
of the mobile phase buffers can also change overtime if the buffers are stored at room
temperature, which contributes to minor changes in the retention time of same
compounds run through a column on different experimental days.
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Figure 28. Analysis of RelQBs and RSHCd-catalyzed pyrophosphoryltransferase
reactions in vitro using HPLC. Reactions were conducted separately in the presence
of the indicated substrate with either 3.0 µM RSHCd or RelQBs. The sample filtrates
alongside the standards were run through a strong anion exchange column using a
gradient elution at the flow rate of 1.0 mL/min. Absorbance at 252 nm as a readout is
presented showing that RelQBs produces ppGpp and pppGpp from GDP and GTP,
respectively. Whereas RSHCd produces triphosphate alarmones in the presence of
GDP that co-elute with the GTP standard. This experiment was conducted by and
chromatogram produced by Astha Pokhrel (Poudel et al. manuscript in preparation).
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Members of the RSH superfamily synthesize (pp)pGpp and (p)ppApp via the
transfer of a pyrophosphoryl group from ATP to the 3’-OH group of GXP and/or AXP
(148,149,158). Under the experimental conditions used in our pyrophosphate transfer
reactions, RSHCd appeared to produce triphosphate products in the presence of GDP
(Appendix D and Fig. 28). Contrary to the fundamental reaction mechanism of RSHcatalyzed reactions to produce (pp)pA/Gpp, RSHCd synthesizes magic spot with a
guanosine entity bound to three phosphate groups even when GDP is the substrate.
Therefore, based on our TLC and HPLC data, we currently hypothesize that RSHCd is
producing a three-phosphate alarmone using GDP as a substrate in an ATP-dependent
manner via non-canonical mechanism(s). The enzyme catalysis is potentially driven by
the initial hydrolysis of GDP to GMP followed by the addition of a pyrophosphate moiety
from ATP to the 3’-OH of GMP.
We believe that RSHCd itself could be responsible for the hydrolysis of GDP, which
the enzyme utilizes to produce putative 5’-pGpp-3’ for two reasons. One, purification of
RSHCd from E. coli cells can result in the copurification of contaminant GDPases that
hydrolyze GDP during pyrophosphoryltransferase reactions. But the use of hexa-histidine
specific nickel affinity purification technique followed by a stringent protein dialysis
procedure out rules the possibility of contamination by native E. coli GDPases. Two, the
notion that RSHCd is either directly producing GTP from GDP in the presence of
radiolabeled ATP or a byproduct of ppGpp synthesis reaction appears to hold untrue in
this case. Sobala et al. demonstrated that M. extorquens RSH (RSHMex) produces
ppGpp and pppGpp in the presence of ATP and GDP or GTP, respectively, in addition
with γ-32P-GTP (258). According to their findings, γ-32P-GTP migrates slowly on PEIcellulose plates than pGpp and ppGpp when run in 0.85 M KH2PO4 mobile phase buffer
(258). We found that RSHCd-synthesized magic spot co-migrates with RelQBssynthesized pGpp in 1.5 M KH2PO4. Furthermore, RSHCd does not produce ppGpp in
the presence of GDP unlike RSHMex. This suggests that RSHCd carries an intrinsic
GDPase activity and is able to synthesize the magic spot via non-conventional
mechanism(s). Furthermore, E. coli GppA and NuDiX family hydrolases degrade pppGpp
and ppGpp to ppGpp and pGp, respectively (176,179,180). This means that even if
RSHCd were contaminated with native E. coli hydrolases that metabolize (pp)pGpp, the
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contaminants would not yield radiolabeled pGpp products that are clearly visible as spots
in our autoradiograms.
SUMMARY
Here we show that the full-length RSH homolog of C. difficile exhibits a strict
utilization preference for GDP in vitro (147). The enzyme may transiently bind GTP but
failure to produce pppGpp suggests that the enzyme is unable to accommodate a
pyrophosphate transfer from ATP to GTP (147). Furthermore, the enzyme also fails to
utilize GMP and ADP for a substrate but readily utilizes GDP at a wide range of
environmental pHs without demonstrating any metal cofactor specificity (147). We
previously concluded that the full-length enzyme produces ppGpp in the presence of GDP
substrate (147,248). However, our more recent in vitro pyrophosphotransferase reactions
using RelQBs as a positive control and full-length RSHCd indicate that the latter enzyme
is in fact producing a triphosphate alarmone. HPLC analyses using an anion exchange
column to separate and resolve RSHCd and RelQBs-catalyzed products further revealed
that the alarmone synthesized by RSHCd co-elutes with the GTP standard, confirming
that the protein is catalyzing the synthesis of small alarmone triphosphate nucleotide in
the presence of GDP. This finding is unique as it indicates that RSHCd produce magic
spot via non-conventional route(s), not previously reported in the analyses of other RSHfamily enzymes. Furthermore, we postulate that the alarmone synthesis activity of RSHCd
is regulated by the hydrolase domain and/or the CTD. Expression of RSH-REL is
extremely toxic to bacterial growth and just like its full-length counterpart, RSH-REL can
only produce magic spot in the presence of GDP. Additionally, we were able to detect
intracellular ppGpp upon expression of RSH-REL in E. coli cells. Based on our TLC assay,
however, RSH-REL does not produce ppGpp. Therefore, we believe that the intracellular
ppGpp extracted and detected using HPLC is actually due to the production and
accumulation of ppGpp by E. coli cells as a consequence of growth phase-induced
nutrient starvation and cytoplasmic changes (Fig. 25C). ppGpp is a more potent effector
of the SR in stressed E. coli cells, indicating that the bacteria produce detectable levels
of ppGpp (178).
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We also speculate that the HD of RSHCd requires regulation by the CTD,
presumably via interaction with branched-chain amino acids. Based on the mobility of
RelQBs-produced pGpp (where GMP is the substrate) and RSHCd-produced magic spot
(where GDP is the substrate) in our TLC autoradiograms, we believe that RSHCd
exclusively synthesizes pGpp. Nonetheless, analysis of RSHCd catalyzed magic spot
using more sensitive techniques such as LC-MS along with the structural analysis of the
magic spot through
alarmone identity.

31

Phoshporus NMR will also deem essential in confirming the
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CHAPTER III

CHARACTERIZATION OF RSH-MEDIATED MAGIC SPOT SIGNALING IN
CLOSTRIDIOIDES DIFFICILE

OVERVIEW
Long RSH enzymes are transcriptionally regulated, with transcription increasing
during late exponential phase or stationary phase, or upon induced nutrient deprivation
by inhibitors of biosynthetic pathways (147,158,182-184). The specific nutrients whose
limitation triggers RSH-mediated (pp)pGpp synthesis vary between bacterial species
(158,182,183,185). In E. coli, the SR is triggered by amino acid starvation, which results
in RelA-mediated (pp)pGpp synthesis. Interestingly, fatty acid starvation and iron
limitation specifically induce E. coli SpoT-dependent accumulation of (pp)pGpp and
ppGpp, respectively (268,269). In B. subtilis, the SR is also stimulated in response to lipid
starvation (185). Since Gram-positive organisms typically encode one or two SASs in
combination with a long RSH enzyme, the SASs in B. subtilis are transcriptionally
regulated during bacterial growth phase where relQ expression is upregulated during
exponential phase and relP expression is upregulated in the late exponential phase
(158,168). Furthermore, genes encoding S. aureus RelQ and RelP are also regulated at
the transcriptional level by vancomycin, exposure to ethanol and alkaline shock
(158,199).
Clostridioides difficile genome encode a monofunctional RelQ and a bifunctional
RSH (147). We have shown that full-length RSHCd produces putative pGpp, not ppGpp
in the presence of GDP substrate via yet to be determined mechanism(s). To investigate
whether the extracellular signals that regulate C. difficile rsh transcription include bacterial
stationary phase onset, nutrient limitation, and exposure to antibiotics, we have employed
highly sensitive and quantitative molecular tools such as quantitative reverse
transcriptase-PCR (qRT-PCR) and a fluorescent translational reporter (147). Through
qRT-PCR, we have analyzed the mRNA transcript levels of C. difficile rsh and relQ at
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different phases of bacterial growth to find that rsh transcription is positively regulated by
stationary phase onset (147). Unlike rsh, relQ transcription is not affected by growth
phase, suggesting that C. difficile relQ expression is potentially induced by factors that
cause cell wall stresses (147). Notably, bacterial stationary growth phase is associated
with many adverse conditions, including nutrient limitation, accumulation of waste and
metabolic byproducts and alterations in environmental pH (270). To evaluate whether
nutrient limitation during bacterial stationary phase onset contributes to the positive
regulation of C. difficile rsh transcription, we have used qRT-PCR to study rsh and relQ
mRNA transcript fold-change in bacterial cells cultured in different media conditions,
including regular Brain heart infusion medium supplemented with 5% yeast extract
(BHIS), spent BHIS, and phosphate buffered saline (PBS). In this case, growth of C.
difficile 630Derm strain in regular BHIS corresponded with normal growth conditions,
whereas spent medium represented nutrient limited growth conditions. Based on our
analysis, we found that C. difficile rsh is positively regulated by starvation stress,
suggesting that nutrient limitation is one of many factors that triggers the stringent
response in this pathogen.
Previous studies have also employed antibiotics as a stress inducer in
Clostridioides difficile, notably, without directly demonstrating rsh and relQ transcriptional
regulation. For example, Emerson et al. demonstrated that exposure of C. difficile 630
strain to amoxicillin, clindamycin, and metronidazole results in the general upregulation
of numerous transcriptional and translational machineries (271). Microarray analyses
revealed that amoxicillin upregulates rpoB, rpoC and rpoA (encoding components of the
RNA polymerase) and ribosomal protein-encoding genes, along with tRNA synthetases
and genes encoding tRNA-associated enzymes (271). Transcripts of putative ppGpp
metabolizing enzymes are also significantly upregulated upon exposure to amoxicillin and
clindamycin (271). Furthermore, expression of genes encoding bacterial cell wall proteins
and those involved in peptidoglycan synthesis pathways are induced by ampicillin,
clindamycin, metronidazole, and mainly amoxicillin (271). Interestingly, components of
the secretion apparatus (secE, secY, and secA2) are also upregulated by these
antibiotics, suggesting that C. difficile alters the composition of its cell wall to withstand
the pressures exerted by and to reduce the penetration of antibiotics (271). Notably,
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changes in the cell wall composition in response to antibiotics confer intermediate
vancomycin resistance in S. aureus, suggesting that antibiotics cause changes in
bacterial transcriptional profiles, leading to the development of virulence traits such as
antibiotic tolerance (271,272).
To investigate whether antibiotics play a role in the transcriptional regulation of C.
difficile rsh and relQ, we utilized an anaerobic fluorescent transcriptional reporter
incorporating the oxygen-independent flavoprotein phiLOV2.1 (147,273). We placed the
phiLOV2.1 gene under the control of the rsh and relQ promoter regions from 630Derm
and R20291 strains to monitor rsh and relQ transcription in two genetic variants of C.
difficile upon exposure to sublethal concentrations of clindamycin and metronidazole
(147). We found that the activity of the magic spot synthetase promoters in the presence
of clindamycin is stimulated in a strain-specific manner (147). We also found that rsh
transcription is positively regulated by exposure to metronidazole in the hypervirulent
R20291 background, suggesting that the transcriptional regulation of full-length rsh in
Clostridioides difficile is a general response to antibiotic stresses rather than a response
to the inhibition of a specific synthetic pathway (147). Since the use of clindamycin is
associated with risk factor development for CDI and metronidazole is losing clinical
significance for CDI treatment, we postulate that the expression of rsh upon exposure to
these antibiotics contributes to C. difficile tolerance and survival in the host.
In summary, this chapter focuses on elucidating environmental stimuli that
positively regulate rsh gene transcription, resulting in the cytoplasmic accumulation of
putative pGpp. All aspects of this chapter previously appeared as an article in the
reference (147). The rights and permission to use the materials of the publication is given
in Appendix M. Figure numbers and formats have been modified from the publication.
METHODS AND MATERIALS

Plasmid and strain construction
The plasmid pRF185::phiLOV2.1 (provided by Gillian Douce, University of
Glasgow), containing the phiLOV2.1 gene under the control of the tetracycline-inducible
promoter Ptet, was digested with BamHI and KpnI to remove the original promoter
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(Appendix A). The predicted promoters upstream of rsh (CD630_27440 and
CDR20291_2633) and relQ (CD630_03450 and CDR20291_0350) were amplified from
630Δerm and R20291 genomic DNA using promoter-specific forward and reverse primers
(Appendix B). Prsh (promoter upstream of rsh) was amplified separately from 630Δerm
and R20291 genomic DNA, while PrelQ (promoter upstream of relQ) which is fully
conserved between the two strains, was amplified only from 630Δerm background. The
primers introduced cut sites for BamHI and KpnI, which were used to digest the amplified
promoters.

The

promoters

were

subsequently

ligated

into

the

digested

pRF185_phiLOV2.1 plasmid to yield Prsh630Δerm::phiLOV2.1, PrshR20291::phiLOV2.1, and
PrelQ630Δerm::phiLOV2.1 plasmids (Appendix A). These plasmids were PCR verified for
promoter insertion using vector-specific as well as promoter-specific primers (Appendix
B). The reporter plasmids were then individually transformed into competent E. coli
HB101 cells (NEB) carrying the helper plasmid pRK24. HB101 with pRK24 were
conjugated with C. difficile 630Δerm and R20291 strains as described in details
elsewhere (119). Prsh630Δerm::phiLOV2.1 and PrshR20291::phiLOV2.1 were conjugated into
their isogenic background strains and PrelQΔerm::phiLOV2.1 was mated into both C. difficile
strains. After conjugation, transconjugants were selected on BHIS agar treated with 10
µg/mL thiamphenicol and 100 µg/mL kanamycin (E. coli sensitive). Finally,
transconjugants were verified by PCR using both promoter-specific and vector-specific
primers (Appendix B).
Promoter activity analysis using fluorescent phiLOV reporter constructs
C. difficile strains containing phiLOV reporter plasmid (Appendix A) were grown
anaerobically at 37°C in BHIS-Tm10 for 12 to 16 hrs. To monitor growth phase-dependent
promoter activity of rsh and relQ genes, ON cultures of 630Derm were inoculated at the
ratio of 1:20 into fresh BHIS-Tm10 media the next day and grown with OD measured at
600 nm. Samples were collected when cultures reached the OD600 of 0.8 (exponential
phase) and 1.2 (stationary phase onset). When cultures at the final volume of 3 mL
reached the target OD600 values, cell numbers in each sample for fluorescence
measurements were normalized to cell culture OD of 0.20 at 600 nm. To monitor
antibiotic-induced promoter activity, ON starter cultures were inoculated 1:50 into fresh
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BHIS-Tm10 media containing metronidazole and clindamycin at the indicated
concentrations and grown for ~2 hrs (Appendix E). OD600 was recorded for each sample
to monitor growth. To minimize variations in fluorescence signal from background cellular
autofluorescence, cell numbers in each sample were equalized on collection in the
manner reported elsewhere (273). Each sample was collected at a volume that would
give a cell count equivalent to 3 mL of the culture with the lowest OD600. After collection,
cells were pelleted in a microcentrifuge and suspended in 400 µL of reduced 1X PBS
within the anaerobic chamber. Duplicate 200 µL samples were also aliquoted into a clearbottomed black 96-wells microplate (ThermoFisher Scientific) for the purpose of
measuring sample fluorescence intensity. Sample fluorescence and sample OD630 were
measured using 440/30 excitation and 508/20 nm emission filters on a plate reader from
BioTek. The instrumental parameters for all fluorescence measurements included a
sensitivity limit of 65. Fluorescence measurements were blanked against 1X PBS and
were reported as E508/A630 absorbance units (AU).
Bacterial strains and growth conditions
Appendix A lists the bacterial strains and plasmids used herein. C. difficile
630Δerm and R20291 were grown at 37°C in tryptone yeast (TY) medium or in BHIS, as
indicated. The strains were grown in an anaerobic chamber (Coy Laboratory Products,
Grass Lake, MI) with an atmosphere of 85% N2, 10% CO2, and 5% H2. Bacterial strains
carrying the respective phiLOV2.1 plasmid were maintained in 10 µg/mL thiamphenicol
(Alfa Aesar), and 50 or 100 µg/mL kanamycin (Bio Basic Canada Inc). To study the effect
of antibiotics on the promoter activity of rsh and relQ genes, 0.3 µg/mL metronidazole
(Beantown Chemical) or 16 µg/mL clindamycin (Tokyo Chemical Industry) was used. The
sublethal concentrations of the antibiotics used are included in Appendix E.
RNA isolation and real-time quantitative PCR
Total RNA from C. difficile 630Δerm cultured in BHIS was isolated as previously
described (119). Primers were designed using the PrimerQuest tool from IDT DNA
technologies. Samples for RNA isolation were collected when cultures reached OD600 of
0.8, 1.2 and 1.6 (stationary phase). Samples were also collected after culturing in spent,
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plain BHIS media and PBS. Complementary DNA (cDNA) samples were prepared from
200 ng RNA using random hexamers and the Tetro cDNA synthesis kit (Bioline). Realtime PCR reactions were performed with 2 ng of cDNA template using the SensiMix SYBR
and fluorescein kit (Bioline). Primers (Appendix B) were designed using PrimerQuest tool
from IDT DNA. The rpoC mRNA transcript was measured and used as an internal control
for normalization. Controls with no reverse transcriptase were also included for all
templates and primer sets. For data analysis, the standard 2-ΔΔCt method was employed
with normalization to rpoC and at OD600 of 0.8.
RESULTS

C. difficile rsh transcription is induced by stationary-phase onset
Transcription of relA/rsh gene in E. coli and several stringent response mounting
organisms is induced by nutrient limitation during the onset of stationary phase of growth.
To confirm that C. difficile rsh transcription is also regulated by bacterial growth phase,
we have examined the transcript levels of rsh and relQ at cell culture optical densities
(OD600) of 0.8, 1.2, and 1.6, corresponding to exponential growth, stationary phase onset,
and stationary phase, respectively (147). qRT-PCR-based analysis revealed that rsh
transcription increases ~3-fold when cells leave the exponential growth phase and
remains elevated in the stationary phase (Fig. 29A). In the contrary, relQ transcription is
unaffected by bacterial growth phase, suggesting that transcription of C. difficile rsh is a
response to changes in bacterial growth once the cells enter into the stationary phase,
which is characterized by many adverse conditions (Fig. 29A) (147). We also utilized our
phiLOV-based transcriptional reporter strain (630Derm) to examine the transcriptional
regulation of C. difficile rsh in response to stationary phase onset. Strains carrying the
respective fluorescent transcriptional reporter were grown at OD600 of 0.8 and 1.2 (147).
Supporting our qRT-PCR data, we found rsh promoter activity to be induced by ~3-fold
upon onset of stationary phase (Fig. 29B) (147). Notably, the promoter activity from the
tetracycline-inducible control and from PrelQ appeared to be unaffected by growth phase,
suggesting that C. difficile relQ does not respond to growth phase but potentially to cell
wall stresses (Fig. 29B) (147).
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Figure 29. Stationary phase onset stimulates C. difficile rsh transcription. (A) qRTPCR analysis shows that rsh mRNA levels increase by ~3-fold upon stationary phase
onset, representative of bacterial OD600 of 1.2. (B) The fluorescent phiLOV
transcriptional reporter also shows a 3-fold increase in the promoter activity of rsh
between exponentially growing cells and cells entering stationary phase at an OD600
of 1.2. Adapted from Pokhrel et al. 2020.
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rsh transcription is stimulated by nutrient limitation
To evaluate nutrient limitation as a candidate for the activation of the stringent
response in C. difficile, we used qRT-PCR to compare the mRNA transcript levels of rsh
and relQ in cells cultured either in plain BHIS, spent BHIS, or PBS media. When cultured
in spent media, we found rsh gene transcription to be positively regulated with ~10-fold
increase in the transcript levels compared to those from cells cultured in plain BHIS media
(Fig. 30). We also found that relQ transcription is unchanged in spent media, suggesting
that nutrient limitation induces the stringent response in Clostridioides difficile via
upregulation of the rsh gene (Fig. 30).
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Figure 30. Nutrient limitation induces C. difficile rsh transcription. qRT-PCR
analysis shows that transcription levels of rsh increases by ~10-fold when C. difficile
cells are cultured in spent medium, representative of nutrient limitation or starvation
condition. relQ transcription in unaffected by nutrient limitation. Multiple t test
comparison between BHIS and spent BHIS. ** P 0.001220. This experiment and figure
are the courtesy of Dr. Erin B. Purcell.

93

rsh and relQ transcription is induced by antibiotic stress
Adeo et al. demonstrated that antibiotic stress induces the stringent response in
methicillin-resistant S. aureus, contributing to the pathogen’s antibiotic tolerance
phenotype (274). To confirm that antibiotic-induced stress regulates C. difficile rsh and
relQ transcription, we used the phiLOV2.1 reporter to monitor the transcription of rsh and
relQ upon treatment with sublethal concentration of clindamycin and metronidazole
(Appendix E) (147). Notably, rsh promoters that control the expression of the rsh gene
are differentiated by a single purine substitution in the 630Derm and R20291 genomes,
whereas the relQ promoters are 100% identical in both genetic variants of the pathogen
(Fig. 31) (147). Therefore, we constructed two translational reporters in which the
phiLOV2.1 gene was placed under the control of rsh promoter from both 630Derm and
R20291 strains (147). As expected, we found that the promoter activity in the tetracyclineinducible negative control was unaffected by clindamycin in both genetic variants (Figure
32A) (147). But the activity of rsh and relQ promoters was increased in a strain-specific
manner from clindamycin exposure (Fig. 32A) (147). The rsh promoter activity was
uninduced by clindamycin exposure in the 630Derm background while demonstrating a
50% increase in promoter activity in the R20291 background (Fig. 32A) (147). relQ
promoter activity, on the other hand, was upregulated 2.8-fold in 630Derm background
but remained uninduced in R20291 (Fig. 32A) (147). To investigate if magic spot
synthesis can also be stimulated by exposure to metronidazole, we repeated this assay
by exposing cells to sublethal concentration of metronidazole (Appendix E). The
tetracycline-inducible control promoter was uninduced by metronidazole treatment.
Interestingly, both rsh and relQ promoter activities remained unaffected by metronidazole
exposure in the 630Derm background (Fig. 32B) (147). However, rsh promoter activity
increased by 80% in the R20291 background, while relQ promoter showed no activity
(Fig. 32B) (147). These findings suggest that the epidemic strain responds to stress
induced by different types of antibiotic via upregulation of rsh gene expression. The nonepidemic strain, on the other hand, does not respond to metronidazole via rsh or relQ
transcription but induces transcription of relQ when exposed to clindamycin.
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Figure 31. Sequence alignment of the upstream promoter regions. The sequence
of promoters used in the (A) Prsh and (B) PrelQ translational reporters are provided. A
purine base substitution in the promoter sequences of rsh between R20291 and
630Derm is depicted in a red box. Adapted from Pokhrel et al. 2020.
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Figure 32. C. difficile rsh and relQ transcription is induced by antibiotic stress.
PhiLOV2.1 transcriptional reporter activity after two hours of exposure to 16 μg/mL
clindamycin (A) and 0.3 μg/mL metronidazole (B) in the C. difficile 630Δerm and
R20291 genetic backgrounds. Fluorescence activity normalized by cell density in the
presence and absence of antibiotics was compared by Two-Way ANOVA. n.s., not
significant, * P < 0.05, ** P < 0.01, **** P < 0.0001. Adapted from Pokhrel et al. 2020.

96

SUMMARY
The stringent response is a ubiquitous stress signaling in bacteria, which is
regulated by different combinations of RSH superfamily enzymes (158). These enzymes
are in turn differentially regulated by factors, including nutrient limitation or starvation,
antibiotic and alcohol exposure, alkaline shock and oxidative stress (149,158). Regulation
of RSH/SAS-mediated (pp)pGpp signaling occurs either at the transcriptional level or
post-translational level (158). Long RSH enzymes are known to be transcriptionally
regulated by stationary growth phase and nutrient limitation induced by inhibitors of
biosynthetic pathways such as mupirocin and serine hydroximate (269). We have
identified that stationary phase onset and nutrient limitation also induce C. difficile rsh
transcription (147). Furthermore, we have identified antibiotic exposure as a stimulus that
positively regulates C. difficile rsh transcription in a strain- and stress-dependent manner
(147). The non-epidemic 630Δerm and epidemic strain R20291 appear to exhibit different
transcriptional responses to clindamycin and metronidazole (147). Notably, R20291
contains an intact ermB gene that renders the strain resistant to erythromycin (147).
Therefore, we postulate that the presence of an intact ermB gene in R20291 potentially
influences the strain’s perception of antibiotic-induced stress and phenotypes (147).
Nevertheless, clindamycin and metronidazole have distinct mechanism of antimicrobial
action against pathogens, suggesting that C. difficile rsh transcription could be the
predominant and a general response to extracellular stress caused by different classes
of antibiotic in this organism (147).
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CHAPTER IV

EFFECTS OF DISRUPTING THE STRINGENT RESPONSE IN CLOSTRIDIOIDES
DIFFICILE STRESS SURVIVAL

OVERVIEW

Transcriptional regulation of rsh (and relQ in some) is not the only mechanism by
which bacterial cells mediate (pp)pGpp signaling. The activity of other intracellular
proteins can also influence alarmone levels in response to post-translational regulation
by extracellular stimuli (275,276). Furthermore, stringency or stress response in bacteria
doesn’t always involve (pp)pGpp alarmones as the key pleiotropic effector for
reprogramming cellular processes (277). Therefore, it is critical to define RSH’s
contribution, independently from RelQ’s, in the accumulation of putative pGpp as well as
the biological consequences of the alarmones in stressed C. difficile cells. It is also
important to determine whether (pp)pGpp signaling stimulates C. difficile virulence traits
such as antibiotic resistance, sporulation, and toxin production, even biofilm formation.
One such way to determine the contribution of (pp)pGpp in C. difficile physiology during
stresses is by disrupting alarmone synthesis via RSH inhibitors such as Relacin and/or
by suppressing rsh and relQ genes at the transcriptional and translational level.
As mentioned previously, SASs in Gram-positive bacteria are known to respond to
cell wall stressors, including β-lactam family of antibiotics, heat, and alkaline shock (158).
Based on our fluorescent translational reporter assays, transcription of C. difficile relQ is
not induced by bacterial stationary phase onset or nutritional depletion in the environment.
We also found that C. difficile relQ responds to clindamycin and metronidazole antibiotics
in a strain-specific manner (147). Notably, both clindamycin and metronidazole are
cytoplasmic antibiotics that inhibit bacterial protein synthesis and DNA replication,
respectively. Given that Gram-positive SASs respond to cell wall/envelope stresses, we
postulate that C. difficile relQ is transcriptionally regulated by ampicillin exposure and/or
is responsible for alarmone-driven bacterial beta-lactam tolerance. On the other hand,
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positive transcriptional regulation of C. difficile rsh appears to be a general response of
the bacteria when exposed to different classes of antibiotic, suggesting that rsh
transcription contributes to general antibiotic tolerance in C. difficile R20291 variant (147).
To determine the significance of rsh and rsh translation in C. difficile survival during
antibiotic stress, we have employed an RNA-based gene-silencing tool called RNA
interference (RNAi) that suppresses the molecular translation of targeted genes (68,147).
Through this tool, we have induced the expression of antisense RNA (asRNA)
complementary to the 5’untranslated region (5’UTR) of the rsh mRNA in the epidemic
R20291 strain using genomic and molecular cloning techniques described elsewhere
(68). We found that induction of the asRNA specific to the mRNA of C. difficile rsh using
a sublethal concentration of anhydrotetracycline (Appendix F) suppresses R20291
accumulation upon exposure to metronidazole (147). While the observed effect on
bacterial accumulation is modest, we believe that rsh plays a direct role in C. difficile
metronidazole tolerance and survival.
Due to the role of (pp)pGpp in bacterial survival and virulence factors production,
compounds targeting RSH enzymes and (pp)pGpp alarmones have been screened,
developed, and characterized (233,235,236,240,278-280). The ppGpp structural analog,
Relacin competitively inhibits the activity of most full-length RSH family synthetases
(233,235). The compound reduces (pp)pGpp accumulation, stationary phase onset and
survival, biofilm formation, and sporulation in Bacillus species (233). Notably, Relacin
does not affect the activity of SAS family synthetases or inhibit in vivo (pp)pGpp
accumulation in E. coli, indicating that anti-stringent response inhibitors are not
universally effective (233). To study the inhibitory effects of Relacin on RSHCd magic
spot synthesis activity in vitro and in vivo, we have conducted pyrophosphate transfer
reactions in the presence of increasing concentrations of Relacin (147). We found that
Relacin inhibits the magic spot synthesis activity of RSHCd in a dose-dependent manner
(147). We also found that Relacin independently has no discernible effect on the
accumulation of C. difficile R20291 in vivo, however, the compound increases bacterial
antibiotic susceptibility to both clindamycin and metronidazole (147). This suggests that
Relacin is active against RSHCd during antibiotic-induced stringent response mechanism
in Clostridioides difficile.

99

In summary, this chapter focuses on the effects of disrupting the RSH-mediated
stringent response mechanism in C. difficile antibiotic stress tolerance and survival. All
aspects of this chapter previously appeared as an article in the reference (147). The rights
and permission to use the materials of the publication is given in Appendix M. Figure
numbers and formats have been changed unless stated otherwise in the figure legends.
METHODS AND MATERIALS

Overexpression and purification of C. difficile RSH
Restriction enzymes and DNA ligase used in this study were purchased from New
England Biolabs. Phusion DNA polymerase for polymerase chain reactions was
purchased from ThermoFisher Scientific. rsh (CDR20291_2633) was amplified from the
genomic DNA of C. difficile R20291 using primers (Appendix A) that added a C-terminal
hexa-histidine tag, ligated into the pMMBneo expression vector at the KpnI and PstI
restriction sites, and transformed into E. coli BL21. The plasmid was confirmed by PCR
using rsh gene-specific primers (Appendix B).
E. coli expression strain carrying pMMBneo vector ligated with hexa-histidine
tagged rsh was grown in LB-Kan50 at 37°C to an OD of 0.16 to 0.25 at 600 nm (if OD600
reached above this range, cell cultures were diluted into fresh LB-Kan50 at the desired
OD value), at which point the temperature was dropped to 30°C and expression was
induced using 0.5 mM IPTG for 16 hrs. Cells were lysed by sonication while suspended
in the lysis buffer composed of 10 mM Tris-HCl (pH 7.8), 300 mM NaCl, 5 mM MgCl2, 50
mM NaH2PO4, 10% glycerol, 0.5 mg/mL lysozyme, 10 mM imidazole, 0.25 mM DTT and
5 mM PMSF. Post-lysis buffer treatment, the lysates were clarified by centrifugation and
subsequently transferred to a gravity column filled with HisPure Ni-NTA resin (GBiosciences). Protein purification was conducted according to the manufacturer’s
protocol. Notably, all purification buffers included 5 mM MgCl2 which was found to be
critical for protein stabilization and purification. Purified RSHCd was dialyzed ON at 4°C
against a dialysis buffer composed of 15.7 mM Tris-HCl (pH 7.6), 471.9 mM NaCl, 15.69
mM MgCl2, 1.57 mM DTT, 1.5 mM PMSF, and 15.7% glycerol. Concentration of the
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protein was determined spectrophotometrically. Protein aliquots were stored at -80°C for
subsequent use.
In vitro measurement of RSHCd synthetase activity
Synthetase assays in the presence of Relacin (a gift from Sigal Ben-Yehuda,
Hebrew University of Jerusalem) were conducted in a buffer composed of 10 mM TrisHCl (pH 7.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT and 0.12 mM ATP. A 5X
buffer stock was mixed with the indicated concentrations of GDP (0.2 to 0.6 mM), with
covarying MgCl2, 1.0 μCi of γ-32P-ATP (approval to use 32P isotope is presented in
Appendix L), and concentrations of Relacin ranging from 0 to 5 mM (233). Reactions were
initiated by adding RSHCd at a final concentration of 0.6 µM and a reaction volume of 10
µL. Reactions were stopped by spotting 2 µL samples on a PEI-cellulose plate, allowing
the spots to dry. The plates were subsequently developed in 1.5 M KH2PO4 (pH 3.64) and
autoradiographed using the Storm 860 phosphorimager (GE Healthcare Life Sciences).
Magic spot signal was quantitated using ImageJ software. RSHCd activity was reported
as the percentage of magic spot produced.
Construction of RNAi strains
The vector pMSPT (Appendix A) was a gift from Dr. Julian G. Hurdle (Texas A&M
University). It was used to express anhydrotetracycline (ATc)-inducible asRNA to the
mRNA of C. difficile rsh. The pMSPT vector we received was derived by cloning a paired
termini region (synthesized by GenScript) into pUC57 at BamHI/SacI sites of pRPF185
as reported elsewhere (68). Antisense fragments were designed and synthesized to span
~50 base pairs (bp) upstream and downstream of the start codon in order to mimic
naturally occurring bacterial asRNAs that block translation upon binding to the ribosome
binding site (RBS). The antisense fragment synthesized by GenScript was amplified using
gene-specific primers (Appendix B), digested, and cloned into the SphI/ XhoI sites of
empty pMSPT vector. The derived construct or plasmid, termed as pMSPT::as_rsh
(Appendix A) contained the gene with its own RBS expressed from the Ptet promoter.
The plasmid was subsequently PCR verified for antisense gene insertion using vectorspecific primers (Appendix B). The RNAi plasmid and the empty vector plasmid were both
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individually electroporated into E. coli HB101 cells (NEB) carrying the helper plasmid,
pRK24. HB101 with pRK24 were conjugated with C. difficile R20291 strains as described
elsewhere (119). Transconjugants were selected on BHIS agar supplemented with 15
µg/mL thiamphenicol and 100 µg/mL kanamycin. Finally, transconjugants were verified
by PCR using C. difficile relQ gene-specific and pMSPT vector-specific primers (Appendix
B). C. difficile relQ primers were used in colony PCR to confirm that the transconjugants
were C. difficile, whereas the vector-specific primers were used to confirm the success of
the conjugation process.
Bacterial strains and growth conditions
Appendix A lists the bacterial strains and plasmids used herein. C. difficile R20291
strain was grown at 37°C in TY medium or BHIS medium, as indicated. The strain was
grown in an anaerobic chamber (Coy Laboratory Products, Grass Lake, MI) with an
atmosphere of 85% N2, 10% CO2, and 5% H2. Wild type R20291 strain as well as bacterial
strains carrying the pMSPT::as_rsh or pMSPT empty plasmid were maintained using the
following antibiotics in the indicated concentration: 15 µg/mL thiamphenicol (Alfa Aesar),
50 or 100 µg/mL kanamycin (Bio Basic Canada Inc), 0.075 or 0.3 µg/mL metronidazole
(Beantown Chemical), or 16 µg/mL clindamycin (Tokyo Chemical Industry) as indicated
in Appendix E.
End-point growth/ cell accumulation assay using R20291 and RNAi strains
ON starter cultures of wild type R20291 strain was inoculated 1:50 into fresh TY
medium and grown till OD600 ~0.8 (exponential phase). At this point, using a 96-welled
microtiter plate, the starter cultures were added to reduced TY medium treated with 2 mM
Relacin, with or without 16 µg/mL clindamycin or 0.3 µg/mL metronidazole from time point
0 min. The plate was subsequently incubated anaerobically at 37°C for 12 to 18 hrs. Postincubation, the plates were taken out of the anaerobic chamber and OD630 was measured
using a plate reader (BioTek) to measure cell accumulation.
For the RNAi strains, growth following the induction of asRNA to the mRNA of C.
difficile rsh was performed by using the standard media dilution technique using a 96welled microtiter plate. To determine the sublethal concentration of ATc to use for
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inducing as_rsh without inhibiting bacterial growth and viability, increasing concentrations
of ATc were added to BHIS medium in the absence of antibiotics (Appendix F). Plate was
incubated for 24 hrs after which the sublethal concentrations of ATc that partially inhibited
growth was recorded (Appendix E). The concentration of ATc (0.5 µg/mL) that moderately
inhibited growth was further used to induce as_rsh in assays where the growth of
unstressed vs stressed strains using 0.075 µg/mL metronidazole was monitored after 12
hrs of anaerobic incubation at 37°C in BHIS medium treated with 15 µg/mL thiamphenicol.
RESULTS

Relacin inhibits RSHCd synthetase activity in vitro and reduces bacterial antibiotic
survival in vivo
Relacin inhibits (pp)pGpp synthesis in B. subtilis and D. radiodurans by
competitively binding to the SD active site of the bifunctional RSH enzymes in vitro (233).
Upon incubating purified RSHCd with GDP, ATP, and increasing concentrations of
Relacin, we found that Relacin also inhibits RSHCd synthetase activity in a dosedependent manner in vitro (Fig. 33) (147). Notably, Relacin appears to inhibit RSHCd
pyrophosphoryltransferase activity in millimolar concentrations consistent with its
efficacious dose against other RSH/REL enzymes, indicating that the molecule itself is
not a promising candidate to use in the clinical settings for the management of CDI (147).
We also investigated the effects of Relacin on the accumulation of R20291 cells over a
period of 12 hrs (147). We treated cells with 2 mM Relacin in the absence of any stringent
response inducing factors and found that Relacin does not affect bacterial survival under
normal growth conditions (Fig. 34A) (147). Interestingly, when R20291 cells are
pretreated with 16 µg/mL clindamycin or 0.3 µg/mL metronidazole, the compound
appears to increase bacterial susceptibility to both antibiotics (147). The intracellular
accumulation of (pp)pGpp causes a delayed growth phenotype in bacterial cells and puts
cells in a state of quiescence, which notably, contributes to bacterial antibiotic tolerance
(242). We found that treatment with clindamycin and metronidazole appears to suppress
R20291 accumulation overtime, which could be due to the production and intracellular
accumulation of the putative pGpp alarmones (Fig. 34B and 34C). But bacterial
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accumulation was further suppressed in the presence of Relacin, suggesting that the
molecule specifically targets RSHCd during the stringent response cascade in C. difficile
(Fig. 34B and 34C) (147).
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Figure 33. Relacin affects RSHCd synthetase activity in vitro. Relacin inhibits the
activity of RSHCd in a dose-dependent manner. Activity at each Relacin concentration
was compared to that in the 0 mM Relacin condition by ordinary One-Way ANOVA. * P
0.0173, * P 0.0279, *** P 0.0009, **** P 0.0004. Adapted from Pokhrel et al. 2020.
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Figure 34. Effect of disrupting RSH-regulated stringent response mechanism in
C. difficile antibiotic survival. (A) Relacin alone has no impact on the ON
accumulation of C. difficile R20291. Cell density after overnight growth was compared
with and without Relacin by ordinary One-Way ANOVA. (B-C) 18 hrs cell density in the
presence of sublethal clindamycin (B) and metronidazole (C) with and without Relacin.
The cell density of antibiotic treated samples with and without Relacin were compared
by Unpaired t test. n.s., not significant, * P < 0.05, ** P < 0.01, *** P < 0.001. Adapted
from Pokhrel et al. 2020.
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rsh plays a role in bacterial antibiotic tolerance and survival in vivo
Due to the observed modest effect of Relacin on metronidazole treated
hypervirulent R20291 strain, we investigated the significance of RSH for C. difficile
survival during metronidazole-induced stress. We induced the expression of asRNA
specific to the mRNA of rsh using our pMSPT::as_rsh vector carrying R20291 RNAi strain
(Appendix A) (147). Induction of the asRNA has previously been shown to deplete mRNA
transcript levels and to knock down translation in C. difficile (68,147). Upon silencing rsh
translation in vivo in the epidemic strain pre-treated with sublethal concentration of
metronidazole, we found R20291 accumulation to be dramatically suppressed overtime
(Fig. 35) (147). This suggests that rsh and its gene product contribute to the accumulation
and survival of C. difficile cells during metronidazole-induced stress (147). We also
postulate that rsh confers metronidazole tolerance in C. difficile, further establishing that
the antibiotic is no longer effective at killing the pathogen.
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Figure 35. Significance of rsh in antibiotic stress survival. Knock down of C. difficile
rsh gene with ATc inducer (0.5 µg/mL) negatively impacts the accumulation of R20291
strain in the presence of metronidazole (0.075 µg/mL). The cell densities of antibiotic
treated samples with and without ATc were compared by ordinary One-Way ANOVA.
n.s., not significant, ** P 0.0042. Adapted from Pokhrel et al. 2020.

SUMMARY
The stringent response governs virulence traits and phenotypes in many
organisms, including biofilm production, spore formation, virulence factor expression, and
survival of pharmacological and immune stresses (149). We have found that Relacin is
effective at inhibiting RSHCd synthetase activity in a dose-dependent manner in vitro
(147). While Relacin does not have any effect against bacterial accumulation and survival
under normal growth conditions, we found that inhibition of RSHCd synthetase activity,
mediated by Relacin, amplifies the potency of both metronidazole and clindamycin
against C. difficile R20291 strain (147). Notably, we found the effect of Relacin on
antibiotic efficacy to be modest (147). Furthermore, we found Relacin to be effective
against RSHCd synthetase activity in millimolar concentration, suggesting that the
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molecule is not a suitable candidate for clinal use in managing CDI. Furthermore, knock
down of R20291 rsh gene in the presence of metronidazole substantially reduced
bacterial accumulation, confirming that rsh translation and subsequent production of
putative pGpp is required for C. difficile to respond to and survive antibiotic stress in the
host (147).
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CHAPTER V

NUTRIENT-SPECIFIC MOTILITY AND BIOFILM REGULATION OF
CLOSTRIDIOIDES DIFFICILE

OVERVIEW

Clostridioides difficile is an obligate anaerobic pathogen that persists as dormant
spores in the aerobic environment (13). Once ingested by the host, the pathogen
germinates into rapidly reproducing vegetative cells that can secrete toxins (13). The
clinical spectrum of C. difficile infection ranges from asymptomatic colonization to lifethreatening pseudomembranous colitis, toxic megacolon, sepsis and death (13). CDI is
defined when patients experience symptomatic diarrhea and test positive for C. difficile
toxin A and/or B or the presence of toxin-producing strains in the stool (6,42).
Pseudomembranous colitis or colonic histopathological characteristics revealed by
endoscopy also defines CDI (6,7,281). But bacterial colonization without the onset of
symptoms, which still leads to disease progression remains an unclear aspect of C.
difficile pathogenesis. Studies have revealed that C. difficile colonizes between 0 to 17.5
% of healthy individuals without causing clinical signs of CDI (6,282,283). Notably, a high
prevalence of asymptomatic colonization is found in institutionalized patients, particularly
with underlying medical conditions, or in health-care workers (6,284-286). Furthermore,
asymptomatic colonization can also be found in infants and neonates, mainly during the
first four weeks of life (6,287). Analysis of PCR ribotypes have shown that individuals from
different age groups are colonized with identical toxigenic strains of C. difficile without
showing any clinical signs of CDI (288,289). Whether symptomatic or asymptomatic,
colonization of C. difficile, nevertheless, serves as a reservoir of the pathogen and a mean
of bacterial transmission from one host to another (6).
One of the key mechanisms regulating C. difficile colonization in the host is the
disruption of the indigenous microbiota community (42). The intestinal microbiota is a
complex ecosystem consisting of numerous bacterial species (6). In healthy adults, the
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intestinal microbiota is predominantly constituted of species belonging to the
Bacteroidetes and Firmicutes phyla, with roles in metabolism, nutritional function,
maturation of the immune system, and conferring host colonization resistance to enteric
pathogens (6,42,290). Due to the beneficial contributions of the indigenous microbiota to
the host, disruption or dysbiosis of the microbiota community negatively impacts
microbiota structure and functions (6). Consequently, host colonization resistance is
attenuated, resulting in the germination, growth, and rapid multiplication of C. difficile
within the host intestine (6). Factors such as diet, geography, antibiotic use, and the
development of gastrointestinal complications influence microbiota diversity between
individuals (6,291).
Antibiotic exposure (especially cephalosporins, penicillins, and fluoroquinolones)
is the primary risk factor for CDI development and is postulated to increase host
susceptibility to CDI by disrupting the intestinal microbiota community (6,292,293). The
impact of antibiotic administration on the host microbial structure and composition has
been studied extensively. CDI patients exhibit changes in the gut microbiota composition,
including a significant decrease in Bacteroidetes family species with an increase in the
members of the Proteobacteria such as Pseudomonadales (6,42). Within the Firmicutes
phylum, CDI patients report a decrease in butyrate producing Ruminococcacea and
Lachnospiraceae, Bacteroidaceae, and Clostridia cluster IV and XIVa with a
corresponding increase in Lactobacillales (42,294). In animal models of infection, prior
clindamycin exposure has confirmed the findings for human patients and demonstrated
a decrease in the abundance of commensal species (295). Similarly, animal models
lacking pre-antibiotic treatment fail to exhibit the debilitating symptoms of CDI,
presumably owing to an undisrupted microbiota community (42,295,296). Changes in the
gut microbiota of asymptomatic carriers of C. difficile are less defined but studies have
shown that there is a comparable decrease in microbial diversity and species structure in
both CDI and asymptomatic carrier groups in contrast to the healthy group (42,297).
Interestingly, the structure of the microbial communities are strikingly different among CDI
patients and asymptomatic carriers (42). Indigenous microbiota of the carrier group is
dominated by Firmicutes and Bacteroidetes, suggesting that the composition of
microbiota in this group resembles that of healthy individuals (42,297). Studies using
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murine models of infection also support the findings that colonization with certain bacterial
taxa such as Lachnospiraceae prevents the progression of CDI from symptomatic or
asymptomatic colonization (42,298).
Apart from altering the native microbiota structure and composition, antibiotic
treatment also induces substantial changes in the gut metabolome. The intestinal
microbiota is responsible for fermenting carbohydrates and amino acids into short chain
fatty acids (SCFAs) (299,300). Furthermore, the microbiota metabolizes lipids, amino
acids, and proteins, ensuring a balanced colonic health that affects the growth and
survival of enteric pathogens (300,301). However, antibiotic-induced disruption of the
normal microbiota results in a metabolic environment that largely favors the colonization
and spread of enteric pathogens. Theriot et al. reported that cefoperazone treatment in
murine models increases the concentration of primary bile acids, including taurocholate,
taurocholenate sulphate, and tauroursodeoxycholate, with a corresponding decrease in
secondary bile acid, deoxycholate (300). To establish colonization, C. difficile spores must
germinate into vegetative cells using primary bile acids as germinant. Therefore,
antibiotic-induced increase in the concentrations of primary bile acid promotes C. difficile
germination in animal models, further indicating that antibiotics disrupt members of the
commensal microbiota with roles in the metabolism of primary bile acids into secondary
bile acids, which inhibit C. difficile growth (44,45,300). Theriot et al. also reported that
cepfoperazone treatment increases the level of sugar alcohols and carbohydrates in
murine models, including mannitol, sorbitol, arabitol, xylitol, ribitol, gluconate, sucrose,
raffinose, stachyose, galactose, lactate, and fructose (300). The reported increase in the
levels of carbohydrates and alcohols coincided with a decrease in free short-chain fatty
acids, including acetate, propionate, butyrate and valerate, suggesting that indigenous
microbiota-mediated fermentation of carbohydrates is decreased from antibiotic exposure
(300). Upon testing the ability of C. difficile to utilize these sugars and alcohols both
independently and in conjugation with murine cecal contents, it was revealed that C.
difficile successfully germinates and outgrows in a niche that is rich in these metabolites
(300).
According to Theriot et al., antibiotic treatment also increases the concentration of
N-acetylneuraminic acid (NEU5A) or sialic acid in the gut (300). NEU5A is a branched
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carbohydrate and a component of the O-glycosylated MUC2 core protein, which is largely
constituted by mucins of the intestinal mucus (302). C. difficile adheres to gut mucins in
vitro and has been observed within the mucus of mice and humans in vivo, suggesting
that C. difficile colonizes the intestinal mucus (302-309). In addition to NEU5A, the mucin
is O-glycosylated with GlcNAc, N-acetylgalactosamine, galactose, and fucose
(302,310,311). These O-glycosylated carbohydrates are degraded and released as free
glycans via hydrolase enzymes encoded by mucin-degrading native species
(302,311,312). Notably, free glycans serve as nutrients to the commensal microbes as
well as to colonic enteric pathogens, including V. cholerae, C. jejuni, and S. typhimurium
that swim towards the intestinal mucus to compete with and outnumber the native
microbiota community (302,313-316). Like many motile bacteria, these organisms
regulate their motility in response to nutrients by controlling the activity of motor
complexes that rotate their flagella. According to Courson et al., long periods of flagellar
rotation cause unidirectional runs, whereas transient changes in rotational direction
causes tumbles that reorient cells to run in new directions (317). Furthermore, sustained
runs cause bacterial dispersal, but frequent tumbles reduce run lengths and confine cells
in one region of the niche or locality (317). The speed of flagellar rotation can also
influence bacterial dispersal (317). Nevertheless, bacteria alter their tumbling frequency
and/or velocity to control their motility towards a more concentrated source of nutrients or
chemoattractants (317). Notably, C. difficile also readily responds to nutrient availability
in the niche. Sporulation, toxin production, and metabolism of c-di-GMP in this organism
are influenced by the nutrient composition of the bacterial growth medium (317-319).
Like many motile intestinal pathogens, C. difficile produce flagella and can swim
through liquid and semi-solid media (119,317). This bacterium also moves on solid
surfaces with the aid of TFP (111,317). To investigate if nutrients regulate C. difficile
R20291 motility, we have designed and constructed portable rose cell chambers that can
be used in any inverted microscope under aerobic conditions (317). At the single-cell
level, we found that free NEU5A glycans reduce bacterial swim velocity and displacement
without affecting bacterial tumbling frequency (317). Since NEU5A is associated with C.
difficile colonization in vivo, we postulated that the reduction in bacterial motility and
biofilm formation by R20291 may be coordinately regulated by the same signaling
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mechanism(s). Biofilm is a virulence factor that enables bacteria to resist stresses from
antibiotics and host immune system. Very recently, Engevik et al. demonstrated that C.
difficile RT027 strain chemotaxes toward and adheres to MUC2 of the intestinal mucus
layer in murine models (302). Chemotaxis is defined as the directed movement of bacteria
in response to chemical gradients that facilitate movement toward and away from
favorable and unfavorable conditions, respectively. According to Engevik et al., NEU5A
is the least preferred chemoattractant for C. difficile followed by GlcNAc, and mannose
(302). However, culturing of C. difficile cells in a minimal medium supplemented with each
monosaccharide as the primary source of carbon demonstrated that all mucin sugars
facilitate bacterial growth, resulting in a delayed stationary phase-onset (302). Based on
Engevik et al., mannose is the most preferred chemoattractant exhibiting maximal
bacterial growth. But supplementation of a growth medium made from the cecal contents
of gnotobiotic mice (also depleted in amino acids and carbohydrates) with GlcNAc and
NEU5A has previously been reported to enable C. difficile division (317,320). These
findings show that C. difficile respond to unchained NEU5A as a food source.
Engevik and group additionally reported that C. difficile interacts with mucusassociated and mucin-degrading microbes within biofilms such as Bacteroides,
Ruminococcus, and Akkermansia in the antibiotic-treated gut (302). Given that C. difficile
does not code for glycosyl hydrolases responsible for cleaving O-glycosylated mucin
components, the pathogen depends on glycosyl hydrolases-encoding species to utilize
free monosaccharides, suggesting that mucin degradation is a crucial step in the mucosal
colonization and growth of C. difficile (302). To investigate whether C. difficile R20291
directly assembles as biofilm in the presence of high NEU5A concentration, we conducted
the standard plate-based biofilm assays requiring crystal violet staining. Based on our
analyses, C. difficile R20291 forms biofilm in BHIS medium independently of a GLU,
GlcNAc, and NEU5A gradient. However, the strain appears to produce significantly robust
single-species biofilm at 32 mM NEU5A, suggesting that NEU5A-specific motility
suppression of the hypervirulent strain may be regulated by signaling network(s) that also
inversely regulate biofilm formation.
In summary, this chapter focuses on evaluating nutrient-regulated motility
stimulation and/or suppression of C. difficile R20291 strain. Antibiotic-induced shifts of
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the colonic microbiome and metabolome create a niche suitable for C. difficile
germination, growth and colonization (300). Therefore, this chapter focuses on nutrientdependent colonization mechanisms adopted by C. difficile which ultimately contribute to
virulence and/or transmission. Several aspects of this chapter, including the methods and
materials section previously appeared as an article in the reference (317). The rights and
permission to use the materials of the publication is given in Appendix M. Figure numbers
and formats have been modified from the actual publication unless stated otherwise in
the figure legends.
METHODS AND MATERIALS

Bacterial strains and growth conditions
C. difficile strain R20291 was grown in BHIS medium in an anaerobic chamber at
37°C maintained at an atmosphere composed of 85% N2, 10% CO2, and 5% H2. Migration
assays were performed in BHIS and BHIS with 0.3% agar in the presence of GLU, ARA,
or NEU5A at the indicated concentrations. Growth curves were performed in BHIS
supplemented with the indicated metabolites to a final concentration of 32 mM and
inoculated at the ratio of 1:20 with ON cultures of R20291. Doubling times were calculated
using the Prism (GraphPad) software and the non-linear curve fits to the exponential
growth equation Y = Y0*expo (K*X) where Y0 denotes the initial optical density, Y is the
measured optical density, and X is time. Doubling times were determined by fitting the
data between 0 and 5 hours in order to exclude entry of bacterial cells into the stationary
phase of growth.
Macroscopic motility assays
Macroscopic motility assays were carried out in supplemented or unsupplemented
BHIS medium with 0.3% agar. ARA, GLU, or NEU5A was added to the molten agar to the
indicated final concentration. Plates were prepared outside of the anaerobic chamber and
left to dry ON, then transferred to the anaerobic chamber to equilibrate for at least 24
hours prior to use. Sterilized and O2 reduced toothpicks were used for inoculation of
individual colonies of R20291 into the motility agar. Each toothpick was used to stab a
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soft agar (which was divided into two even sections using a sharpie on the plate base)
twice to allow for duplicate measurements. Migration or bacterial swarm diameters were
measured manually using a ruler after 12 and 24 hrs of incubation at 37°C. The mean
diameters and standard deviations of four biologically independent samples measured in
duplicate (total of 8) were reported. One biological replicate had to be excluded from the
24 hrs plain BHIS condition because cell populations grew into each other, spread across
the agar, and made measurements of motility impossible.
Rose cell imaging chamber construction
As mentioned elsewhere, sealed rose cell chambers with gas impermeable
gaskets were constructed for the imaging of anaerobic bacteria using an aerobic
microscope (321). Aluminum top and bottom plates with imaging windows and 25 mm
square glass coverslips were prepared for use with a Nikon Ti-E inverted microscope.
Screw holes were milled into each corner of the top and bottom aluminum plates. Gaskets
were cut from 3 mm thick rubber with a central circular or square opening (18 mm
diameter). The screw holes in the gaskets were aligned to those in the aluminum chamber
plates. Before use, all components of the rose cell chambers were sterilized in 10%
bleach followed by rinsing in deionized water. The components were left to dry prior to
use.
Sample preparation for imaging
Starter cultures of C. difficile R20291 were grown ON in BHIS medium. These
cultures were diluted 1:50 and allowed to grow for ~3 hrs the following day so that the
cells will have entered exponential growth phase. 150 µL of dilution culture was then
mixed with fresh BHIS medium and nutrient supplement at desired concentrations for a
total sample volume of 1,500 µL. Within the chamber, the sample was injected through
the bottom port of the chamber through the rubber gasket using a 1 mL syringe until all
gas escaped from the top needle. After sample injection, both top and bottom needles
were removed, allowing the holes in the rubber gasket to seal on its own. The edges of
the imaging chamber were parafilmed and removed from the anaerobic chamber, sprayed
with 10% bleach and 70% ethanol for sterilization purpose before imaging. Microscopy
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was initiated roughly 8 mins after chamber assembly for every single-cell analysis
experiments.
Microscopy set-up
Live-cell, time-lapse differential interference contrast microscopy was performed
on a Nikon Ti-E inverted microscope equipped with Nikon Perfect Focus System,
apochromat TIRF 60X Oil Immersion Objective Lens (numerical aperture of 1.49), a
condenser (numerical aperture of 0.52), pco.edge 4.2 LT sCMOS camera, and SOLA SE
II 365 Light Engine along with complementary DIC components. Stage temperature was
maintained at 36.5oC ± 0.5oC to monitor bacterial motility at 37oC using a Nevtek Air
Stream microscope stage warmer and a microscope enclosure prepared in house. 100
µs exposures at a frame rate of 10 frame/sec for 10 seconds was used to record movies
of bacterial motility. Three biologically independent samples were imaged in each medium
condition; 600 X 600-pixel windows were imaged at three randomly selected locations
per sample. The first ten cells that entered the field of view were analyzed.
Decontamination of the rose cell chambers
After each imaging experiment, the microscope stage and sample holder were
wiped with 10% bleach and 70% ethanol. The parafilm wrap was peeled off the rose cell
chamber and placed into biohazard waste bin. The sample chamber was submerged in
a 50% bleach solution and disassembled. All components of the chamber were allowed
to soak in the bleach solution for at least 10 mins. Glass coverslips were gently removed
and discarded as biohazardous waste. Aluminum and rubber components were rinsed
with deionized water and then soaked in ~117 mM sodium thiosulfate for at least 30 mins
to neutralize bleach. Components were subsequently washed with ethanol and dried prior
to reusing.
Single-cell analysis
Image analysis was performed using a bunch of Nikon Elements imaging Suite
and the ImageJ software. The line segment tool was used in ImageJ to measure
unidirectional run of each bacterial cell over time from which the velocity and
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displacement factors were calculated. Each reorientation was considered the peak as
well as the end of a run but the start of a new one. Only runs whose beginnings and ends
took place within the field of view and the plane of focus were considered for motility
measurements. For each cell, the run lengths, run durations, and number of tumbles were
recorded. Swimming velocity was calculated by dividing displacement by time.
Plate-based, single-species biofilm assay
ON cultures of C. difficile R20291 were diluted 1:100 into fresh buffered BHIS (38.7
mM NaH2PO4 and 11.3 mM Na2HP04 at pH 7.43 ± 0.05) media. A total of 2 mL samples
per well was deposited in 24-well polystyrene non-treated plates (Costar, USA) with 0
mM, 4 mM, 8 mM, 16 mM, and 32 mM of GLU, NEU5A and GlcNAc. The 24-well plates
were always reduced for at least 72 hrs prior to setting up single-species biofilm assays.
The stock solution of each metabolite was prepared as a 10X stock in plain BHIS media,
filtered sterilized, and stored in aliquots in –20 °C for long-term use. Prior to plate set up,
buffered BHIS, plain BHIS and 10X stock solutions of all sugar metabolites were taken
into the chamber to reduce overnight. Post-set up, the plates were incubated at 37°C
within the anaerobic chamber for at least 48 hours. Once incubation was complete, the
plates were taken out of the anaerobic chamber and placed on a portable rack. Spent
media from the plates were subsequently removed via pipetting and wells were gently
washed once with filter sterilized 1X PBS. Biofilms were air dried for 5 to 10 mins and
stained with crystal violet (CV; 0/1% w/v) for 30 mins. CV stain was removed through
pipetting after which the wells were washed twice with PBS then air-dried for ~10 mins.
Dye bound to the biofilm biomass was solubilized with 70% reagent alcohol and the
absorbance, corresponding to the biofilm biomass, was measured at 570 nm with a plate
reader (BioTek). When necessary, the solubilized CV dye was diluted for all readings to
remain in the linear range of the spectrophotometer. Autoclaved BHIS and same media
condition with different sugar metabolite was used for blanking in the assays. Biofilm
assays using NaCl were conducted in the same manner at the indicated concentrations
of the non-sugar osmolyte.
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RESULTS

C. difficile regulates motility in a nutrient-specific manner
The C. difficile genome encodes a predicted methyl-accepting chemotaxis protein
(CDR20291_0463) within a putative chemotaxis operon (CDR20291_0458 to
CDR20291_0467), suggesting that the bacteria could regulate flagella-dependent motility
to respond to unknown nutrients (317). The levels of NEU5A increases in animal models
as a result of cefoperazone-induced dysbiosis of the gut microbiome and metabolome
(300). To investigate if NEU5A regulates the motility of C. difficile R20291, we inoculated
individual colonies of the strain into BHIS medium with 0.3% agar that has a level of
viscosity comparable to that of the intestinal mucus and measured bacterial dispersal
from the site of inoculation (317,322-324). We performed these macroscopic motility
assays because available nutrients that bacteria can metabolize suppress motility by demotivating bacteria to seek new territories. We found that BHIS medium supplemented
with 1% of any metabolite reduces R20291 dispersal post-12 hrs of incubation (Fig. 36A)
(317). Notably, NEU5A appeared to reduce migration of inoculated colonies from the
inoculum site most dramatically (Fig. 36A) (317).
Supplementation of BHIS medium with arabinose also reduced motility of R20291
after 12 hrs of incubation (Fig. 36A) (317). This shows that the addition of substrates that
are not metabolizable to the bacteria still contributes to motility suppression at earlier
timepoints, potentially due to the impact of high carbohydrate concentration on the
osmolarity of the medium (317,325). After 24 hrs of growth, however, migration through
the agar in the presence of arabinose had no effect on the swarm diameter, suggesting
that the bacteria eventually adapt to the nutrient-independent effects of the medium
supplemented with ARA (Fig. 36B) (317). Nonetheless, by including arabinose in our
motility analyses, we have controlled for the possibility of observing an osmolarity
response of cells vs nutrient-derived response in the presence of GLU and NEU5A.
Hence, supplementation with 1% GLU and NEU5A reduces migration by 22% and 69%,
respectively, after 24hrs of incubation, suggesting that the presence of metabolically
accessible nutrients in the niche inhibits C. difficile dispersal (Fig. 36B) (317).
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To ensure that the observed motility differences from supplementation with 1%
monosaccharide were not due to differences in the molar concentrations of each
supplement tested, we remeasured bacterial swarm diameters on soft agar supplemented
with 32 mM ARA and 32 mM GLU (where 32 mM concentration corresponds to 1%
NEU5A) (Fig. 36C and 36D) (317). As expected, neither ARA nor GLU at 32 mM caused
any significant motility suppression post-12 and 24 hrs of incubation (Fig. 36C and 36D)
(317). This suggests that the inhibition of bacterial swarming on the soft agar is specific
to high NEU5A concentration in the environment.
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Figure 36. C. difficile motility through soft agar is regulated by nutrients. (A, B)
Migration of C. difficile R20291 through BHIS, 0.3% agar supplemented with 1% ARA,
GLU or NEU5A. (C, D) Migration of R20291 through BHIS, 0.3% agar supplemented
with 32 mM of ARA or GLU. Swarm diameters were measured post-12 (A, C) and 24
(B, D) hrs of inoculation. Measurement of four biologically independent swarms per
condition (X2). Motility in each medium was compared to migration in BHIS-agar by
Unpaired t-test; n.s., not significant, * P < 0.05, ** P < 0.01, **** P < 0.0001. (E)
Representative images of C. difficile R20291 24 hrs after inoculation. Adapted from
Courson et al. 2019.
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To confirm that motility suppression regulated by NEU5A or suppression of migration of
C. difficile R20291 on the soft agar is not due to bacterial growth inhibition, we monitored
bacterial growth in the presence of various monosaccharides at 32 mM concentration
over the course of 12 hrs (317). We found that none of the monosaccharides slowed
growth in liquid culture, confirming that the observed effect of nutrient supplementation in
the motility agar (Fig. 36E) is due to motility suppression rather than suppression of cell
division and growth (Fig. 37A) (317). The calculated doubling times of R20291 in BHIS
supplemented with the indicated sugar are comparable to each other (Table 3). The
findings that the bacteria exhibit a normal growth phenotype in the presence of all sugars
studied at 32 mM concentration but substantially reduces motility in response to NEU5A,
suggest that C. difficile R20291 senses nutrient availability in the niche and reduces its
motility away from sites that are rich in specific nutrients (317).
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Figure 37. C. difficile growth in the presence of different sugars at 32 mM
concentration. (A) Growth curves in medium supplemented with either 32 mM ARA,
GLU or NEU5A are comparable to the growth of the bacteria in plain BHIS medium. (B)
Growth curve as in (A) showing how the doubling times were calculated between 0 and
5 hrs of growth in the respective media. Adapted from Courson et al. 2019.
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Table 3.
C. difficile replicates normally in the presence and/or lack of different
metabolites. Doubling times of C. difficile R20291 in BHIS with 32 mM supplementation
of either ARA, GLU or NEU5A. Doubling times were calculated between 0 and 5 hrs of
growth in plain BHIS or BHIS supplemented with the respective metabolite. Adapted
from Courson et al. 2019.

Medium

Doubling time (hrs)

Plain BHIS

1.74

+ 32 mM ARA

1.54

+ 32 mM GLU

1.59

+ 32 mM NEU5A

1.30
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Imaging of live C. difficile R20291 cells using home-built portable rose cell
chambers
Based on our macroscopic motility assays, NEU5A specifically suppresses
R20291 motility or swarming from the initial site of inoculation on a soft agar. To verify
this finding on the single-cell level, we have utilized a rose cell chamber (317). The use
of a rose cell chamber involves assembling a gas impermeable rubber gasket with a
central hole that is sandwiched immediately between two glass cover slips followed by
two aluminum plates at the top and bottom (Fig. 38A) (317). The rubber gasket is pierced
with two standard needles, one that allows gas and fluid exchange to occur with the
surrounding and another that allows for venting displaced air along with sample injection
into the assembled chamber (317). Assembled chambers are reduced in the anaerobic
chamber (although time consuming, the chamber can be assembled within the anaerobic
chamber itself) and injected with liquid culture after which the needles are removed to
allow the bacterial culture to be sealed inside of the rose cell chamber (317). The chamber
is then placed on an aerobic inverted microscope and maintained at 37°C (317). By doing
so, we found that within this device, C. difficile R20291 can grow and multiply normally
overtime (317) (Fig. 38B). As depicted in the figure, growth is indicated by an increase in
bacterial cell density as a function of time (Fig. 38B). We recorded images at various time
points while the cells grew and found that after 6 hrs, bacteria continued swimming and
multiplying, confirming that the home-built rose cell chambers preserve R20291 growth
and viability (Fig. 38B) (317).
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Figure 38. Extended live-cell microscopy of C. difficile R20291 using a rose cell
chamber. (A) Side view of rose cell chamber assembly. (B) Cell division and growth of
R20291 within the imaging chamber in BHIS medium. Panels show the time course in
which the cells were incubated at 37°C within the chamber. Scale bar indicated at 10
µm. Adapted from Courson et al. 2019.
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Analysis of C. difficile R20291 motility at the single-cell level
To measure motility in BHIS media supplemented with increasing concentrations
of NEU5A, we recorded fast time-lapse videos (317). To prepare cultures for imaging, ON
cultures of R20291 were diluted 1:50 into fresh BHIS media and allowed to grow for ~3
hrs, letting cells to reach late lag or early exponential phase of growth (317). Chambers
were subsequently injected with BHIS supplemented with indicated concentrations of
NEU5A (0, 10, 16, 25, and 32 mM) and 1:10 dilutions of the early exponential phase
culture (317). To quantify bacterial motility within the chamber, we measured net
displacement, unidirectional run length, and velocity during unidirectional runs of at least
ten randomly selected cells within each movie (317). We found that supplementation with
10 mM NEU5A exhibited no significant effect on displacement, while 16 mM NEU5A
caused a modest but significant increase in bacterial displacement (Fig. 39A) (317). At
32 mM concentration, however, bacterial displacement was significantly inhibited (Fig.
39A). At 25 mM, NEU5A reduced net displacement by 20% from 88.4 µm to 71.0 µm, and
at 32 mM, NEU5A further reduced displacement. The motility videos used for the
quantification of displacement are included in Courson et al. and that the link to the videos
is included in Appendix G.
To verify if reduction in displacement caused by increasing NEU5A concentrations
is due to reduction in bacterial swimming speeds, we calculated the flagella-dependent
swimming velocities of each cell (317). We measured run velocity only during
unidirectional runs even if that required us to include multiple frames of movement in the
same direction (317). We found that NEU5A reduced swimming velocity at concentrations
higher than 25 mM since 10 mM and 16 mM NEU5A had no significant effect on velocity
(Fig. 39B) (317). Supplementation of BHIS medium with 25 mM and 32 mM NEU5A
reduced velocity from 21.3 µm/sec to 15.8 µm/sec and 75% to 5.4 µm/sec, respectively
(Appendix G, movies 2-5) (317).
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Figure 39. NEU5A reduces net displacement and velocity. (A) Net displacement (B)
linear swimming velocity of R20291 during unidirectional runs within 10 sec in BHIS
with indicated concentrations of NEU5A. Means and standard deviations of 49-146 cells
are shown per condition. One-Way ANOVA analysis of variance comparing
displacement and velocity of cells in supplemented media to those in plain BHIS.
Turkey’s multiple comparison test., n.s., not significant; **** P < 0.0001. Adapted from
Courson et al. 2019.
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Analysis of C. difficile R20291 motility via the tumbling mechanism
To quantify bacterial motility within the rose cell chamber, we also measured
bacterial tumbling frequency of cells within each movie (317). Notably, reducing
swimming velocity is not the only mechanism that bacteria employ to limit dispersing away
from regions of high nutrient concentration or availability in the niche (317). Bacteria can
stay closer to nutrient-rich sites by increasing flagella-dependent tumbling (317). To
determine if C. difficile also alters its tumbling frequency in the presence of high NEU5A
concentration, we quantified the reorientations of individual cells in the movies (317). We
reported the number of tumbles per second of recorded motility because not all the cells
analyzed managed to stay within-frame for the full 10 secs exposure duration (317). Upon
doing so, we found that the average tumble frequency was not affected by
supplementation with NEU5A at any concentrations tested (Fig. 40A) (317). The majority
of cells did not tumble and supplementation with NEU5A appeared to make no difference
in the observed trait (Fig. 40A) (317). Of the subset of cells that tumbled and were
analyzed separately to study the effect of NEU5A, we found that NEU5A decreases
tumbling frequency rather than increasing it (317). Tumbling cells in all medium conditions
tumbled at the rate of 0.1-0.25 times/sec (Fig. 40B) (317). Only 7.3% of cells incubated
in 32 mM NEU5A tumbled more than 0.25 times/sec in comparison to 10-20% of cells
that tumbled in other media (Fig. 40B) (317). The average reorientation frequency of
tumbling cells in 32 mM NEU5A was 0.22 tumbles/sec, which notably was lower than 0.32
tumbles/sec in plain BHIS or in any of the other media conditions supplemented with lower
NEU5A concentrations (Fig. 40C) (317). These findings suggest that C. difficile R20291
senses high NEU5A concentration in the niche as is the case post-antibiotic treatment,
notably without changing its tumbling frequency.
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Figure 40. NEU5A has no effect on C. difficile R20291 tumbling. (A) Tumble
frequency of C. difficile R20291 in BHIS supplemented with indicated concentrations of
NEU5A. Tumble counts were normalized by the duration of each cell’s motility to control
for cells that left the field of view during 10 secs exposure. (B) Percentage of the total
cells exhibiting the indicated number of tumbles/secs in each condition is given. (C)
Normalized frequency of cells that show a non-zero rate of tumbling. Turkey’s multiple
comparison test., n.s., not significant. Adapted from Courson et al. 2019.
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High NEU5A concentration regulates biofilm formation by C. difficile R20291
Since flagellum-dependent motility and TFP-mediated biofilm formation are
inversely regulated by c-di-GMP in C. difficile, we investigated the impact of high NEU5A
concentration in bacterial biofilm formation. We hypothesized that NEU5A serves as a
potential signal in the host during C. difficile infection that regulates intracellular c-di-GMP
pool and the associated physiological responses. Using plate-based biofilm assays, we
found that C. difficile R20291 forms relatively more biofilm in media supplemented with
NEU5A, GlcNAc, and GLU metabolites than in unsupplemented medium (Fig. 41).
Notably, the bacteria formed single-species biofilm in the presence of both GLU and
GlcNAc regardless of the monosaccharide concentrations (Fig. 41). However, the
bacteria produced significantly more biofilm biomass at the highest NEU5A concentration
tested (Fig. 41). This suggests that C. difficile responds to NEU5A abundancy and
availability in the niche by producing biofilms above the threshold levels.
Previous studies have demonstrated that C. difficile 630 forms higher amounts of
biofilm in BHIS supplemented with fermentable sugar such as GLU, fructose, and ribose
in the presence of stress-causing insults (326). Since we were evaluating the impact of
glucose in bacterial biofilm formation to determine if there is a correlation between motility
suppression and sessile biofilm production in response to nutrients, we did not include
glucose in our biofilm media. According to Dapa et al., both glucose and 0.3 M NaCl
induce biofilm formation by 630 and R20291 strains where 0.3 M NaCl slightly inhibits
biofilm production in caparison to 100 mM GLU (127). Consistent with literature evidence,
we found that C. difficile R20291 form biofilm in the presence of increasing concentrations
of NaCl (Fig. 42A), however, 32 mM NEU5A causes R20291 to produce more biofilm than
does 0.3 M NaCl (Fig. 42B). Observed significant loss of biofilm during PBS washes led
to this measurement which, notably, under-reports the amount of biofilm actually
produced by R20291 in the presence of 32 mM NEU5A. Higher ionic strengths reduce
the repulsion between a bacterial cell and a material surface, and that osmotic stress
caused by NaCl promotes biofilm formation in Gram-positives such as Staphylococcus
species and Listeria monocytogenes (327). The finding that C. difficile R20291 forms
more biofilm in 32 mM NEU5A than in 0.3 M NaCl suggests that while osmolytes generally
induce biofilm formation, the bacteria is also responding to NEU5A as a nutrient. We have
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shown that 32 mM NEU5A does not impact bacterial growth negatively but inhibits
dispersal from the site of inoculation on a soft agar (317). We have also shown that higher
NEU5A concentration suppresses displacement and swimming velocity without affecting
bacterial tumbling (317). Together, these observations indicate that NEU5A is not a
repellent and rather a food source that promotes R20291 auto- aggregation and biofilm
formation.

Figure 41. 32 mM NEU5A induces robust single-species biofilm formation by C.
difficile R20291. Cultures of R20291 were incubated for 48 hrs at the indicated
concentrations of NEU5A, GlcNAc, and GLU. Measurement of bacterial biomass using
0.1% crystal violet staining and 570 nm absorbance readings demonstrated that
R20291 forms significantly more biofilm at 32 mM NEU5A. Production of biofilm in BHIS
is independent of a GlcNAc and GLU gradient. Two-way ANOVA multiple comparison
(cell means regardless of rows and columns) analysis of biomass produced at different
concentrations of the unchained mucin monosaccharides., n.s., not significant, *** P
0.0003. Means and standard deviation of 6 biologicals are shown of two assays
performed on different days.
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Figure 42. Effect of NaCl on biofilm production by C. difficile R20291. (A) Biofilm
formation kinetics by R20291 in the presence of NaCl at the indicated concentrations
using 0.1% CV staining procedure and measurement of biomass at 570 nm. Biofilm
formation is comparable between 0 to 0.15 M non-sugar osmolyte but robust at 0.3 M
NaCl. (B) R20291 produce biofilm in 32 mM NEU5A as well as in 0.3 M NaCl although
at the population level, more independent biologicals produce more biomass in 32 mM
NEU5A. Statistical significance determined by Unpaired t test., n.s., not significant, * P
0.0355. Means and standard deviation of 6 total biologicals are shown for two separate
assays performed on different days.
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SUMMARY

C. difficile is responsive to nutrient availability in its niche and we have found that
the bacteria suppresses its movement in a nutritionally favorable environment. When
added to a soft agar growth medium supplemented with either GLU or NEU5A, C. difficile
can reduce motility at the population level, suggesting that the bacteria is sensing these
free monosaccharides as a food source (317). In the presence of the non-metabolizable
sugar ARA, C. difficile R20291 fails to exhibit any effect on motility over 24 hrs, confirming
that the observed motility response is specific to sugars metabolizable by the bacteria
(317). Notably, the molar concentration required to reduce R20291 motility is higher for
GLU (55 mM at 1%) than for NEU5A (32 mM at 1%) (317). Unlike GLU, NEU5A supplies
nitrogen and carbon as nutrients. Therefore, it remains to be elucidated whether the
pronounced effect on motility exerted by NEU5A is specific or is a general read-out of the
bacterium’s global metabolic state (317). Since the organism codes for predicted
chemotaxis gene products, we initially postulated that NEU5A-regulated motility
suppression contributes to and/or is driven by bacterial directional motility in the presence
of a NEU5A gradient (317). Engevik et al. recently demonstrated that C. difficile R20291
prefer NEU5A the least among other mucin monosaccharides, including GLU and GlcNAc
(302). This finding suggests that R20291 does not readily respond to a NEU5A gradient
when a plethora of significantly relevant metabolites are abundant in the niche. Therefore,
we presume that C. difficile R20291 responds to NEU5A gradient strictly under
circumstances where the metabolite profiles of the host have been changed as a
consequence of intestinal dysbiosis. Post-cefaperozone treatment, a negative foldchange in GLU and GlcNAc have been reported in the gut of animal models, indicating
that R20291 chemotaxis to NEU5A for survival when the levels of competing metabolites
are low (300). Moreover, C. difficile R20291 may also reach NEU5A-rich sites
independently of the chemotaxis mechanism (87).
Planktonic cells initiate biofilm formation to either resist adverse environmental
conditions or to stay put in nutritionally favorable environments to establish colonization
and infection (328). Based on our findings, C. difficile reduces unidirectional motility at
higher NEU5A concentrations (317). Therefore, we postulated that NEU5A induces
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motility suppression of R20291 while promoting single-species biofilm formation in a
highly coordinated fashion, potentially under the regulation of the same signaling
mechanism(s) such as the c-di-GMP signaling. We found that C. difficile R20291 forms
biofilm in the presence of all monosaccharides tested. However, the bacteria form
significantly higher amounts of biomass in 32 mM NEU5A than in the same concentration
of GLU or GlcNAc. C. difficile is known to form biofilm in the presence of 0.3 M NaCl,
which causes osmolarity stress to the pathogen (127). Based on our data, biofilm
production by R20291 is influenced by osmolarity as well as nutrient availability. Unlike
biofilm formation, however, C. difficile motility is influenced specifically by metabolizable
nutrients rather than by osmolytes or factors contributing solely to changes in cellular
osmolarity.
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CHAPTER VI

CONCLUSIONS

This dissertation investigates the response of Clostridioides difficile to extracellular
conditions. The (pp)pGpp-mediated stress response is a globally conserved mechanism
that bacteria and some eukaryotes employ to respond to extracellular stresses (149). We
have shown that the C. difficile genome encodes a long bifunctional RSH and a
monofunctional RelQ enzyme that are members of the RSH superfamily (147,248).
RSHCd contains two catalytic domains in the N-terminal end and regulatory domains in
the C-terminal end, with a potential role in the reciprocal regulation of the enzyme’s
hydrolysis and synthesis activity (147). Unlike many of its Gram-positive RSH/Rel
homologs, RSHCd does not bind GTP despite harboring the highly conserved RXKD
motif in the amino acid sequence of its synthetase domain (147). The RXKD motif appears
to influence RSHCd synthetase activity in the presence of high Mg2+ concentrations,
suggesting that RSHCd-catalyzed pyrophosphate transfer reactions involve a singledivalent cation mechanism. However, the motif does not influence RSHCd substrate
preference and utilization in a manner similar to RelSeq and RelMtb. Both RelSeq and
RelMtb prefer GTP and readily produce pppGpp, suggesting that guanosine
pentaphosphate alarmone has a physiological relevance to several Gram-positive
organisms during the stringent response (160,243). In the contrary, RSHCd poorly binds
GTP and does not accommodate pyrophosphate transfer from ATP to GTP (147).
RSHCd exclusively utilizes GDP as a substrate to synthesize the magic spot in
vitro (147). We have shown that RSHCd synthetase activity is robust in a wide range of
environmental pHs and that the enzyme can utilize a diverse array of metal cofactors that
are structurally and chemically distinct (147). The failure of RSHCd to utilize GTP at an
equimolar concentration of GDP and an excess in the same substrate pool suggests that
the enzyme strictly utilizes GDP (147). We previously identified the magic spot produced
by RSHCd as ppGpp since the enzyme exclusively utilized GDP under the conditions
used (147,248). However, using RelQBs as a positive control, which utilizes GMP to
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synthesize pGpp, we found that RSHCd-catalyzed alarmone migrates similar distances
on PEI-cellulose plates as RelQBs-produced pGpp. The comparable mobility of the magic
spot produced by RSHCd and RelQBs, notably, using two distinct substrates, lead us to
conclude that RSHCd is synthesizing a three-phosphate alarmone instead of ppGpp via
non-canonical mechanism(s). Additionally, a time-course analysis of RSHCd synthetase
activity using HPLC also demonstrated that the signal of the triphosphate product
increases with an increase in the reaction time, suggesting that the enzyme is producing
putative pGpp in the presence of GDP and ATP (Appendix H). Future structural analysis
using
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Phosphorus NMR is necessary to confirm the identity of the triphosphate

alarmone produced by RSHCd in the presence of GDP. Detection and quantification of
alarmone accumulation in vivo is also imperative to establish that RSHCd produces pGpp
via non-conventional mean(s). Like Bacillus species, C. difficile genome also encodes
two putative NuDiX hydrolases that could potentially degrade pppGpp and ppGpp to
pGpp, suggesting that C. difficile may synthesize the tetraphosphate and the
pentaphosphate forms of magic spot under certain conditions (Appendix I).
To access the role of the CTD in regulating RSHCd synthetase activity, we have
designed and cloned a synthetase-only gene called rsh-rel that codes for C. difficile RSHREL enzyme. We found that the overexpression of C. difficile rsh-rel completely shuts
down bacterial growth compared to rsh, which only partially inhibits growth. This suggests
that expression of RSH-REL, lacking regulation by an intact hydrolase domain and/or the
CTD, leads to the uncontrolled accumulation of the magic spot in bacterial cytoplasm
(147). Notably, the toxicity associated with RSH-REL overexpression and subsequent
magic spot production was attenuated by supplementing the bacterial growth medium
with a combination of glucose and casamino acids (147). Like RSHCd, RSH-REL
exclusively utilizes GDP to produce putative pGpp in vitro. We also examined the
hydrolase activity of RSHCd in the presence of exogenous ppGpp and Mn2+ ion and found
that RSHCd exhibits a relatively modest hydrolysis activity in isolation. Failure to detect
hydrolysis product PPi via TLC suggests that the HD of RSHCd potentially requires
activation regulation by branched-chain amino acids known to bind the ACT domain of
several well-characterized Rel/RSH CTD (166).
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Although the SR is a ubiquitous stress signaling pathway, factors contributing to
the transcriptional regulation of rsh in diverse species vary dramatically (158). We found
that C. difficile rsh is transcriptionally regulated by bacterial stationary phase onset and
nutrient limitation (147). We also found that rsh transcription in C. difficile R20291 is
induced by exposure to clindamycin and metronidazole (147). Interestingly, Relacin
inhibits RSHCd synthetase activity in vitro but exerts no effect on bacterial accumulation
in vivo (147). Exposure to antibiotics partially suppresses C. difficile R20291 accumulation
from the intracellular production of (pp)pGpp and activation of the SR. Notably, the
treatment of antibiotic-exposed C. difficile with 2 mM Relacin appeared to further
suppress bacterial accumulation or load, suggesting that Relacin inhibits bacterial
accumulation during the SR, presumably by inhibiting RSHCd-mediated putative pGpp
synthesis (147). We have also confirmed the significance of rsh and rsh translation to C.
difficile R20291 using a gene-silencing tool. Our data demonstrated that rsh translation in
response to metronidazole is involved in bacterial antibiotic stress tolerance and survival.
Furthermore, we have directly examined the significance of rsh gene in C. difficile R20291
virulence. Using ICelligence electrical cell impedance assay where R20291 and MadinDarby canine kidney (MDCK) cells were co-cultured in gold microelectrode wells, we have
shown that induction of asRNA specific to the mRNA of C. difficile rsh increases the lag
time of MDCK cells to transition from proliferating to nonviable cells (Appendix J). While
the MDCK cells are eventually killed from C. difficile toxicity (bacterial toxins lead to
disruption of the mammalian epithelium monolayers and subsequent detachment from
the assay wells causing reduction in impedance) and nutrient limitation in the growth
medium, the observed delay in MDCK detachment or death corresponding to higher
cellular index in the inducer-treated group indicates that rsh directly contributes to
pathogenesis in C. difficile R20291 strain (Appendix J).
Finally, this dissertation also investigated nutrient-regulated mechanisms
contributing to C. difficile host colonization. C. difficile is responsive to nutrients in the
environment and as a motile organism, the bacteria utilize its motility machineries to
respond to attractants and repellents accordingly (110). Based on a study by Theriot et
al., antibiotic exposure alters the colonic microbiome and metabolome, creating an ideal
niche for C. difficile germination and growth (300). Unchained NEU5A becomes abundant
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and readily available to the pathogen post-cefoperazone treatment in the gut, suggesting
that the bacteria utilize this mucin monosaccharide as a food source (300). Furthermore,
Ng et al. demonstrated that C. difficile 630 genome carries a NEU5A catabolic operon
like S. typhimurium and can metabolize free NEU5A, promoting higher pathogen densities
within the intestinal lumen of mouse models (329). We have found that C. difficile R20291
suppresses its flagella-dependent motility at high NEU5A concentrations by decreasing
bacterial displacement and swimming velocity (317). Notably, C. difficile does not
attenuate motility by increasing its tumbling frequency (317). We hypothesized that the
bacteria respond to NEU5A gradients in the host and maintain flagella-dependent
chemotaxis to reach NEU5A-rich sites. However, a recent study demonstrated that
NEU5A is one of the least preferred chemoattractants for C. difficile, indicating that
R20291 cells respond to NEU5A gradient via chemotaxis only under conditions in which
the levels of GLU and GlcNAc are substantially low (302).
While the chemotaxis mechanism largely governs the net direction of movement
of bacteria for approaching attractants, it is not the only way pathogens can sense and
move toward favorable environments (87). For instance, enterohemorrhagic E. coli can
sense butyrate via positive transcriptional regulation of flagellar gene synthesis, which in
turn enhances flagellum-driven motility of the pathogen to reach the surface of the
intestinal mucosa (87,330). Furthermore, V. cholerae can sense high bile concentration
using a two-component sensing and response system, which increases bacterial motility
from the intestinal lumen to the bile-rich locations (87,331). This suggests that C. difficile
R20291 could potentially rely on system(s) apart from chemotaxis to reach NEU5A-rich
sites. Upon arriving at the target sites, the bacteria suspend flagella-driven motility but
may or may not use flagella for other roles, including adhesion and biofilm formation
during C. difficile infection. Purcell et al. reported that TFP contributes to biofilm formation
by C. difficile in a c-di-GMP and class II_4 riboswitch-dependent manner (111). They also
reported that c-di-GMP promotes TFP biosynthesis and surface motility, with the R20291
strain exhibiting significantly higher pilA1 gene transcription corresponding to higher
biofilm formation than 630/630Δerm strain (111). Since c-di-GMP represses flagellummediated motility in C. difficile by down regulating the expression of genes in the ƒlgB
operon (including sigD that positively regulates toxin gene expression) and facilitates
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autoaggregation and biofilm formation, we hypothesized that R20291 form biofilm in the
presence of high NEU5A concentration and that NEU5A may be one of the many signals
that impact cytoplasmic c-di-GMP pool and signaling in this organism.
Based on our quantification analyses using crystal violet assays and absorbance
measurements at 570 nm, we found that C. difficile R20291 form biofilm in the presence
of all sugar metabolites evaluated. Interestingly, R20291 cells appeared to form robust
biofilm with significantly more biomass in the presence of 32 mM NEU5A than in GLU or
GlcNAc at the same concentration. These findings indicate that C. difficile R20291
maintains colonization in the host by responding to NEU5A abundancy through robust
single-species biofilm formation. However, the bacteria do not respond the same way to
the same concentration of GLU and GlcNAc. Furthermore, our plate-based assays also
revealed that biofilm formation by C. difficile R20291 is induced by osmolarity, while
motility of the strain is not dependent on factors or monosaccharides such as ARA that
impact cellular osmolarity. Overall, these findings indicate that motility suppression and
biofilm formation of R20291 caused by 32 mM NEU5A may be inversely regulated by the
same regulatory network(s) such as the c-di-GMP signaling. Recently, glucose-6phopshate was shown to serve as a signal for P. aeruginosa SagS system to activate its
motile-sessile switch function in a c-di-GMP-dependent manner (332). Glucose-6phosphate increases diguanylate cyclase NicD expression, resulting in the corresponding
increase in bacterial attachment and biofilm formation (332). Overall, this finding
demonstrates the feasibility of our current hypothesis that NEU5A, much like glucose-6phosphate, serves as a signal to induce R20291 biofilm formation via the c-di-GMP
signaling network.
Using portable rose cell chambers to image bacterial aggregation upon incubation
in buffered biofilm medium supplemented with 32 mM NEU5A, we have found that C.
difficile R20291 form long chains of replicating cells (Appendix K) in a manner similar to
B. subtilis during the production of ECM and biofilm formation (333). Notably, the chains
appear to be longer when R20291 culture is treated with 0.3 M NaCl, with visibly fewer
spores (Appendix K). We postulate that the deviation in cellular aggregation pattern and
spore formation is attributable to the differential regulation of cell behaviors in the
presence of a stress-inducing osmolyte versus a growth-facilitating food source. Future
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characterization of R20291 biofilm architecture and matrix composition at 32 mM NEU5A
using CLSM and TEM will provide more knowledge about the significance of this
monosaccharide to C. difficile host colonization and pathogenesis. Furthermore,
transcriptomic analyses with and without 32 mM NEU5A will provide mechanistic insights
into the inverse regulation of motility and biofilm formation by R20291. We believe that
the expression of genes involved in the biosynthesis of flagella (those in the F3 regulon
and sigD) and/or genes regulating flagellar motility (ƒliC, ƒliD) along with those involved
in chemotaxis will be downregulated in NEU5A-derived R20291 biofilms with a concurrent
upregulation of TFP biosynthesis and assembly genes (such as pilA1 and pilB1) (127).
To determine if c-di-GMP signaling directly regulates the observed motility suppression
and biofilm formation traits in C. difficile R20291 at elevated NEU5A concentrations,
transcriptional profiling of genes encoding c-di-GMP cylases, class I and II riboswitches,
and phosphodiesterases through microarray analyses or more advanced RNA
sequencing technology will be useful. Additionally, we postulate that spo0A, with role(s)
in biofilm formation and attachment by C. difficile and C. perfringens will be differentially
expressed in R20291 biofilms ± 32 mM NEU5A (127). spoOA gene encodes SpoOA, the
master regulator of sporulation in Bacillus and Clostridium species such that spoOA
deletion attenuates biofilm formation (127,132). Upregulation of spoOA in R20291
biofilms at high NEU5A concentrations will suggest that NEU5A potentiates C. difficile
pathogenesis by promoting sporulation and dissemination. While the role of c-di-GMP
signaling in C. difficile sporulation remains to be elucidated, positive regulation of spoOA
gene expression in R20291 biofilms in the presence of concentrated NEU5A will further
denote that NEU5A serves as a signal during host microbial dysbiosis that primes C.
difficile to sporulate rather than produce toxins.
As a concluding remark, we have shown the contributions of the stringent response
mechanism in Clostridioides difficile tolerance and survival of extracellular stresses,
providing significant implications toward the screening and/or designing of RSHCdspecific inhibitors with potency higher than that of Relacin’s.
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APPENDIX A

SUMMARY OF STRAINS AND PLASMIDS USED
Name

Description

Reference

Escherichia coli
DH5α

F- φ80lacZΔM15 Δ(lacZYAargF) U169 recA1 endA1
hsdR17, phoA supE44 thi-1
gyrA96 relA1 λ- tonA

BL21

fhuA2 [lon] ompT gal [dcm] ΔhsdS

HB101

NEB

HB101 pRK24
RT1255
RT1270

New
England
Biolabs
(NEB)
NEB

HB101 transformed with pRK24

273

pMMBneo::R20291_rsh-His6 in
DH5α
pMMBneo::R20291_rsh-His6 in
BL21
Clostridioides difficile

248
248

630

Wild type

630∆erm

108

R20291

Wild type 630 lacking erythromycin
resistance gene ermB
Wild type

CEP18

pRF185::phiLOV2.12.1 in R20291

147

CEP19

pRF185::phiLOV2.12.1 in 630∆erm 147

CEP21

PrelQ630∆erm::phiLOV2.12.1 in
R20291
Prsh630∆erm::phiLOV2.12.1 in
630∆erm
PrelQ630∆erm::phiLOV2.12.1 in
630∆erm
PrshR20291::phiLOV2.12.1 in
R20291
Plasmids

147

Low copy expression vector, Ptac,
neo cassette, KanR
tetR

147

R20291 rsh ligated into KpnI/PstI
sites of pMMBneo

147

CEP22
CEP23
CEP25

pMMBneo
pRF185
pMMBneo::R20291_rsh-His6

147
147
147

273

175

pMMBneo::R20291_rshRELHis6

rel amplified from R20291 rsh and
ligated into KpnI/PstI sites of
pMMBneo
pRF185::phiLOV2.12.1
phiLOV2.1 downstream of
tetracycline-inducible promoter
ligated into BamHI/KpnI sites of
pRF185
PrelQ630∆erm::phiLOV2.12.1 Predicted promoter upstream of
630∆erm relQ amplified and
ligated into BamHI/KpnI sites of
pRF185::phiLOV2.12.1
Prsh630∆erm::phiLOV2.12.1 Predicted promoter upstream of
630∆erm rsh amplified and ligated
into BamHI/KpnI sites of
pRF185::phiLOV2.12.1
PrshR20291::phiLOV2.12.1
Predicted promoter upstream of
R20291 rsh amplified and ligated
into BamHI/KpnI sites of
pRF185::phiLOV2.12.1
pMSPT
Low copy expression vector

147

pMSPT::as_rsh

Antisense RNA to the mRNA of
Cdrsh ligated into the SphI/XhoI
sites of pMSPT
Low copy expression vector

147

rsh-rel amplified from full-length
rsh and ligated into KpnI/PstI sites
of pBAD33
High copy expression vector

147

rsh-rel amplified from full-length
rsh and ligated into NdeI/XhoI sites
of pET24a

147

pBAD33
pBAD33::rsh-rel
pET24a
pET24a::rsh-rel

273

147

147

147

68

176

APPENDIX B
SEQUENCES OF PRIMERS USED
Name

Sequence (5’ to 3’)
Underlined region = restriction enzyme cut site
Cloning primers

Reference

rsh_F KpnI

CAGGTACCGGTTATATGCATGATAAAGAAT
TACAAG

248

rsh_R PstI

248

pRF185_F

CCCTGCAGCTAATGGTGATGGTGATGGTGAT
TTGTCATTCTATAAATAC
CTGGACTTCATGAAAAACTAAAAAAAATATTG

pRF185_R

CACCGACGAGCAAGGCAAGACCG

147

phiLOV2.1_F

GCTAGCCCAGGTATGATTGAAAAAAGTTTTG
TTATTACTG
CATGGATCCTTATTAAACATGATCTG

147

TATAGGATCCGGAAAGTTACCAGGTGAAGTT
GA
ATATGGTACCCCACCTATTTTGTATAAAATTT
TAATATATATG
TATAGGATCCATGGCAAGCAAGTTATATCG

147

phiLOV2.1_R
Prsh_F BamHI
Prsh_R KpnI
PrelQ_F BamHI
PrelQ_R KpnI

147

147

147
147

relQ_F

ATATGGTACCCCTTTATTTGTTTTTTATGACCT 147
TC
CAAGAATTCCACTATGGAGCTTGTAATCA
147

relQ_R

CAAGGATCCCATATTGCTCACCCTTTATTTG

147

pMSPT_F

CTAAAGGGCAAAAGTGAGTATGG

147

pMSPT_R

GACGAGCAAGGCAAGACC

147

rsh_as_F

GGTATGCATGCTGCATAAAC

147

rsh_as_R

CCTAGCTCTCGAGACCAAC

147

rshREL_F KpnI

CAGGTACCATGAAAGAAGAAACTCAATCTG

147

rshREL_R PstI

CCCTGCAGCTAATGGTGATGGTGATGGTGA
CTATTAAATACATCTTCTTTAAGTGC
GACCATATGAAAGAAGAAACTCAATC

147

GTGCTCGAGACTATTAAATACATCTTC

This study

pET24a::rshrel_F
pET24a::rshrel_R

This study

177

pBAD33::rshrel_F
pBAD33::rshrel_R

CAGGTACCATGAAAGAAGAAACTCAATCTG

This study

CCCTGCAGCTAATGGTGATGGTGACTATTAAA
TACATCTTCTTTAAGTGC
qRT-PCR primers

This study

rpoCq_F

147
CTAGCTGCTCCTATGTCTCACATC

rpoCq_R
rsh_qF
rsh_qR

CCAGTCTCTCCTGGATCAACTA
AAAATAGGTGGTTAT
TCAATTTTATTATCCCTCCTTTGA

147
147
147

relQ_qF

CATTGCGGGTTCAAAGGAAAT

147

relQ_qR

CATTGCGGGTTCAAAGGAAAT

147

178

APPENDIX C
SIGNAL QUANTIFICATION USING A TLC AUTORADIOGRAM

(B)

32P-ATP

Total signal = 4 – 1
32P-ATP signal = 5 – 2
Magic spot signal = 6 – 3
%Magic spot signal = (6 – 3) / (4 - 1)

Magic spot

Initial spot

Signal quantification using a TLC autoradiogram. Regions of interest (ROIs) defining
the total, 32P-ATP, and magic spot signal are shown for a blank lane and an
experimental lane. Signal intensity within each blank ROI is subtracted from the
experimental value, and the 32P-ATP and the magic spot signals are normalized to the
total signal using the equations given to present the percentage of the total radioactive
signal attributable to ATP hydrolysis and magic spot or putative 5’-pGpp-3’ alarmone
synthesis. Adapted from Pokhrel et al. 2018.
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APPENDIX D
RSHCd PRODUCES PUTATIVE TRIPHOSPHATE ALARMONES

Autoradiograms of in vitro pyrophosphate transfer reactions catalyzed by RSHCd and
RelQBs in the presence of GMP, GDP, GTP, and ADP (RSHCd only). RelQBs utilizes
GMP, GDP, and GTP to produce 5’-pGpp-3’, 5’-ppGpp-3’, and 5’-pppGpp-3’,
respectively. RSHCd is unable to utilize GMP, GTP, and ADP. When either protein is
lacking in the incubation mixture (where NP denotes no protein), magic spot is not
synthesized. RSHCd-produced magic spot migrates similar distance with RelQBsproduced pGpp (black oval), suggesting that RSHCd-catalyzed magic spot could be
pGpp. The first three autoradiograms (left to right) were produced by Asia Poudel and
the last one by Astha Pokhrel (Poudel et al. manuscript in preparation).
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APPENDIX E
SUBLETHAL CONCENTRATIONS OF ANTIBIOTICS USED

1.5

1.0

Abs630

Abs630

2.0

0.5

1.5
1.0
0.5

Clindamycin [µg/mL]

8

7
1.

4
6.
8
13
.5

4

0.

3.

2

128

0.

64

1

32

0.

16

0

0

0.

0.0

0.0

Metronidazole [µg/mL]

Sublethal

Clindamycin

Metronidazole

concentration

(µg/mL)

(µg/mL)

0.25X

4.00

0.075

0.5X

8.00

0.15

1X

16.0

0.30

Sublethal concentrations of antibiotics metronidazole and clindamycin for C. difficile
R20291 were determined using the standard minimum inhibitory concentration (MIC)
technique. ON starter cultures of R20291 were inoculated 1:10 into fresh BHIS media
treated with increasing concentrations of either antibiotic. Cells were incubated
anaerobically at 37°C for 12 hrs to monitor cell accumulation and growth inhibition. The
sublethal concentrations used in the study for four independent biologicals are shown.
Adapted from Pokhrel et al. 2020.
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APPENDIX F
SUBLETHAL CONCENTRATIONS OF ANHYDROTETRACYCLINE

1.0

empty vector
as_rsh

OD630

0.8
0.6
0.4
0.2
0.0
0

0.06 0.12

0.2

0.4

0.6

0.8

ATc (µg/mL)

Minimum inhibitory concentration for ATc against C. difficile RNAi strains were analyzed
in BHIS plus thiamphenicol (15 µg/mL) medium with increasing concentrations of ATc.
ON starter cultures of RNAi strains were inoculated into media at the ratio of 1:20 and
incubated anaerobically at 37°C for 24 hrs to monitoring growth inhibition. The MIC
against empty vector (pMSPT) and asRNA vector (pMSPT::as_rsh) expressing strains
are shown for two biological replicates. 0.5 µg/mL was determined to be the sublethal
concentration of ATc against both RNAi strains to be used for end-point cell
accumulation assays. Adapted from Pokhrel et al. 2020.
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APPENDIX G
MOTILITY VIDEOS OF R20291 IN THE PRESENCE OF NEU5A

https://doi.org/10.1016/j.anaerobe.2019.102080.
Link is adapted from Courson et al. 2019.
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APPENDIX H
TIME-COURSE ANALYSIS OF RSHCd ACTIVITY IN VITRO

HPLC analysis of RSHCd-mediated three-phosphate alarmone production with
increasing incubation time. Synthetase activity was performed in a buffer containing 10
mM Tris-HCl (pH 7.5 ± 0.5), 5 mM ammonium acetate, 2 mM KCl, 0.2 mM DTT, 0.12
mM ATP, 0.6 mM GDP, and 1.2 mM MgCl2. Reaction was initiated by adding RSHCd
at a final concentration of 3.0 µM and incubated at 37°C on a portable dry bath for a
total duration of 30 mins. At 10 mins intervals, ~45 µL samples were transferred into
VIVA SPIN 500 spin column (Corning) with a MWCO of 30 KDa and spun at 12,000 X
g for 5 mins at 20°C. Filterates/samples were run through a strong anion exchange
column the following day along with a 20 µM 5’-ppGpp-3’ standard (Trilink) using a
gradient elution profile. Absorbance at 252 nm was used to detect the standard (std)
(blue peak) and the triphosphate compound at different time points. With increasing
incubation time, there is an evident increase in the signal of putative pGpp as depicted
in the chromatogram. This experiment was performed, and chromatogram produced by
Astha Pokhrel (Poudel et al. manuscript in preparation).

184

APPENDIX I
C. DIFFICILE GENOME ENCODES FOR TWO PUTATIVE NUDIX ENZYMES

NuDiX box

Protein sequence alignment of NahA (YvcI) homologs in different species including C.
difficile strain 630. Multiple sequence alignment of YvcI homologs from B. subtilis
(BSU_34780), B. anthracis (BA_5385), B. halodurans (BH_3570), and C. difficile 630
(CD630_07050, CD630_12200, CD630_19840). Alignment was obtained with
BoxShade Server-EMBnet (with consensus lines). Numbers on the sides of the
sequences indicate the residue numbers in the corresponding proteins. Dark shading
(black) represents identical amino acid residues among sequences being aligned,
whereas light shading (grey) represents amino acid residues with matching polarity.
Protein accession numbers were retracted from Yang et al. 2020.
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APPENDIX J

Cell index

SIGNIFICANCE OF RSH GENE TO C. DIFFICILE TOXICITY

Time (hr:mm:sec)
+ Inducer

- Inducer

Significance of rsh in C. difficile virulence examined in real-time using iCeLLigenceTM
real-time cell analyzer (Agilent). The assays involved culturing 300 µL of MDCK cells
(ATCC) in Dulbecco’s modified eagle medium (DMEM) from VWR in the wells of the
16-well microtiter plates (with a gold microelectrode biosensor array) within a CO2
incubator. Post-incubation, the apparatus was taken into the anaerobic chamber where
MDCK cells were cultured in BHIS-Tm15 media with as_rsh expression vector carrying
RNAi strain (R20291 variant), and with or without 0.5 µg/mL ATc. C. difficile toxicity was
measured for a total of 72 hrs (5 mins interval for the first 24 hrs and 15 mins interval
for the remaining 48 hrs).
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APPENDIX K
MICROSCOPIC ANALYSIS OF R20291 AGGREGATION

+ 0.3 M NaCl

Portable rose cell chamber was injected with 1:100 dilution of ON starter culture of
R20291 cells in buffered BHIS medium diluted with 0.3 M NaCl. The chamber was
parafilmed and placed on the stage of a Nikon Ti-E inverted microscope. Live-cell DIC
microscopy was performed to image R20291 aggregation in the presence of 0.3 M NaCl
over a period of 48 hrs. Stage temperature was maintained at 36.5°C ± 0.5°C using a
Nevtek Air Stream stage warmer. Red arrows indicate chaining of replicating cells for
single-species biofilm formation. C. difficile produce biofilm in response to osmolarity
stress. Scale bar shown is 50 µm.
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+ 32 mM NEU5A

Portable rose cell chamber was injected with 1:100 dilution of ON starter culture of
R20291 cells in buffered BHIS medium diluted with 32 mM NEU5A. The chamber was
parafilmed and placed on the stage of a Nikon Ti-E inverted microscope. Live-cell DIC
microscopy was performed to image R20291 aggregation in the presence of 32 mM
NEU5A over a period of 48 hrs. Stage temperature was maintained at 36.5°C ± 0.5°C
using a Nevtek Air Stream stage warmer. Red arrow(s) indicate replicating cells making
contacts with one another to form extended, notably shorter chains for the initiation of
single-species biofilm formation than in 0.3 M NaCl. Magenta arrows indicate spores.
Unlike biofilm produced by R20291 in the presence of NaCl, the biofilm community of
R20291 in 32 mM NEU5A may be dominated by spores. Scale bar shown is 50 µm.
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APPENDIX L
PROPOSAL AND APPROVAL TO USE 32P
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